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Learn from yesterday, live for today, hope for tomorrow.  
The important thing is not to stop questioning. 
 

















































Chronic illness: the largest problem in modern health care 
Major advances in health care have led to the minimisation of infectious diseases in 
the 20th century. People tend to live longer and healthier lives, especially in the more 
developed countries. In the 21st century we have a new problem: worldwide around 
50% of the disease burden is caused by non-communicable diseases which frequently 
run a chronic or recurrent course (WHO 2008). In high income countries, this type of 
diseases accounts for even 85% of the burden of disease (WHO 2008). In the 
Netherlands, there are around 4.5 million adults with such a chronic illness and 
expectations are that these numbers will accumulate in the near future (Gommer et al. 
2010). Prevalent chronic illnesses are cardiovascular disease, diabetes and various 
mental disorders. Chronic illnesses are conditions that need "continuous adjustments 
by the affected person and interactions with the health care systems" (Improving 
chronic illness care & Group Health Research Institute 2012). The quality of care for 
chronic illnesses is often below the optimal standard. A review concluded that in the 
United States, adults with a chronic condition receive just over 50% of recommended 
care according to quality indicators (McGlynn et al. 2003). Care for chronic illnesses is 
complex and differs from care for acute diseases. While a reactive approach and one 
or more health care providers working independently is appropriate for acute diseases, 
chronic conditions need continuous and more proactive attention from both patients 
and providers. Common problems in care for patients with chronic conditions are the 
fragmented communication between health care providers involved, the absence of 
planned interactions and insufficient involvement of the patient in the care process 
(Wagner et al. 2001). 
 
Improving care for chronic illnesses: the chronic care model 
As a reaction to problems identified in chronic care, multifaceted strategies were 
developed to improve and integrate care. Those strategies were directed at improving 
knowledge of the provider or the patient about the chronic illness, or did address 
organisational changes such as adding a nurse specialist to a primary care practice 
team. A review about diabetes care (Renders et al. 2001) shed some light on the 
effectiveness of different strategies by indicating that strategies focussing on both the 




adding patient education or a nurse care manager improve patient outcomes. This 
evidence led researchers to conclude that a model was needed that included various 
forms of interventions that could be used as a theoretical framework: the chronic care 
model (Wagner et al. 2001).  
The chronic care model has six elements that should foster quality improvement: self-
management support, decision support, delivery system design, clinical information 
systems, health care organisation, and community resources  (see Table 1) 
(Bodenheimer et al. 2002).Effort directed at improvements on all of these levels, 
should result in enhanced self-management, efficient and high quality encounters 
between health care professionals and patients and improved patient outcomes 
(Bodenheimer et al. 2002). 
The chronic care model was widely adopted, particularly in managed care settings, to 
improve the quality of care for different chronic illnesses and numerous studies have 
been performed evaluating its effectiveness. A recent review suggests that the model 
leads to quality improvements in most types of chronic care (Coleman et al. 2009). 
Due to the variation in the elaboration of the chronic care model, it is difficult to 
summarise results of the studies. There is no consensus yet about which elements are 
crucial for the effectiveness of the chronic care model (Vrijhoef 2010). 
 
The use of the chronic care model in mental health care 
At the same time of the development of the chronic care model, researchers in the 
field of depression made similar movements towards a different organisation of 
primary care. They found that interventions consisting of providing feedback about 
depression scores of patients did not lead to better outcomes for patients with 
depression (Katon & Gonzales 1994). A collaborative care model was developed 
which had many similarities with the chronic care model of Wagner and colleagues 
(Katon et al. 2001; Katon et al. 2010). The collaborative care model as evaluated in the 
early trials encompassed patient education materials, the use of allied health 
professionals (care managers) who provided monitoring and follow-up and sometimes 
provided evidence based psychotherapy, the use of a monitoring tool (PHQ-9), a 






Table 1. Elements of the chronic care model  
1. Self management support 
• Emphasise the patient's central role. 
• Use effective self-management 
support strategies that include 
assessment, goal-setting, action 
planning, problem-solving, and follow-
up. 
• Organise resources to provide support.   
2. Decision support 
• Embed evidence-based guidelines into 
daily clinical practice. 
• Integrate specialist expertise and 
primary care. 
• Use proven provider education 
methods. 
• Share guidelines and information with 
patients. 
 
3. Delivery system design 
• Define roles and distribute tasks 
among team members. 
• Use planned interactions to support 
evidence-based care. 
• Provide clinical case management 
services for high risk patients. 
• Ensure regular follow-up. 
• Give care that patients understand 
and that fits their culture. 
 
4. Clinical information systems 
• Provide reminders for providers and 
patients.  
• Identify relevant patient 
subpopulations for proactive care. 
• Facilitate individual patient care 
planning. 
• Share information with providers and 
patients. 
• Monitor performance of team and 
system. 
5. Health care organisations 
• Visibly support improvement at all 
levels, starting with senior leaders. 
• Promote effective improvement 
strategies aimed at comprehensive 
system change. 
• Encourage open and systematic 
handling of problems. 
• Provide incentives based on quality of 
care. 
• Develop agreements for care 
coordination. 
6. Community resources and policies 
• Encourage patients to participate in 
effective programs. 
• Form partnerships with community 
organisations to support or develop 
programs. 
• Advocate for policies to improve care. 
 
 







supervised the caseload of care managers and the use of IT support to facilitate 
outcome monitoring and caseload supervision (Katon et al. 2010). 
The rationale behind these collaborative care programs was that patient outcomes 
could be improved by 1) organising primary and secondary care practice differently 
(i.e. adding a care manager and consultant psychiatrist to the primary care team), 2) 
making treatment more systematic and pro-active and 3) enhancing patient self-
management. Many randomised controlled trials were conducted and evidence 
accumulated rapidly that collaborative care was more effective than care as usual for 
primary care patients with depression in the United States (Gilbody et al. 2003). At 
present, over 60 trials considering collaborative care management for depression have 
been conducted, also in specific groups such as patients with depression and diabetes 
(Van der Feltz-Cornelis et al. 2010), teenagers or low-income patients (Gilbody et al. 
2006; Thota et al. 2012). Two meta-analyses considering publications until 2004 
(Gilbody et al. 2006) and from 2004 until 2009 (Thota et al. 2012) concluded that 
collaborative care leads to a significant improvement compared to care as usual for 
patients with depression, with a small to moderate clinical effect.  
 
Expanding the evidence of collaborative care for mental disorders 
Most research on collaborative care for mental disorders stems from managed health 
care settings in the United States. However, there are some important differences 
between primary care in the United States and in European countries which may 
influence the implementation and comparative effectiveness of collaborative care (de 
Jong et al. 2009). When we look at the primary care system in the Netherlands, for 
example, general practitioners receive a more extensive training in mental health care 
than general practitioners in the United States. Furthermore, accessibility of mental 
health services is generally lower for American citizens compared to Dutch citizens 
due to financial barriers (Russell 2010; Westert et al. 2010). Lastly, in the United States 
primary care practices usually employ a larger number of professionals than in the 
Netherlands (de Jong et al. 2009). For those reasons, it is important to test if 
collaborative care may also improve care in a system such as seen in the Netherlands. 
Furthermore, as research has focussed mainly on collaborative care for depression, 





Fortunately, research on collaborative care outside the United States and research 
focussing on mental disorders other than depression is emerging. A few collaborative 
care studies in primary care were conducted in the Netherlands. Van der Feltz-
Cornelis and colleagues (2006) examined a collaborative care model involving 
psychiatric consultation in primary care for patients with medically unexplained 
symptoms and compared this to care as usual. They found that the collaborative care 
model resulted in better patient outcomes than care as usual (Van der Feltz-Cornelis et 
al. 2006). In a study of Van Orden and colleagues (2009) a collaborative care program 
for patients with diverse mental health problems was compared to referral to specialist 
mental health care. This study indicated that collaborative care was as effective as 
specialist mental health care and that patients in the collaborative care group needed 
fewer treatment sessions, had shorter waiting times, a shorter duration of treatment 
and generated lower health care costs (van Orden et al. 2009). In a recent study about 
collaborative care for depression it was shown that significantly more patients with 
major depression receiving collaborative care responded adequately to treatment than 
patients receiving usual primary care (Huijbregts et al. 2012).  
 
Collaborative care for anxiety disorders 
Research about collaborative care for anxiety disorders is scarce and almost inexistent 
outside the United States. Collaborative care does seem to be a promising method to 
improve care for anxiety disorders (Rollman et al. 2005; Roy-Byrne et al. 2010; Roy-
Byrne et al. 2005a; Roy-Byrne et al. 2001). Anxiety disorders have many similarities 
with chronic somatic conditions and with depression (although there also differences 
such as potential avoidance behaviour that is typical for patients with anxiety 
disorders). First, most anxiety disorders are fairly chronic: around half of the patients 
with an anxiety disorder still suffers from the disorder 7 years later  (Rhebergen et al. 
2011). Second, as in care for chronic conditions, different (mental) health care 
professionals are involved in the treatment for anxiety disorders next to the general 
practitioner. Third, self-management, or learning to cope with anxiety is a very 
important aspect of reducing the impact of the anxiety on a patient's life (Oosterbaan 
& Verhaak 2012). Last, the quality of treatment for anxiety disorders is often below 




care model might improve care, by integrating mental health expertise into primary 
care, ensuring evidence-based treatment, systematic monitoring and follow-up and 
supporting self-management of the patient. 
 
Collaborative stepped care: the way forward for improving treatment of anxiety 
disorders? 
In health care systems where expenditures are increasing rapidly and where there is a 
shortage of personnel, the efficiency of health care delivery is increasingly important.  
During the 1990's "doing more with less" became a popular statement (Davison 
2000). In health care, this idea was translated into stepped care, which means that 
treatment is started with the least intrusive and expensive intervention possible and 
more intrusive and expensive interventions are only offered when the therapeutic goal 
is not reached (Davison 2000). Stepped care appeals to researchers and policy makers 
to create a more efficient mental health care system and was included in several 
clinical guidelines (Spijker et al. 2010; National Institute for Health and Clinical 
Excellence 2011). However, despite the evidence of the equal effectiveness of low-
intensity treatments compared to high-intensity treatments (van Boeijen et al. 2005; 
Cuijpers et al. 2010), evidence for the relative effectiveness or efficiency of a complete 
stepped care program for mental health problems compared to usual primary care is 
limited and equivocal (Bower & Gilbody 2005; Richards 2012). For example, one 
randomised controlled trial found a positive effect of a stepped care program to 
prevent anxiety and depression in elderly individuals compared to care as usual (van't 
Veer-Tazelaar et al. 2009). A subsequent randomised controlled trial found no 
difference in treatment response between a stepped care program and care as usual in 
elderly individuals with depressive symptoms (van der Weele et al. 2012). Both trials 
were conducted in Dutch primary care. A recent randomised controlled trial 
conducted in the Netherlands found no evidence of improved patient outcomes when 
comparing a comprehensive stepped care program to usual primary care in adults with 
depressive or anxious symptoms (Seekles et al. 2011). The authors argue that a low 
need for treatment, a high chronicity of anxiety and depression and a low adherence 
to the guided self-help step might have influenced the minimal effectiveness of the 





collaborative care program might increase the effectiveness (Seekles et al. 2011). 
Collaborative care may indeed provide the adequate framework to provide stepped 
care. In collaborative care, patient adherence is encouraged by the use of a treatment 
plan and regular follow-up by the care manager. Furthermore, the structured 
collaboration between the general practitioner, care manager and psychiatrist may 
prevent a patient from dropping out of treatment and may contribute to a more 
flexible approach to the stepped care program when the first steps do not seem to be 
the adequate treatment for a particular patient. However, a collaborative stepped care 
model for anxiety disorders in primary care has not yet been evaluated.  
 
 
Figure 1. The collaborative care model for anxiety disorders 











Panic disorder and generalised anxiety disorder as target conditions for 
collaborative stepped care  
Panic disorder and generalised anxiety disorder are two anxiety disorders for which 
the collaborative stepped care model may be suitable. Both disorders are prevalent in 
primary care and disabling, generally run a chronic course, produce high costs in 
health care and society and are often inadequately treated in primary care while 
evidence based, short duration treatments do exist. Social phobia is also a prevalent 
disorder in primary care, however, evidence based short duration protocols for 
treating this disorder in primary care are of limited availability (Seekles et al. 2012) 
 
Prevalence and course of panic disorder and generalised anxiety disorder 
Panic disorder is an anxiety disorder characterised by frequent unexpected panic 
attacks and a persistent fear of having these attacks (American Psychiatric Association 
2001). A panic attack is a sudden increase in anxiety, accompanied by disturbing 
physical symptoms such as palpitations, nausea and dizziness. Often, people who 
experience panic attacks start avoiding activities or public places from which escaping 
might be difficult, such as travelling by train or going to a busy mall (agoraphobia). 
The 12 month prevalence of panic disorders is estimated at 1.5% in the general 
population (de Graaf et al. 2010) and 4% in primary care (Roy-Byrne et al. 2005b). 
Generalised anxiety disorder is characterised by excessive and uncontrollable worrying 
(American Psychiatric Association 2001). People with a generalised anxiety disorder 
anticipate negative life events to happen such as the loss of a loved one or financial 
bankruptcy. They also experience physical symptoms of sustained anxiety such as 
difficulty concentrating, muscle tensions and sleep problems. The prevalence of 
generalised anxiety disorder in the general population is estimated at 1.7% (de Graaf et 
al. 2010) and at 5.8% in primary care attendees (Roy-Byrne et al. 2005b). The course of 
a panic disorder and generalised anxiety disorder is chronic or intermittent. Although 
the majority (57%) of adults having a panic disorder reaches remission within two 
years, many of them still experience subclinical anxiety symptoms or a recurrence of 
panic attacks (Batelaan et al. 2010). Generalised anxiety disorder tends to have a more 
chronic course than panic disorder, with only 23% of adults with generalised anxiety 





2011). In conclusion, panic disorder and generalised anxiety disorder are prevalent and 
chronic conditions that need continuous attention of both the patient and health care 
providers.  
 
Consequences of panic disorder and generalised anxiety disorder 
Anxiety disorders rank third on the list of leading causes of the burden of disease in 
the Netherlands, accounting for 4.4% of the total burden of disease in the 
Netherlands (Gommer et al. 2010). Both panic disorder and generalised anxiety 
disorder lead to considerable disability (Bruffaerts et al. 2012), reduced quality of life 
(Olatunji et al. 2007) and absence from or reduced productivity at work (de Graaf et al. 
2012). The negative impact of panic disorder and generalised anxiety disorder on 
quality of life and productivity is comparable to or even greater than seen in 
depression and chronic conditions such as arthritis or heart disease (Buist-Bouwman et 
al. 2006; Bruffaerts et al. 2012). Patients with panic disorder or generalised anxiety 
disorder generate considerable health care costs (Andlin-Sobocki & Wittchen 2005). 
For example, they visit the general practitioner more frequently (de Waal et al. 2008) 
and they make use of specialists more often than patients without a mental disorder 
(Roy-Byrne & Wagner 2004; Roy-Byrne et al. 2005b). Consequently, panic disorder 
and generalised anxiety disorder are not only a burden for patients and their relatives, 
but also for the health care system and the society as a whole. 
 
Evidence-based treatment for panic disorder and generalised anxiety disorder 
Several effective treatment methods for panic disorder and generalised anxiety 
disorder are available, of which the most well established are cognitive behavioural 
therapy and antidepressant medication (van Balkom et al. 1997; Landelijke Stuurgroep 
Multidisciplinaire Richtlijnontwikkeling in de GGZ 2010; National Institute for Health 
and Clinical Excellence 2011). Antidepressants are considered to sort their effect by 
altering the uptake of neurotransmitters in the brain. They must be taken daily, for at 
least six months (Bandelow et al. 2012). Cognitive behavioural therapy is a form of 
psychotherapy, teaching a patient with anxiety to recognise thoughts that lead to 
anxiety and how to modify these thoughts (Craske 2009). Another important element 




that people are encouraged to engage in situations they fear and they tend to avoid 
because of their anxiety. Most patients with panic disorder or generalised anxiety 
disorder receive care in primary care (Stein et al. 2011; Verhaak et al. 2012). However, 
while many patients with anxiety disorders receive some psychological support in 
primary care, a minority of patients receives adequate treatment with cognitive 
behavioural therapy or antidepressants in primary care (Young et al. 2001; Smolders et 
al. 2009; Stein et al. 2011). 
 
Problems in treatment for panic disorder and generalised anxiety disorder 
Several problems hamper the treatment of panic disorder and generalised anxiety 
disorder in current primary care. First of all, many patients with an anxiety disorder 
may not be recognised as having an anxiety disorder. Patients are hesitant to seek help 
for their anxiety problems for different reasons, such as wanting to solve the problem 
on their own (van Beljouw et al. 2010), avoidance of distress, or a low confidence in 
professional help (Prins et al. 2009). Patients often find it difficult to disclose their 
problems to a medical doctor (Kadam et al. 2001). When they do have an encounter 
with their general practitioner they tend to ask help for the physical symptoms 
accompanying the anxiety disorder, which makes it difficult for general practitioners 
to recognise and discuss the anxiety disorder (Tylee & Walters 2007). A second 
problem in primary care treatment for panic and generalised anxiety disorder, is that 
most patients are treated with antidepressants (Smolders et al. 2009; Stein et al. 2011), 
while the majority of patients prefers psychological treatment (Prins et al. 2009). This 
may have to do with the limited time available for general practitioners and the limited 
training they have had in providing cognitive behavioural therapy (Van Marwijk et al. 
2004). Furthermore, patients are not always willing to be referred or to seek treatment 
from a mental health professional (Prins et al. 2009) and sometimes there are financial 
or practical barriers such as insurance coverage or waitlists that limit access to mental 
health care (Grembowski et al. 2002; Koopmans & Verhaak 2012). On the other hand, 
lengthy treatments in specialised mental health care are not always wanted or needed 
to treat patients effectively (van Boeijen et al. 2005). Hence, an increase in the 
provision of short duration, effective psychological treatments provided in the 





professionals in primary care use short duration evidence based therapies, such as 
guided self-help (Zwaanswijk & Verhaak 2009). A different problem in primary care 
concerns the continuity of care. Because of the fragmented contacts between health 
care providers, information about the (ongoing) treatment of a patient is often 
inadequately transferred or shared (Muntingh et al. 2012). Furthermore, structural 
monitoring and follow-up to prevent a relapse of the disorder when treatment has 
been successfully concluded is uncommon in primary care (Muntingh et al. 2012). 
 
Collaborative stepped care for panic disorder and generalised anxiety disorder: 
the solution to all problems encountered in primary care? 
A collaborative stepped care model may be an effective and efficient method to tackle 
the problems mentioned above. In the collaborative stepped care model, a care 
manager, general practitioner and psychiatrist work together to provide high quality 
treatment in primary care, while avoiding unnecessary prescription of medication or 
referral to specialty mental health care. The care manager provides stepped care, short 
duration evidence based treatment in the primary care practice and ensures continuity 
of care by structurally monitoring the patient’s symptoms. The general practitioner 
may use anxiety scales to assist in detecting and diagnosing anxiety disorders and 
makes use of an algorithm to effectively prescribe antidepressant medication. The 
psychiatrist is available to advise the care manager and general practitioner and adjust 
the treatment plan when necessary. The professionals share information about the 
ongoing treatment and the patient is actively involved in treatment to promote self-
management and adherence to treatment. However, the effectiveness of collaborative 
stepped care for anxiety disorders has not been thoroughly studied yet. Therefore, the 
primary aim of this thesis is to evaluate the effectiveness of collaborative stepped care 
for panic disorder and generalised anxiety disorder in primary care. Furthermore, the 
costs of collaborative stepped care relative to its effectiveness is examined. Last, 
because correct recognition and diagnosis of the anxiety disorder is a prerequisite for 
the provision of collaborative stepped care, manners to improve recognition and 





Outline of this thesis 
 
Chapter 2 aims to answer the question whether collaborative care for anxiety 
disorders in primary care is an effective intervention. The literature was systematically 
searched for randomised controlled trials reporting about the effectiveness of 
collaborative care for adults with anxiety disorders in primary care in reducing anxiety 
symptoms. Five randomised controlled trials were included and the results of these 
studies are statistically summarised.  
 
Chapter 3 is comprised of two articles addressing the question whether collaborative 
stepped care for panic disorder and generalised anxiety disorder is more effective in 
reducing anxiety symptoms than care as usual. In the first article, the methods and 
design of a randomised controlled trial to evaluate this question are described. The 
design was a cluster randomised controlled trial in which half of the participating 
primary care professionals were trained to provide collaborative stepped care and half 
of the primary care professionals would provide care as usual. The second article 
describes the results of this cluster randomised controlled trial in which 43 primary 
care practices with 31 mental health professionals participated and 180 patients with 
panic disorder or generalised anxiety disorder were recruited. The reduction in anxiety 
symptoms of patients in the collaborative stepped care group (114 patients) and the 
care as usual group (66 patients) over the course of one year is compared. 
Furthermore, the actual care delivered to patients in both groups is described to 
provide insight into the working and the feasibility of the collaborative stepped care 
model.  
 
Chapter 4 evaluates whether collaborative stepped care is cost-effective compared to 
care as usual. The medical costs of both interventions are calculated based on contacts 
with health care providers and medication costs. Subsequently these costs are related 
to the quality of life gained in both groups. A second analysis also takes costs into 
account that are related to the productivity of participants (i.e. sickness absence or 






Chapter 5 describes two studies that examine how recognition and assessment of 
anxiety disorders may be improved using a questionnaire. The first study investigates 
the added value of the Patient Health Questionnaire (PHQ) in detecting anxiety 
disorders in 170 primary care patients at risk for anxiety disorders and in 141 patients 
identified by their general practitioner as having a probable anxiety disorder. Patients 
were recruited within the cluster randomised controlled trial described in chapter 3. A 
second study assesses the ability of the Beck Anxiety Inventory (BAI) to measure the 
severity of anxiety symptoms in primary care patients with different anxiety disorders. 
Patients were recruited in a large cohort study (the Netherlands Study of Depression 
and Anxiety, NESDA). The mean scores of 1601 primary care patients with panic 
disorder with or without agoraphobia, generalised anxiety disorder, social phobia or 
agoraphobia and of patients with no disorder, a depressive disorder or multiple 
disorders are compared.  
 
Finally, in chapter 6 the main findings of this thesis and implications for research and 
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Background The effectiveness of collaborative care interventions targeting patient, 
provider and system changes have not been statistically summarised for patients with 
anxiety disorders.  
Data sources A comprehensive literature search for published articles was performed 
using PubMed, Psycinfo, Embase, Cinahl and Cochrane library.  
Study eligibility criteria Randomised controlled trials examining the effects of 
collaborative care for adult primary care patients with an anxiety disorder, compared 
to care as usual or another intervention were included.  
Study appraisal and synthesis methods The selection of studies and risk of bias 
assessment were performed by two independent reviewers. The standardised mean 
difference on an anxiety scale closest to twelve months follow up was calculated and 
summarised using a random effects meta-analysis. 
Results Of the 2556 studies found, five studies were included that all compared 
collaborative care to care as usual. The studies included a total of 1931 participants 
and varied in risk of bias. Collaborative care was superior to care as usual (ES = 0.27 
95% CI 0.01-0.67). For patients with panic disorder (four studies), the effect size was 
moderate (ES = 0.44, 95% CI 0.30-0.59).  
Conclusion Collaborative care seems to be a promising strategy for improving 
primary care for anxiety disorders. However, the number of studies is small and 
research almost exclusively originates from the United States.  





1.1 Background  
Anxiety disorders constitute the most prevalent category of psychiatric disorders 
(Kessler et al. 2010). Anxiety disorders have a negative impact on quality of life and are 
associated with significant health care and productivity costs (Lepine 2002). Most 
anxiety disorders run a chronic or intermittent course (Yonkers et al. 2003), thereby 
causing sustained disability. Adults with an anxiety disorder mainly receive care in 
primary care (Young et al. 2001; Wang et al. 2005; Kessler et al. 2005). In many 
countries however, the quality of care for adults with anxiety disorders leaves room 
for improvement (Young et al. 2001; Fernandez et al. 2007). Although clinical 
guidelines recommend cognitive behavioural therapy or antidepressant medication as 
the treatment of choice in primary care, these evidence based treatments are not often 
adequately applied in primary care (Stein et al. 2011). Several barriers exist in providing 
evidence based care for anxiety disorders in primary care, which may be related to 
patient characteristics, provider characteristics or the organisational context of primary 
care (Nutting et al. 2002; Roy-Byrne et al. 2005a; Smolders et al. 2010). Diagnosing an 
anxiety disorder in primary care is difficult, because anxiety disorders are often 
accompanied by physical symptoms, social problems or depressive symptoms (Kessler 
et al. 2005; Kroenke et al. 2007). Moreover, patients are often hesitant to seek help for 
their anxiety problems (Prins et al. 2008; van Beljouw et al. 2010). Once a diagnosis has 
been made, there are other problems that form a barrier for effective treatment. On 
the level of the patient, low adherence to pharmacotherapy or psychotherapy is a 
frequently seen problem (van Geffen et al. 2009; Taylor et al. 2012). For primary care 
physicians it is often difficult to treat anxiety disorders as they may not have the 
necessary time and skills to provide cognitive behavioural therapy (Van Marwijk, 2004). 
The health care system contains barriers such as limited accessibility of mental 
health services (Grembowski et al. 2002; Richards 2012) and an organisation of care 
based on reactive interactions with patients, while this may not be the right approach 
for patients with chronic or fluctuating conditions such as anxiety disorders 
(Wagner et al. 2001). Historically, efforts for improving the quality of care have been 





alone does not seem to lead to a significant improvement of the quality of care 
(Gilbody et al. 2003). Therefore, multifaceted interventions that focus on patient, 
provider and organisation of care have been proposed as the most promising strategy 
to improve primary mental health care (Gilbody et al. 2003; Heideman et al. 2005). 
Collaborative or integrative care models are such multifaceted interventions aimed at 
improving the quality and organisation of primary mental health care. These models 
bring mental health expertise into primary care by introducing new members into the 
primary care team. Typically, this new member is a "care manager" with a background 
in mental health, who coordinates care, provides evidence based interventions and 
actively monitors the patient's symptoms (Katon et al. 2001). The care manager works 
in close collaboration with the primary care physician and both providers have access 
to the tailored advice of a psychiatrist. Although collaborative care models vary in the 
professionals involved, type of interventions used, the intensity of treatment and 
follow-up, a few essential elements have been described. These elements consist of 
cooperation between the primary care physician and at least one other professional, 
provision of evidence based treatment and active monitoring of symptoms and 
follow-up (Gilbody, Bower, Fletcher, Richards, and Sutton, 2006; Katon et al. 1995; 
van Steenbergen-Weijenburg et al. 2010). Interventions or organisational models 
similar to collaborative care are sometimes referred to as integrated care, enhanced 
care or care management.  
The core feature of collaborative care is the collaboration of the primary care 
physician with a mental health care provider. In some collaborative care models, the 
primary care physician is only supported by a psychiatrist. In other collaborative care 
models, a nurse care manager is introduced in the primary care team who is supervised 
by a psychiatrist. The addition of a care manager to the primary care team is an 
interesting opportunity, because a (nurse) care manager is more accessible than a 
psychiatrist and can be trained to provide psychological interventions in the primary 
care setting. However, the organisation of care becomes increasingly difficult if more 
professionals are involved and the direct involvement of a psychiatrist might also have 
an advantage. Therefore, it may be interesting to know if the effects of collaborative 
care models including a care manager and a consultant psychiatrist differ from the 
effects of collaborative care models that include a consultant psychiatrist alone. 
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1.2 Rationale  
Evidence of the effectiveness of collaborative care in the treatment of depression is 
well established and was reviewed thoroughly in two meta-analyses including 37 
studies (Gilbody et al. 2006; Bower et al. 2006), demonstrating an overall benefit of 
collaborative care interventions over care as usual, with a small but robust clinical 
effect (d=0.25). A recent meta-analysis expanded this evidence reviewing 32 studies 
published during or after 2004, with a pooled effect size of 0.34 (Thota et al. 2012). 
Although anxiety disorders are just as prevalent and disabling as depression and may 
even be more chronic conditions (Rhebergen et al. 2011), studies about collaborative 
care for anxiety disorders have been scarce (Smolders et al. 2008). In a review of 
Smolders and colleagues (2008) only 3 collaborative care studies were included and 
results were not statistically summarised. Recent reviews about psychotherapies in 
primary care did exclude studies about collaborative care for anxiety disorders (Cape et 
al. 2010; Wampold et al. 2011; Seekles et al. 2012). Therefore, a systematic review and 
meta-analysis is needed to summarise results from (cluster) randomised controlled 
trials about the effectiveness of collaborative care for anxiety disorders in adult 
primary care patients. Furthermore, the effects of components of collaborative care 




To examine to what extent collaborative care interventions reduce anxiety symptoms 
in primary care patients with an anxiety disorder versus a control condition or another 
active intervention, we performed a systematic review and meta-analysis of 
randomised, controlled trials. In addition, we evaluated the effects for specific anxiety 













2.1 Eligibility criteria 
In this systematic review, randomised controlled trials (RCTs) were included that 
evaluated collaborative care compared to care as usual or another active intervention 
in adult primary care patients with an anxiety disorder and that reported outcomes on 
a standardised scale for anxiety severity. 
 
2.1.1 Design 
We included RCTs that randomised between patients (individual randomisation) or 
between primary care practices (cluster randomisation). 
 
2.1.2 Participants 
Studies had to include adult (>18 years) subjects recruited in a primary care setting 
with an anxiety disorder as established with a valid diagnostic interview, according to 
research diagnostic criteria or with a cut-off score on a validated scale. Comorbid 
medical or psychiatric conditions were allowed, as long as the intervention focused on 
the anxiety disorder. 
 
2.1.3 Intervention 
Collaborative care interventions were defined by the application of at least two out of 
the three following criteria (Von Korff et al. 1997; Gilbody et al. 2006; Bower et al. 
2006; van Steenbergen-Weijenburg et al. 2010):  
1. The primary care physician is supported by at least one other professional with a 
different field of expertise (e.g. care manager, consultant psychiatrist) and they work 
together in providing care for the patient. 
2. Evidence-based treatment is provided. 
3. Process and outcome of treatment is being monitored. 
Studies evaluating the provision of services by an on-site mental health professional 
were excluded, unless reference was made to enhanced collaboration between the 
primary care physician and the mental health professional.  
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2.1.4 Comparison intervention 
The collaborative care intervention could be compared to care as usual, a waitlist 
condition or another active intervention.  
 
2.1.5 Outcomes 
Studies that reported outcomes on a validated anxiety scale or interview were 
included. Standardised scales or interviews could measure general anxiety (across 
anxiety disorders) or measure a specific type of anxiety (e.g. panic disorder severity).  
 
2.2 Information sources and search 
We searched several medical and psychological databases from inception to May 14th 
2012 without language restriction (Psycinfo, PubMed (Medline), Embase, The 
Cochrane Central Register of Controlled Trials and Cinahl). The highly sensitive 
search was performed by one author (AM) and an experienced librarian, using terms 
related to anxiety, primary care and randomised controlled trials. Both MeSH terms 
and free text words were used. See Box 1 for the full search strategy as performed in 
PubMed. The search in PubMed was adapted for use in the other databases. The 
reference lists of selected randomised controlled trials (RCTs) and reviews were 
checked for potentially relevant titles. The search was limited to published studies. 
 
2.3 Study selection 
Titles and abstracts of retrieved studies were screened independently by two reviewers 
(AM/CFC) using a list of inclusion criteria. If a study appeared eligible (or if eligibility 
was doubtful), the full text of an article was retrieved. All full text articles were 
assessed for eligibility by two independent reviewers (AM and AvB/HvM/CFC). 
Disagreement was resolved by consensus or eventually by a third reviewer.  
 
2.4 Data collection process 
The outcome data were extracted by two reviewers independently (AM and CFC). 
Other relevant characteristics of studies were extracted by one author (AM) using a 






Box 1: PubMed Search History 
Search  Most Recent Queries  Time  Result  
#12  Search #9 OR #10 OR #11 08:53:48 955  
#11  Search #7 Limits: Systematic Reviews 08:49:18 196  
#10  Search #7 Limits: Clinical Trial, Meta-Analysis, Practice Guideline, Randomized 
Controlled Trial 
08:49:04 727  
#9  Search (#7 AND #8) NOT medline[sb] 08:48:29 111  
#8  Search randomized controlled trial [pt] OR controlled clinical trial [pt] OR clinical trial 
[pt] OR comparative study [pt] OR evaluation studies [pt] OR "randomized controlled 
trials as topic"[MeSH Terms] OR "random allocation"[MeSH Terms] OR "double-blind 
method"[MeSH Terms] OR "single-blind method"[MeSH Terms] OR "clinical trials as 
topic"[MeSH Terms] OR "placebos"[MeSH Terms] OR "research design"[MeSH 
Terms:noexp] OR "follow-up studies"[MeSH Terms] OR "prospective studies"[MeSH 
Terms] OR "cross-over studies"[MeSH Terms] OR "drug therapy"[Subheading] OR 
"clinical trial" [tw] OR "latin square" [tw] OR placebo* [tw] OR random* [tw] OR 
control[tw] OR controll*[tw] OR prospectiv* [tw] OR volunteer* [tw] OR trial[tiab] OR 
groups[tiab] OR ((singl* [tw] OR doubl* [tw] OR trebl* [tw] OR tripl* [tw]) AND (mask* 
[tw] OR blind* [tw])) 
08:48:11 6213954  
#7  Search #3 AND #6 08:47:36 4922  
#6  Search #4 OR #5 08:47:24 185546  
#5  Search "Primary Health Care"[Mesh] OR "primary care"[tiab] 08:47:11 91683  
#4  Search ("Family Practice"[Mesh] OR "Physicians, Family"[Mesh]) OR "family 
practice"[tiab] OR "general practice"[tiab] OR"family practices"[tiab] OR "general 
practices"[tiab] OR "family practitioner "[tiab] OR "general practitioner"[tiab] OR 
"family practitioners "[tiab] OR "general practitioners"[tiab] OR family medicine[tiab] 
OR "Physician Assistants"[Mesh] OR "Physician Assistant"[tiab] OR "Physician 
Assistants"[tiab] OR "Nurse Practitioners"[Mesh] OR "Nurse Practitioner"[tiab] OR 
"Nurse Practitioners"[tiab] 
08:46:55 115493  
#3  Search #1 OR #2 08:46:08 149816  
#2  Search Anxiety[tiab] OR Anxieties[tiab] OR anxious[tiab] OR Nervousness[tiab] OR 
Agoraphobia*[tiab] OR Obsessive-Compulsive[tiab] OR Panic*[tiab] OR Phobia*[tiab] 
OR Phobic*[tiab] OR Claustrophobi*[tiab] OR (Stress[tiab] AND trauma*[tiab]) OR 
(Stress[tiab] AND posttrauma*[tiab]) 
08:45:59 118672  
#1  Search "Anxiety"[Mesh:noexp] OR "Anxiety Disorders"[Mesh] 08:45:16 92083  
http://www.ncbi.nlm.nih.gov/pubmed/advanced - # 
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2.5 Data items 
We extracted the mean and standard deviation of the intervention group and control 
group on anxiety scales at baseline and follow-up. Outcomes for anxiety disorders in 
general  as well as outcomes for specific anxiety disorders were extracted. For studies 
using more than one validated anxiety scale as an outcome measure, we chose the 
scale that was most frequently reported in the other studies. If the mean and standard 
deviation were not reported, we searched for other data to calculate the effect size, 
such as a difference score with a standard deviation or confidence limits and p-value. 
Furthermore, data relevant for the interpretation of the findings were collected: design 
of the study, recruitment method, procedure used to diagnose the anxiety disorder, 
setting, sample size, details of the collaborative care intervention and the comparison 
intervention, anxiety scale used, follow-up measurements and outcomes. Details of the 
collaborative care intervention included the professionals involved (primary care 
physician, psychiatrist, care manager), interventions used, the number of sessions or 
consultations, the use of educational materials, the provision of monitoring and 
follow-up and the form of communication between professionals. For the comparison 
interventions we collected data about medication use and the use of mental health care 
services. Where published protocols of the studies included were available, they were 
used to supplement data about intervention details. 
 
2.6 Risk of bias in individual studies 
The risk of bias of each included study was assessed using a standard form based on 
Cochrane criteria (Higgins et al. 2011) by two reviewers (AM and AvB/HvM) 
independently. The form systematically enquired about possible sources of bias in 
randomised controlled trial, such as the adequacy of the randomisation procedure, 
allocation concealment, handling of missing data and selective reporting. 
Disagreement between reviewers about assessment ratings were resolved by consensus 
or a third reviewer (CFC). 
 
2.7 Summary measures and synthesis of results 
We statistically summarised the effectiveness of collaborative care interventions versus 





the software package Comprehensive Meta Analysis version 2.0 (Borenstein et al. 
2005). We calculated a standardised effect size (Cohens D (Cohen 1988)) from 
reported differences in means on a continuous anxiety scale between interventions at 
12 months follow-up to using the computer program Comprehensive Meta-Analysis. 
Preferably, means and standard deviations were used to calculate the effect size d. 
However, when these data were not available, other reported data such as the 
difference in means and p-value were used or the standard deviation was calculated 
from the confidence interval as described in the Cochrane Handbook (Higgins & 
Deeks 2011). We summarised the standardised effect sizes using the random effects 
model, because we made the assumption that not all collaborative care interventions 
are inherently the same, resulting in a true variation in effect size between studies 
(Borenstein et al. 2009). High resolution plots were created to present the results. 
 
2.8 Assessment of heterogeneity and risk of bias across studies 
To assess the heterogeneity among studies we calculated the I2 statistic which reflects 
the proportion of total variation across studies that is attributable to heterogeneity 
rather than chance. An I2 of 0% means that there is no observed heterogeneity, while 
an I2 of 25%, 50% and 75% may be interpreted as low, medium and high 
heterogeneity respectively (Higgins et al. 2003). Funnel plots were created and Duval 
and Tweedie's trim and fill method was used to examine the possibility of publication 
bias (Duval & Tweedie 2000). This method gives an estimate of the effect size after 
correcting for possible publication bias.   
 
2.9 Additional analyses  
A pre-envisioned subgroup analysis was performed to assess the effectiveness of 
collaborative care for patients with a specific anxiety disorder. In this analysis, a 
disorder-specific outcome measure (when available) was used to calculate the effect 
size. Furthermore, we assessed the influence of the inclusion of a care manager in the 
collaborative care model on the effect size of studies. Therefore, we performed a 
meta-regression in which the effects of collaborative care interventions with both a 
care manager and a consultant psychiatrist were compared to those of collaborative 
care interventions with only a consultant psychiatrist. 





3.1 Study selection 
The literature search resulted in a total of 4035 retrieved citations. In addition, we 
examined references of 9 reviews and all the references of the retrieved studies, which 
resulted in 40 extra possibly relevant titles. After removal of duplicates, 2556 abstracts 
were available (see Figure 1). For 18 studies the full text paper was retrieved and 
examined for inclusion. After the exclusion of 13 studies (9 no collaborative care; 3 no 
separate outcome reported for patients with anxiety disorders; 1 report of other study) 
there were 5 studies that met all the inclusion criteria. 
 
3.2 Characteristics of included studies 
Five studies involving 1931 subjects (996 in the collaborative care condition, 935 in 
the control condition) were included in the review and the subsequent meta-analysis. 
Table 1 shows an overview of characteristics of the included studies.  
 
3.2.1 Design 
Four studies were individually randomised controlled trials (Rollman et al. 2005; Roy-
Byrne et al. 2010; Roy-Byrne et al. 2005b, Roy-Byrne et al. 2001); one study used cluster 
randomisation on the level of primary care practices (König et al. 2009). The number 
of participants in each study ranged from 115 to 1004. Four of the studies were 
conducted in the United States (Rollman et al.2005; Roy-Byrne et al. 2010; 2005b; 
2001); one study took place in Germany (König et al. 2009). 
 
3.2.2 Participants  
Two studies included only patients with panic disorder (Roy-Byrne et al. 2005b; 2001). 
One study (Rollman et al. 2005) included patients with panic disorder and/or 
generalised anxiety disorder and one study (Roy-Byrne et al. 2010) included patients 
with panic disorder generalised anxiety disorder, social phobia and posttraumatic 
stress disorder. These four studies used a structured interview to classify the anxiety 
disorder (CIDI, PRIME-MD). One study (König et al.  2009) focused on anxiety in 





studies used screening to recruit participants (Rollman et al. 2005; König et al. 2009), 
one study used referral of primary care physicians as recruitment method (Roy-Byrne 
et al. 2010) and two studies used both methods to recruit participants (Roy-Byrne et al. 
2005b; 2001). 
 
3.2.3 Collaborative care interventions 
The elaboration of the collaborative care model varied considerably between studies. 
In all studies, a primary care physician and a psychiatrist were involved, while in three 
studies a care manager was introduced as well (Rollman et al. 2005; Roy-Byrne et al. 
2010; 2005b). The care managers had different backgrounds, being master-level or 
doctoral-level behavioural health specialists (Roy-Byrne et al. 2005b), non-behavioural 
health specialists (Rollman et al. 2005) or clinical anxiety specialists (variety of 
registered nurses, social workers and psychologists, Roy-Byrne et al. 2010). All studies 
used evidence-based interventions, consisting of antidepressant medication and/or 
cognitive behavioural therapy. In one study (Roy-Byrne et al. 2001) the intervention 
consisted of psycho-education and medication management, in the other studies a 
form of CBT (guided self-help or face to face) was also offered. In four studies 
(Rollman et al. 2005; Roy-Byrne et al. 2010; 2005b; 2001) systematic follow-up by the 
care manager or the consultant psychiatrist was part of the collaborative care 
intervention and in two studies anxiety symptoms were monitored by the care 
manager with an anxiety scale (Rollman et al. 2005; Roy-Byrne et al. 2010). Studies 
varied in what they reported about actual care that was delivered (see Table 2). All but 
one study (König et al. 2009) reported medication use and the number of contacts 
patients had with the care manager or psychiatrist during follow-up. Two studies 
(König et al. 2009; Rollman et al. 2005) reported the percentage of patients that had 
contact with a mental health professional (other than the care manager/psychiatrist). 
The study of König and colleagues (2009) did not report how many patients received 
the intended intervention (CBT by the primary care physician).  
 
3.2.4 Comparison interventions 
All studies compared the collaborative care intervention to care as usual by the 
primary care physician and did provide information about the content of usual care 
Effectiveness of collaborative care: systematic review 
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(Table 2). Pharmacotherapy was the most frequently reported treatment method in 
usual care. See Table 2 for an overview of the percentage of patients receiving 
pharmacotherapy, appropriate pharmacotherapy, counselling, CBT and (specialised) 
mental health care as reported in the included studies.  
 
 
Figure 1. Prisma flowchart. From: Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA 
Group (2009). Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The 




































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Table 2. Care received in the collaborative care and care as usual conditions 
 
*Highest % of patients that have received a form of care at any follow-up measurement
 
a 
Appropriate type of medication 
b 
Adequate type, dose and duration of medication 
c
 Any antipanic pharmacotherapy 
d
 3 or more sessions counselling plus at least 4 of 7 CBT techniques 
e
 SSRI/SNRI pharmacotherapy 
f
 3 or more telephone contacts with CM 
g
 3 or more telephone contacts with CM about CBT workbook 
h
 Any psychotropic medication 
I
 Appropriate type, dose and duration 
j







































NA NA NA NA NA 25% 
Roy-Byrne 
























NA 18% 26% 
König 
 et al. 2009 
NA NA NA NA NA NA NA NA 33% 33% 
Roy-Byrne 


















3.2.5 Outcome measures 
All studies included a continuous outcome to measure general anxiety, although 
different scales were used. Three studies (Roy-Byrne et al. 2010; 2005b; 2001) used the 
Anxiety Sensitivity Index as an outcome measure (ASI (Reiss et al. 1986)), one study 
(Rollman et al. 2005) used a structured interview guide for the Hamilton Anxiety 
Rating Scale (SIGH-A (Shear et al. 2001)), and one study (König et al. 2009) used the 
Beck Anxiety Inventory (BAI (Beck et al. 1988)). Besides a general anxiety measure, 
four studies reported separately about panic disorder outcomes (Rollman et al. 2005; 
Roy-Byrne et al. 2010; 2005b; 2001). Two of these studies reported panic outcomes on 
a panic disorder specific scale, the Panic Disorder Severity Scale (PDSS, (Shear et al. 
1997), Rollman et al. 2005; Roy-Byrne et al. 2001). However, Roy-Byrne and colleagues 
(2001) did only report a non-significant outcome on the PDSS without data necessary 
to calculate the effect size. Roy-Byrne and colleagues (2010) reported PDSS outcomes 
for patients with panic disorder in a separate paper (Craske et al. 2011), where also 
disorder specific outcomes for social phobia, generalised anxiety disorder and 
posttraumatic stress disorder were reported. Rollman and colleagues (2005) reported 
separate outcomes for patients with generalised anxiety disorder. The length of 
follow-up varied from 9 months (König et al. 2009) to 18 months (Roy-Byrne et al. 
2010). König and colleagues (2009) collected the outcome measures by mail (self-
report), while in the other four studies a (blinded) research assistant administered the 
outcome measures by telephone. 
 
3.3 Risk of bias 
Table 3 shows that the risk of bias varied between studies. The most prevalent source 
of bias was the inability to blind patients and professionals for treatment allocation, as 
is common in psychotherapy research (Van der Feltz-Cornelis & Ader 2000). 
Furthermore, one trial (Roy-Byrne et al. 2001) did not provide the statistics of an 
insignificant result on the panic outcome. Of three studies, a published study protocol 
was retrieved: Roy-Byrne and colleagues (2005b) (Craske et al. 2002)), Rollman and 
colleagues (2005) (Rollman et al. 2003) and Roy-Byrne and colleagues (2010) (Sullivan 






Table 3. Risk of bias of included studies 
 Roy-Byrne  
et al. 2001 
Roy-Byrne  
et al. 2005b 
Rollman  
et al. 2005 
König  
et al. 2009 
Roy-Byrne  




Unclear risk Unclear risk Low risk Low risk Low risk 
Allocation 
concealed? 
Unclear risk Low risk Low risk Low risk Low risk 
Patients blinded? Unclear risk High risk High risk Low risk Unclear risk 
Professionals 
blinded? 








Unclear risk Low risk  Low risk Low risk Low risk  
Free of selective 
reporting? 
Unclear risk Unclear risk Unclear risk Unclear risk Low risk 
Free of  
other bias 
Unclear risk Low risk Low risk Low risk Low risk 
Conclusion Unclear risk Unclear risk Low risk Low risk Low risk 
 
3.4 Results of individual studies 
The results of the individual studies at follow-up closest to 12 months are reported in 
Table 1. Four studies reported a larger effect of the collaborative care intervention 
compared to care as usual (Rollman et al. 2005; Roy-Byrne et al. 2010; 2005b; 2001). 
Conversely, König and colleagues (2009) could not demonstrate a higher effectiveness 
of the intervention compared to care as usual. The effect sizes varied from -0.13 
(König et al. 2009) to 0.44 (Roy-Byrne et al. 2005b). The effects of collaborative care 
compared to care as usual for patients with an anxiety disorder were statistically 
summarised using meta-analysis (Figure 2). The pooled effect size of all five studies 




was 0.27 (95% CI 0.07 to 0.48, p=0.009). This means that, combining the existing 
studies about collaborative care for anxiety disorders compared to care as usual, 
collaborative care leads to a significantly larger reduction in anxiety symptoms, with a 
small clinical relevance after 12 months. The Q-value was 15.08 (df=4, p=0.005) 
indicating significant dispersion across studies. The I2 was 73.5%, which indicates that 
a high proportion of the total variation may be attributed to true heterogeneity 
between studies. Retrospective exploration of the heterogeneity revealed that the 
study of König and colleagues (2009) differed markedly from the other four studies in 
design, setting, intervention and outcome. When we excluded this study from the 
meta-analysis the combined effect of the four studies was 0.35 (95% CI 0.30 to 0.47), 
with a Q-value of 0.72 (df=3, p=0.87) and a I2 of 0%. This means that in this analysis, 
excluding the study of König and colleagues (2009), the effect size was moderate and 
heterogeneity between studies was low. 
 











Roy-Byrne et al. 2001 0.398 0.188 0.029 0.767 2.113 0.035 
Roy-Byrne et al. 2005 0.438 0.133 0.177 0.698 3.294 0.001 
Rollman et al. 2005 0.386 0.149 0.093 0.679 2.579 0.010 
König et al. 2009 -0.129 0.117 -0.358 0.099 -1.108 0.268 
Roy-Byrne et al. 2010 0.324 0.064 0.199 0.449 5.100 0.000 
Total 0.272 0.105 0.067 0.478 2.596 0.009 
Figure 2. Meta-analysis for the effect of collaborative care versus care as usual for patients with an 
anxiety disorder at 12 months follow-up 
 
3.5 Additional analysis: disorder specific impact of collaborative care 
A pre-envisioned subgroup analysis was performed for patients with panic disorder. 
Outcomes on the Panic Disorder Severity Scale (PDSS) were used when reported. For 





outcome measure in the meta-analysis. Because Roy-Byrne and colleagues (2001) did 
only report that they found an insignificant result on the PDSS, but did not report the 
statistics necessary for calculating the effect size, we used the ASI score as well. 
However, this may lead to an overestimation of the effect, because the ASI did show 
significant results, while the PDSS did not. Figure 3 shows that the combined effect 
size of the four studies comparing collaborative care to care as usual in patients with 
panic disorder was 0.44 (95% CI 0.30 to 0.59, p<0.001), which may be interpreted as a 
moderate effect size.  
 











Roy-Byrne et al. 2001 0.398 0.188 0.029 0.767 2.113 0.035 
Roy-Byrne et al. 2005 0.438 0.133 0.177 0.698 3.294 0.001 
Rollman et al. 2005 0.573 0.199 0.184 0.962 2.885 0.004 
Roy-Byrne et al. 2010 0.417 0.125 0.172 0.662 3.336 0.001 
Total 0.443 0.076 0.295 0.592 5.851 0.000 
Figure 3. Subgroup-analysis of the effect of collaborative care versus care as usual for patients with 
panic disorder at 12 months follow-up 
 
A meta-analysis on the effects of collaborative care for anxiety disorders other than 
panic disorder was not performed, because only two studies reported separate 
outcomes for anxiety disorders other than panic disorder (Rollman et al. 2005; Roy-
Byrne et al. 2010). In the study of Rollman and colleagues (2005) no significant effect 
was found for patients with generalised anxiety disorder only. Roy-Byrne and 
colleagues (2010) did report the outcomes of patients with panic disorder, generalised 
anxiety disorder, social phobia and posttraumatic stress disorder (PTSD). The authors 
reported significant effects on the ASI at 12 months for all anxiety disorders except 
for PTSD. In a subsequent report (Craske et al. 2011), disorder specific data on 
specific scales were reported, with similar results. See Table 1 for a summary of the 
data. 




3.6 Additional analysis: impact of the inclusion of a care manager  
A meta-regression (Figure 4) was performed to assess the impact of the inclusion of a 
care manager in the collaborative care model on the effect size. Two studies (Roy-
Byrne et al. 2001; König et al. 2009) did only include a psychiatrist and a primary care 
physician and three studies did include a care manager, psychiatrist and a primary care 
physician (Roy-Byrne et al. 2010; 2005b; Rollman et al. 2005). This explorative analysis 
revealed a significant positive effect of the inclusion of a care manager on effect size 
(b=0.33, 95% CI 0.11-0.55). However, because of the low number of studies and the 
variation in effect size between the two studies without a care manager, this 
explorative analysis should be interpreted with caution.  
 
3.7 Publication bias 
Using Duval and Tweedie's trim and fill method (Duval & Tweedie 2000) we 
examined the possibility of publication bias and the estimated effect of publication 
bias on the effect size. The funnel plot (Figure 5) shows that there was an indication 
of publication bias for studies considering all anxiety disorders, in which case the 
effect size would be adjusted from 0.27 to 0.25 (95% CI 0.054 to 0.42) for the main 
analysis. This may indicate that there is some evidence that the effect of collaborative 
care for anxiety disorders is slightly overestimated due to publication bias. However, 
the adjustment for this possible bias is minimal and after adjustment there is still a 
significant positive effect. Furthermore, the asymmetry may be caused as well by true 
heterogeneity between studies (Sterne et al. 2011) mainly attributable to the negative 
result of one study (König et al. 2009). For the sub-group analysis on panic disorder, 
there were no indications for publication bias (Figure 6) and the effect size was not 





Figure 4. Meta-regression analysis of the impact of the inclusion of a care manager in the collaborative 
care model (without care manager (1) vs. with care manager (2)) on the effect size of studies. 
 
 









































4.1 Summary of evidence 
The results of this systematic review and meta-analysis indicate that collaborative care 
is more effective than usual primary care for patients with anxiety disorders at twelve 
months follow-up, particularly for patients with panic disorder. The number of studies 
identified was small, studies were almost exclusively conducted in the United States 
and panic disorder was the only anxiety disorder that could be evaluated separately. 
The risk of bias of included studies varied. Models including a care manager might be 
more effective. 
 
4.2 Strengths and limitations 
A strength of this study is that, to our knowledge, this is the first meta-analysis on 
collaborative care for anxiety disorders. We conducted the review using PRISMA 
criteria (Liberati et al. 2009). Furthermore, we were able to examine the long-term 
effects of collaborative care, which is a strength because long-term results are often 
lacking in effectiveness studies on anxiety disorders in primary care (Seekles et al. 
2012). Because all studies used an anxiety scale as outcome measure, we were able to 
accurately combine results. However, there are several limitations in this systematic 
review and meta-analysis that need consideration.  
We identified only five studies that met our inclusion criteria. As our search was 
limited to published articles we may have missed RCTs that were unpublished, which 
may have resulted in an overestimation of the effect of collaborative care 
interventions (Hopewell et al. 2009). Furthermore, because one study (Roy-Byrne et al. 
2001) did not report the statistics for the insignificant effect on the panic specific 
measure, the effect in the sub-group analysis on panic disorder may have been slightly 
overestimated.  
Caution is warranted for any conclusions about the effectiveness of collaborative care 
for anxiety disorders other than panic disorder because only two studies reported 
separate outcomes for other anxiety disorders than panic disorder and the results of 
these studies were inconsistent (Rollman et al. 2005; Roy-Byrne et al. 2010).  




The results of this systematic review and meta-analysis are limited to results found 
after twelve months. Effects may either be larger (Roy-Byrne et al. 2001) or smaller 
before 12 months (Rollman et al. 2005). Roy-Byrne and colleagues (2010) reported a 
smaller (but significant) effect size after 18 compared to 12 months.  
The concentration of studies in primary care settings in the United States may limit 
the external validity of the results. In depression research however, no evidence was 
found for a different effect of collaborative care across settings or countries (Thota et 
al. 2012). 
 
4.3 Comparison with the literature 
The small number of studies identified is in sharp contrast with the bulk of studies 
conducted in the field of depression research. Nevertheless, the combined effect size 
of 0.27 found in this first meta-analysis of the effects of collaborative care for anxiety 
disorders is similar to the effect size of 0.25 (Gilbody et al. 2006) for depressive 
disorders. Our meta-analysis is a first indication that collaborative care for anxiety 
disorders may be as effective as collaborative care for depressive disorders.  
A meta-regression in the study of Gilbody and colleagues (2006) suggested that 
collaboration between a care manager and primary care physician with access to 
specialist input led to a higher effectiveness than care management alone, although the 
effect was not significant. We compared care management with access to specialist 
input with specialist input alone (collaboration with a psychiatrist) and found a 
significantly better effect for studies using care management with specialist input. 
However, the number of studies in our review was too small to adequately interpret 
this finding. The study of König and colleagues (2009) was the only study that did not 
report a significant effect of the intervention, probably due to a suboptimal 
implementation of the intervention. König and colleagues (2009) suggest that adding 
patient education and a basic package of specialised mental health care may improve 
outcomes, which may be seen as a more elaborate form of collaborative care. 
The adequacy of pharmacotherapy in the usual care conditions in the included studies 
from the United States seems to be higher than what has been reported in the 
literature (Young et al. 2001; Wang et al. 2005; Stein et al. 2011). This may indicate that 





the United States, or that a contamination of the effect has occurred (Richards et al. 
2008). The relatively high quality of pharmacotherapy in the usual care conditions in 
the American studies may have resulted in conservative estimates of the effectiveness 
of collaborate care.  
 
4.4 Implications for practice 
The first trials on collaborative care for anxiety disorders indicate that collaborative 
care may significantly improve patient outcomes in primary care, at least in settings in 
the United States. Although the effectiveness of collaborative care is unclear for other 
settings, it is promising that the trials considering anxiety disorders show similar 
results as the trials considering depressive disorders which have also been conducted 
outside the United States (Gilbody et al. 2006; Thota et al. 2012). However, to achieve 
successful implementation in daily practice, efforts are needed to train, reimburse and 
guide care managers, primary care physicians and supervising psychiatrists to 
implement collaborative care (Lauren Crain et al. 2012). 
 
4.5 Implications for research 
Most importantly, more research is needed on collaborative care for anxiety disorders 
in primary care. Randomised controlled trials are warranted in settings outside the 
United States and that focus on anxiety disorders other than panic disorder. 
Information about the (very) long-term effects and the cost-effectiveness of 
collaborative care for anxiety disorders is also needed. Furthermore, it would be useful 
for decision making if collaborative care and care as usual conditions were described 
in a standardised manner in randomised controlled trials (Boutron et al. 2008) to 
facilitate interpretation of the findings and comparison across studies.  
 
4.6 Conclusion 
This systematic review and meta-analysis evaluated the existing literature and found 
that collaborative care in primary care is effective for adult patients with panic 
disorder and may be effective for patients with other anxiety disorders compared to 
care as usual. More research is needed to evaluate the effectiveness of collaborative 
care in different settings and different anxiety disorders.  
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Background: Panic disorder (PD) and generalised anxiety disorder (GAD) are two of 
the most disabling and costly anxiety disorders seen in primary care. However, 
treatment quality of these disorders in primary care generally falls beneath the 
standard of international guidelines. Collaborative stepped care is recommended for 
improving treatment of anxiety disorders, but cost-effectiveness of such an 
intervention has not yet been assessed in primary care. This article describes the aims 
and design of a study that is currently underway. The aim of this study is to evaluate 
effects and costs of a collaborative stepped care approach in the primary care setting 
for patients with PD and GAD compared with care as usual. 
Methods/design: The study is a two armed, cluster randomised controlled trial. Care 
managers and their primary care practices will be randomised to deliver either 
collaborative stepped care (CSC) or care as usual (CAU). In the CSC group a general 
practitioner, care manager and psychiatrist work together in a collaborative care 
framework. Stepped care is provided in three steps: 1) guided self-help, 2) cognitive 
behavioural therapy and 3) antidepressant medication. Primary care patients with a 
DSM-IV diagnosis of PD and/or GAD will be included. 134 completers are needed 
to attain sufficient power to show a clinically significant effect of ½ SD on the 
primary outcome measure, the Beck Anxiety Inventory (BAI). Data on anxiety 
symptoms, mental and physical health, quality of life, health resource use and 
productivity will be collected at baseline and after three, six, nine and twelve months.  
Discussion: It is hypothesised that the collaborative stepped care intervention will be 
more cost-effective than care as usual. The pragmatic design of this study will enable 
the researchers to evaluate what is possible in real clinical practice, rather than under 
ideal circumstances. Many requirements for a high quality trial are being met. Results 
of this study will contribute to treatment options for GAD and PD in the primary 
care setting. Results will become available in 2011. 
Trial registration: NTR1071 
 




Anxiety disorders are a great burden for patients, the general health system and society 
as a whole. Patients having an anxiety disorder suffer from considerable disability and 
reduced quality of life (Buist-Bouwman et al. 2006). In addition, anxiety disorders are 
associated with significant costs due to the use of health services and reduced 
productivity (Kessler et al. 2001).  
Of the anxiety disorders, panic disorder (PD) and generalised anxiety disorder (GAD) 
are the most disabling (Cramer et al. 2005) and costly (Young et al. 2001; Wittchen et al. 
2002; Andlin-Sobocki & Wittchen 2005)  anxiety disorders that are frequently seen in 
primary care. Research has indicated that four to seven percent of primary care 
attendees suffer from one or both of these anxiety disorders (Roy-Byrne & Wagner 
2004; Lieb et al. 2005; Roy-Byrne et al. 2005a; Kroenke et al. 2007).  
As the majority of these patients is only seen in primary care (Young et al. 2001; Prins 
et al. 2008), this may be a convenient setting to treat these disorders. Treatment for 
PD and GAD can be highly effective (Gorman 2003; Otto & Deveney 2005). In 
recent decades the evidence for the effectiveness of treatments for anxiety disorders 
has been reviewed and described in clinical guidelines for treatment, where cognitive 
behavioural therapy as well as prescription of antidepressants are considered as the 
first choice of treatment for PD and GAD (Andrews et al. 2003; NHG 2004; The 
National Institute for Health and Clinical Excellence (NICE) 2007). However, these 
guidelines are rarely adhered to in primary care. About one third of patients with an 
anxiety disorder treated in primary care receive appropriate treatment as defined by a 
minimal accordance with existing guidelines (Young et al. 2001; Stein et al. 2004; 
Fernandez et al. 2007). 
One of the reasons for the low quality of treatment is poor recognition of anxiety 
disorders. Even when compared to depression, the recognition rate of anxiety 
disorders is low, with about one third of anxiety disorder patients labelled as such by 
their general practitioner (GP) (Weiller et al. 1998; Wittchen & Hoyer 2001; Jackson et 
al. 2007). Several factors are involved in this low recognition rate, such as patients 
unwillingness or inability to discuss their anxiety problems with their GP (Mechanic 




psychiatric disorders. Moreover, GPs frequently work under time pressure and 
perceive they have not enough time to enquire about emotional problems. In 
conclusion, competing demands of the patient, the GP and the primary care structure 
of acute episodic care make diagnosing mental health problems difficult (Nutting et al. 
2000). 
Although ameliorating recognition of anxiety disorders is necessary (Ormel et al. 
1991), it is not sufficient for improving primary health care for these patients (Mathias 
et al. 1994; Schulberg et al. 1997; Rollman et al. 2002). GPs often feel they do not have 
the necessary capabilities to treat these problems (van Boeijen et al. 2005b; Mechanic 
2007). Moreover, the primary care system does not seem to be well organised for care 
for anxiety disorders  (Ormel et al. 1991). As anxiety disorders often have a chronic 
nature (Yonkers et al. 2003), they make a poor fit with the acute disease model of 
primary care (Roy-Byrne et al. 2005a). Therefore, several researchers have proposed to 
use a chronic care model to implement evidence based care into practice. The most 
promising of these strategies are based on Wagner's model of care for chronic diseases 
(Wagner et al. 1996). This model was originally developed to improve treatment for 
chronic diseases like diabetes. The strategies following Wagner's model involve 
collaborative disease management with a pivotal role for a "care manager", who 
coordinates care, works according to an evidence-based treatment protocol, monitors 
treatment response and actively follows the patient. This care manager usually is a 
non-physician professional, who works in close collaboration with the GP. Care 
manager and GP are further assisted by a specialist from secondary care. This model 
was adopted for use with mental disorders, with a nurse practitioner or a psychologist 
as care manager and a psychiatrist functioning as consultant specialist (Katon et al. 
1997; Katon et al. 2001).  
This collaborative care model has been tested extensively in the treatment of 
depression, showing robust positive results (Gilbody et al. 2006; Bower et al. 2006). A 
few studies in the United States have investigated the effectiveness of collaborative 
care for anxiety disorders, especially PD (Roy-Byrne et al. 2001; Rollman et al. 2005; 
Roy-Byrne et al. 2005b) and GAD (Rollman et al. 2005). When compared to other 
strategies for improving care for anxiety disorders in ambulatory care, collaborative 
care seems to be the most effective (Smolders et al. 2008). In two of the studies 
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described above a cost-effectiveness analysis was performed. In both studies, 
collaborative care was more effective than care as usual. Results regarding cost-
effectiveness were inconclusive, with collaborative care being either more or less 
costly than care as usual (Katon et al. 2002; Katon et al. 2006). Researchers of these 
collaborative care trials (Roy-Byrne et al. 2001) and international guidelines (The 
National Institute for Health and Clinical Excellence (NICE) 2007) recommend a 
stepped care approach for mental health care in primary care, with least invasive and 
costly interventions preceding more invasive and expensive forms of care. Such an 
approach may make collaborative care interventions more cost-effective.  
 
This article describes the aims and methods of a randomised controlled trial to test the 
effectiveness of a collaborative stepped care intervention for PD and GAD in primary 
care in the Netherlands. Such a study is warranted for two reasons. First, there has 
been no study on the cost-effectiveness of a collaborative care intervention for anxiety 
disorders that includes a stepped care approach. Second, published studies about 
collaborative care for anxiety disorders all stem from the United States (US), where 
the collaborative care model was originally developed. As there are significant 
differences across health care systems in the US and in European countries (de Jong et 
al. 2009), the results of the collaborative care studies might not be generalised to other 
countries without consideration. To fill this gap in research, we designed a 
collaborative stepped care intervention for GAD and PD in the primary care setting. 
The treatment algorithm is built up from three interventions that have separately been 
proven effective and feasible in the primary care setting (van Boeijen et al. 2005b) (Van 
der Feltz-Cornelis et al. 2006). The interventions consist of guided self-help, cognitive 
behavioural therapy, and antidepressant medication (Van der Feltz-Cornelis et al. 
2006). Other elements of collaborative care include a trained care manager (a mental 
health practice nurse or psychologist) who coordinates care and provides 
psychological treatment, the availability of a consultant psychiatrist for advising GP 
and care manager, telephone follow-up by the care manager and monitoring of anxiety 
symptoms to evaluate treatment progress and outcome. Effects and costs of the 
interventions will be assessed and an economic evaluation will be performed to 




society associated with the burden of anxiety disorders will be taken into account. In 
accordance with the outcomes of similar previous studies, it is hypothesised that the 
collaborative stepped care intervention will be at least more effective and possibly less 





The primary aim of this randomised controlled trial (RCT) is to evaluate the 
effectiveness of collaborative stepped care (CSC) versus care as usual (CAU) in the 
treatment of panic disorder (PD) and generalised anxiety disorder (GAD) in primary 
care, with severity of anxiety symptoms as primary outcome measure. The secondary 
aim is to evaluate cost-effectiveness (costs of the intervention weighed against a 
reduction in anxiety symptoms) and to estimate cost-utility (costs of the intervention 
weighed against gained Quality Adjusted Life Years (QALY's)).  
 
Study design 
The study design is a two-armed, cluster randomised, controlled trial.  
 
Time frame 
This study was initiated in 2008 and will take three years. Results are expected in 2011.  
 
Recruitment of GPs, care managers and psychiatrists 
The study is designed in cooperation with the Netherlands Institute of Mental Health 
and Addiction (Trimbos Institute), the Department of General Practice and Psychiatry 
of the VU University Medical Centre in Amsterdam and the Department of Public 
Health and Primary Care of the Leiden University Medical Centre. GPs in the Leiden 
region that are located in the region of a large mental health centre (Rivierduinen) will 
receive an invitation to participate in the study, after which a researcher (AM) will 
contact all practices by phone to recommend participation. Participating practices will 
be able to decide which professional (e.g. a psychologist, a mental health practice 
nurse or a social worker) will fulfill the role of care manager. If the practice does not 
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have such a professional available, a mental health practice nurse working at the 
regional mental health centre will be available to work in the practice. Experienced 
psychiatrists working at the regional mental health centre will perform as consultant 
psychiatrists for the intervention practices. 
 
Randomisation 
Cluster randomisation will be applied at the level of the care manager to minimise 
contamination of the effect (Van der Feltz-Cornelis & Ader 2000). Randomisation will 
be performed using sequences obtained with an automated random sequence 
generation algorithm following a blocking scheme of variable length with allowance 
for restricted unbalance of at most three. Stratification will be on region, with six 
regions in total, which are based on working units of the regional mental health centre. 
The allocation sequences will be generated by an independent statistician (HA) in the 
manner described above. The care managers will be randomised and allocated to the 
intervention (CSC) or the control group (CAU). PCPs and GPs will be allocated to 
either CSC or CAU in accordance with the randomisation status of their care 
manager. After randomisation, neither care managers nor GPs will be blinded to 
group assignment. Figure 1 presents a flowchart of the recruitment and randomisation 
procedure. 
 
Patient inclusion and exclusion criteria 
Patients with a primary diagnosis of PD with or without agoraphobia and/or a 
primary diagnosis of GAD according to the criteria of the DSM IV ( 2001) will be 
included in the study. Patients who are suicidal, suffer from dementia or other severe 
cognitive disorders, psychotic disorder, bipolar disorder, dependence on drugs or 
alcohol, or with an unstable severe medical condition as diagnosed by their GP or as 
assessed in a diagnostic interview will be excluded. Patients with insufficient 
knowledge of the Dutch language to fill out the questionnaires, patients who are 
already receiving intensive psychological treatment (>2 contacts per month with a 
psychologist or psychiatrist) and patients who are under 18 years of age will also be 
excluded from the study. For reasons of generalisation, no other exclusion criteria are 




(e.g. antidepressants or benzodiazepines) or a diagnosis of co-morbid psychiatric and 




Figure 1. Flowchart showing the recruitment and randomisation of care managers and practices. GP: 
general practitioner, PCP: primary care practice, CM: care manager. 
 
Recruitment of patients 
Recruitment of patients will take place in two phases: a screening phase and a 
diagnostic phase. Patients will either be referred by their GP or will receive an 
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GPs are able to refer a patient by handing a patient an information letter, an informed 
consent form and a short screening instrument: the Patient Health Questionnaire 
anxiety subscale (PHQ22) (Spitzer et al. 1999). This measure has shown good 
psychometric properties for screening for anxiety disorders (Spitzer et al. 1999; Diez-
Quevedo et al. 2001).  
In cluster randomisation, when dependent on referrals of GPs, a known problem is 
the inclusion of patients in the CAU group (Farrin et al. 2005). To diminish 
recruitment bias, referral by GPs is complemented with selection on basis of screening 
in this study. A number of patients will be selected from the electronic medical 
records of the GPs according to the following criteria: they are older than 18 years of 
age and had contact with their GP in the past four months for one of the following 
reasons: psychological or social problems, muscle or skeletal pain, fatigue, 
hyperventilation, fainting, stomach ache, complaints about functioning of the heart or 
head ache. These patients will receive an information letter, an informed consent form 
and the PHQ-22. Of patients who return the PHQ-22 and give informed consent, the 
score on the PHQ-22 will be calculated. Patients will be considered screen-positive if 
they answer affirmatively to the screening questions of the PHQ22 and list at least 4 
symptoms for panic or at least 1 symptom for general anxiety (Spitzer et al. 1999). For 
PD, threshold criteria will be used (Lowe et al. 2003), where as for GAD the sub 
threshold criteria will be used to increase sensitivity (Diez-Quevedo et al. 2001). 
Screen-positive patients will enter the diagnostic phase and will be contacted by 
telephone to perform a diagnostic interview. 
 
Diagnostic phase 
Diagnostic interviews will be conducted by trained research assistants who will be 
blind to the randomisation scheme. The MINI-PLUS International Neuropsychiatric 
Interview is a semi-structured interview that is often used for DSM-IV classification 




interviews are found to have a high concordance with in-person interviews (Wells et al. 
1988). The interviewers will have the opportunity to consult a psychiatrist, who is also 
blind to randomisation status, when they are uncertain of a diagnosis. Patients with a 
primary diagnosis of PD and/or GAD and who do not meet any of the exclusion 
criteria will receive a second information letter, baseline questionnaires and a second 
informed consent form. Patients will be offered the choice of a pen and paper version 
or an internet based version of the questionnaire. If the patient returns the baseline 
questionnaires and gives informed consent, the patient will be included in the study. 
Patients in the CSC group will be invited for a consultation with the care manager 
whereas patients in the CAU group will be advised to seek contact with their GP for 
treatment of their anxiety complaints. GPs in the control group will not be notified of 




The aim of the trial is to detect a clinically relevant difference of 0.5 SD (Cohen’s 
effect size) of CSC versus CAU on the continuous measure of the Beck Anxiety 
Inventory (BAI) (Cohen 1988). Sample size calculation is based on scores of 281 
primary care patients in the multisite Netherlands Study of Depression and Anxiety 
(NESDA) (Penninx et al. 2008) with a diagnosis of PD or GAD in the last six months. 
The mean BAI score in this sample was 16.94, with an SD of 10.49 (range 0-58). 
Hence, the expected difference between CSC and CAU is 6 points on the BAI. To 
demonstrate this difference with alpha = 0.05 and a power of 0.90, 64 cases per arm 
are needed ((1.96 + 1.28)²*10.49²*2)/6²). Since the average class size (n) is estimated 
to be 5 and the intraclass correlation coefficient (rho) is expected to be 0.01 (Adams et 
al. 2004; Gilbody et al. 2008), we apply an inflation factor of 1.04 (inflation factor = 1 
+ (n-1) x rho = 1 + 4 * 0.01 = 1.04) (Cosby et al. 2003). To be able to analyze 67 
completers per arm and with an estimated 25% loss to follow-up, we aim to include 








Figure 2. Flowchart of participants. GP: general practitioner, PCP: primary care practice, PHQ22: 








Care managers randomised to the intervention group will receive three days of 
training in the nature of anxiety disorders, collaborative care, the guided self-help 
intervention and cognitive behavioural therapy (CBT). These training sessions will be 
conducted by a psychologist (AM), the psychiatrist who developed the guided self-
help method (van Boeijen 2006) and two experienced cognitive behavioural therapists 
working at the regional mental health centre Rivierduinen.  
GPs in the intervention group will receive three hours of training in the recognition of 
anxiety disorders, motivating patients for treatment, collaborative care and the 
medication algorithm. A psychiatrist (AvB), a GP (HvM) and a psychologist (AM) will 
provide this training. 
Consultant psychiatrists will receive two hours of training in collaborative care, 
medication for PD and/or GAD and giving consultations in primary care. Two 
psychiatrists (AvB and CFC) and a psychologist (AM) will provide this training.  
 
Treatment in the intervention group 
1. Collaborative stepped care 
In accordance with the collaborative care model, care is provided by a team of the GP, 
the care manager, the patient and a consultant psychiatrist. The collaborative stepped 
care intervention is composed of four steps:  
1) Guided self-help 
2) Cognitive behavioural therapy (CBT) 
3) Antidepressants according to a medication algorithm  
4) Optimisation of medication in primary care or referral to secondary care 
After each step, progress is evaluated with the Beck Anxiety Inventory (BAI) (Beck et 
al. 1988a). The goal of the intervention is remission, according to the BAI score (See 
7. Monitoring for remission criteria). If a patient does not achieve criteria for 
remission after concluding a step, he or she proceeds with the next step. For example, 
when a patient does not achieve criteria for remission concluding the guided self-help 
program (step 1), he or she is offered CBT treatment (step 2). In contrast, when a 
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patient does achieve remission after the guided self-help program, he or she enters a 
program of relapse prevention. 
The care manager coordinates care, delivers guided self-help and CBT and evaluates 
each step. The GP prescribes medication and evaluates progress with the care 
manager. The care manager as well as the GP can consult a consultant psychiatrist 
about treatment decisions. The active phase of the treatment lasts for at least 12 weeks 
and has a maximum of 34 weeks. Patients' adherence to the program is enhanced by 
contracting and active monitoring. Relapse prevention is provided by the care 
manager through monthly follow-up calls, until twelve months after the beginning of 
treatment. Figure 3 depicts the treatment algorithm. 
 
2. Contracting 
When a patient is included in the study, he or she is invited for a first meeting with the 
care manager and GP. They briefly discuss the patients symptoms and explain the 
diagnosis. The patient is actively involved in the treatment plan by contracting. The 
patient receives a copy of the treatment plan.  
 
3. Improving adherence 
Premature termination of treatment and diminished adherence to treatment are 
associated with poorer outcomes. Therefore, patient adherence is encouraged by 
psycho-education, goal setting and by frequent follow-up appointments in which both 
adherence and progress are evaluated. Provider adherence to the treatment protocol is 
encouraged by instructions from the researchers and newsletters, by frequent 
reporting about the care given, by recording of sessions and by regular supervision. 
Care managers attend a supervision group led by a cognitive behavioural therapist 
every three weeks. They also have the opportunity to discuss problems and exchange 







Figure 3. Treatment algorithm 
*Remission is defined as a 50% reduction in score on the BAI plus a score of 11 or below. BAI = 
Beck Anxiety Inventory, CM = care manager, GP= general practitioner. 
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4. Guided self-help 
Step one in the intervention is a guided self-help method based on cognitive 
behavioural principles (van Boeijen et al. 2005a). This intervention was proven 
effective in a randomised controlled trial with patients with PD and/or GAD (van 
Boeijen et al. 2005b). In twelve weeks, the patient works through a self-help manual 
with information about anxiety disorders, automatic thoughts, relaxation techniques 
and exposure in vivo (van Boeijen 2007). Every chapter contains exercises for the 
patients to perform. In five short consultations spread over twelve weeks, the care 
manager informs the patient about the content of the manual, reinforces achievements 
and motivates the patient to continue. In addition, the patient is encouraged to find a 
“helper”, a friend or a relative, who can help him or her perform exercises and 
support the patient to adhere to the program. 
 
5. Cognitive Behavioural Therapy (CBT) 
CBT has been proven effective in numerous studies for both PD and GAD and is 
recommended as a first line treatment in international guidelines (van Balkom 
A.J.L.M. et al. 1995; Hunot et al. 2007). For this study, a short duration protocol was 
developed based on (inter)national guidelines and available manuals for the treatment 
of anxiety disorders with CBT (Clark 1989; Wells 1997; Otto & Deveney 2005). 
A separate treatment protocol for PD and GAD is used, depending on the primary 
diagnosis of the patient. The CBT comprises a course of 6 sessions of 45 minutes 
provided by the care manager. All fundamental elements of CBT are represented in 
this protocol. For PD the main topics are psycho-education (e.g. the "cycle of panic"), 
registration of panic attacks, interoceptive exposure, recognition and modification of 
anxiety evoking automatic thoughts and behavioural experiments. The protocol for 
GAD focuses on psycho-education, recognition and modification of anxiety evoking 
automatic thoughts and meta-cognitions (Wells 2007). Both protocols employ 
homework assignments.  
 
6. Medication 
GPs are encouraged to adhere to an antidepressant algorithm to optimise the 




based on (inter)national guidelines. The algorithm includes time to titrate to daily 
dosages (2 weeks), time to respond (partially or remission, 4 weeks) and step-up 
criteria and methods (e.g. ‘partial response: increase dose’, ‘no response: switch 
medication’). The care manager monitors adherence, adverse effects and response to 
treatment with the BAI. The GP and the care manager consult a psychiatrist when 
necessary. If the patient fulfils criteria for remission, medication treatment should be 
continued until twelve months after the initiation of medication treatment. If the 
patient does not respond or adhere to medication, the GP contacts the psychiatrist to 
discuss the options for further treatment. If further treatment in the primary care 
setting is not feasible, the patient may be referred to specialty mental health care. 
 
7. Monitoring 
The care manager monitors anxiety symptoms with the BAI (Beck et al. 1988). The 
goal of the intervention is remission, defined as a 50 percent reduction in score plus a 
score of 11 or below (see Secondary outcome measures). At the start of treatment the care 
manager administers the BAI and calculates a "target score" (remission) for each 
patient. The care manager then assesses the BAI at the end of step one and step two. 
During step three (medication), the care manager monitors symptoms more 
frequently: in week four and eight of medication use. If the patient switches 
medication this pattern is repeated. 
 
8. Relapse prevention 
If a patient achieves remission after step one, two or three, relapse prevention is 
offered by the care manager. The care manager calls the patient every month, to assess 
anxiety symptoms with the BAI. If the BAI score of a remitted patient increases to a 
score of 12 or above on two consecutive measurements, the care manager consults the 
psychiatrist about the next step to be taken. The patient can “step up” to the next step 
(i.e. step 2: CBT or step 3: medication) or be referred to specialty mental health care. 
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9. Referral to specialty mental health care 
There can be several reasons for referring a patient to specialty mental health care:  
diagnostic uncertainty, complex psychosocial issues, poor response to treatment, 
patient preferences or emerging severe psychopathology. Referral to specialty mental 
health care is always discussed with the consultant psychiatrist.  
 
Treatment in the control group 
Half of the PCPs function as a control group. These GPs and care managers receive 
no training and they provide their usual care to their patients. There is a Dutch 
guideline available for all GPs about the treatment of anxiety disorders in primary care 
(Terluin et al. 2004). Care as usual comprises every form of care the GP is used to 
offer to his patient (e.g. watchful waiting, prescription of medication, referral to a 
mental health care professional or any other form of care the GP offers to his patient). 
The actual content of usual care will be assessed with the Scale for Medical Utilisation 
of Health Services (van der Feltz-Cornelis, 2002).  
 
Data collection 
Measurement will take place at baseline (T0), three (T1), six (T2), nine (T3) and twelve 
months (T4) after inclusion. The filled out pen and paper questionnaires will be 
processed anonymously by blinded research-assistants. The internet-questionnaires 
will be processed automatically. 
 
Outcome parameters 
1. Primary outcome measure 
The severity of anxiety symptoms is measured with the Beck Anxiety Inventory (BAI) 
(Beck et al. 1988a). This measure lists 21 symptoms of anxiety like feeling hot, scared 
or nervous. Patients are instructed to rate how much each of these symptoms 
bothered them in the past week, including today. Each item can be rated on a 4 point 
Likert scale, ranging from 0 (Not at all) to 3 (Severely) yielding a maximum total score 






2. Secondary outcome measure 
Remission 
As there is no standard "remission score" for the BAI, we calculated this score 
following the criteria of clinical significance of Jacobson & Truax (Jacobson & Truax 
1991). These authors state that the best method to define recovery is to calculate the 
mean between the mean score of a population with the disorder and the mean score 
of a population without the disorder. We were able to derive these data of patients 
with or without PD or GAD from the NESDA study (Penninx et al. 2008), resulting 
in a score of 11. Because the BAI score is not a part of the diagnostic procedure, it is 
expected that not every patient will score 11 or higher on the BAI. Therefore, we 
added the element of a 50 percent reduction in score to the definition of remission. In 
sum, remission is defined as a score of 11 or below, plus a 50% reduction in score. 
 
3. Additional outcome measures 
Anxiety severity and impairment 
Anxiety severity and impairment are measured by the Overall Anxiety Severity and 
Impairment Scale (OASIS) (Norman et al. 2006). This scale was developed to measure 
severity of anxiety and impairment caused by anxiety across different anxiety disorders 
and showed good reliability and validity (Campbell-Sills et al. 2008). The scale consists 
of five questions about frequency of anxiety, severity of anxiety, avoidance, 
interference with tasks and interference of social relationships. The scale was 
translated in Dutch according to the forward-backward translation method. 
 
Physical symptoms  
Physical symptoms are measured by the Physical Symptoms Questionnaire (LKV: 
Lichamelijke Klachten Vragenlijst (Hemert 2003)), which assesses the number and 
intensity of functional somatic complaints a patient is experiencing. The Whitely 
Index (dimensional version (Speckens et al. 1996a; Speckens et al. 1996b)) measures 
attitudes about diseases (hypochondriasis). As these symptoms often co-occur with 
anxiety disorders, it is interesting to see whether these symptoms also decrease when 
treating the anxiety disorder. 
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Quality of life 
Quality of life is a measure that allows comparison in different studies and (mental 
and physical) disorders. In this study, quality of life is assessed with the EuroQol (EQ-
5D) (Euroqol group 1995) and the Short Form-36 (SF-36) (Ware & Sherbourne 
1992), both validated instruments for measuring general health-related quality of life. 
The EQ-5D descriptive system consists of five dimensions (mobility, self-care, usual 
activities, pain/discomfort, and anxiety/depression), each with three levels (no 
problems, some problems, and extreme problems), thus defining 243 (3^5) distinct 
health states. The SF-36 is an often used measure that assesses eight health concepts 
(Ware & Sherbourne 1992).  
 
4. Effect modifiers 
Demographic variables 
The following demographic variables are measured at baseline: age, gender, nationality 
and ethnicity, marital status, living conditions, education and work status. 
 
Physical illness 
Co-morbid physical illness is measured at baseline by means of a questionnaire 
developed by Statistics Netherlands (the CBS list), which lists 28 chronic conditions 
(e.g. diabetes type II and vascular disease). Chronic medical illness is found to be 
related to more severe symptoms at baseline, but not to a different treatment response 
in the treatment of anxiety disorders (Roy-Byrne et al. 2005c).  
 
Depressive symptoms 
Depressive symptoms are assessed with the depression-subscale of the Patient Health 
Questionnaire (PHQ9) (Spitzer et al. 1999; Kroenke et al. 2001), a brief and valid 
instrument which measures each of the DSM-IV criteria for major depressive 
disorder. The total score gives an indication about the severity of depressive 
symptoms. Depression is related to more severe symptoms at baseline and after 
treatment, but not to a different treatment response (van Balkom et al. 2008). 




depressive symptoms also reside when treating the anxiety disorder and to be able to 
detect a possible difference between PD and GAD.  
 
Coping 
The use of specific coping styles is measured by the Utrecht Coping List (UCL: 
Utrechtse Coping Lijst) (Schreurs et al. 2007). This list assesses the frequency of using 
seven different coping styles: active coping, palliative reaction, avoidance, seeking 
social support, passive coping, expression of emotions and comforting thoughts. 
Coping styles are found to be related to outcome in mental disorders (Vollrath et al. 
1996). There is a debate whether coping styles are sensitive to change following 
treatment. 
 
Economic evaluation  
The aim of this economic evaluation is to assess the cost-effectiveness and to estimate 
cost utility of CSC compared to CAU. This will be done by relating the difference in 
direct medical costs per patient receiving CSC or CAU to the difference in terms of 
reduction in score on the BAI (cost-effectiveness) and quality adjusted life years (QALY) 
gained (cost-utility). This will yield a cost per unit of the BAI and per QALY estimate. 
QALY’s will be estimated using the 'Dutch EQ-5D tariff', which is used to calculate 
utilities for EQ-5D health states for the cost utility analyses of Dutch health care 
programs and treatments (Lamers et al. 2006). The analyses will also be performed 
including productivity costs.  
 
Medical costs 
For calculating the total direct medical costs, the Trimbos/iMTA questionnaire for 
Costs associated with Psychiatric Illness (TiC-P) (Hakkaart-van Roijen 2002; 
Hakkaart-van Roijen et al. 2006) is used. The Tic-P measures direct costs of medical 
treatment such as the number of contacts with the GP and multiple other care 
providers (e.g. medical specialists and paramedics) during the last three months. 
Medication use is measured during the last four weeks. The costs will be estimated in 
line with the Dutch guidelines for cost calculations in health care (Oostenbrink et al. 
2004). Reference unit prices of the corresponding health care services will be applied, 
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and adjusted to the year of the study according to the consumer price index. Since the 
collaborative stepped care model is a new kind of intervention, a unit price per session 
is currently not available. To determine a reference price for this intervention a micro-
costing study will be performed in at least three PCPs delivering the collaborative care 
intervention. Time for face-to-face contacts with the patient as well as indirect time 
per contact (e.g. mutual consultation contacts between GP and the care manager or 
the consultant psychiatrist) will be measured. For reasons of comparison the costs for 




For collecting data on productivity losses a short form of the Health and Labour 
questionnaire (SF-HQL) (van Roijen et al. 1996) is used. The SF-HLQ consists of 
three modules that measure productivity losses: absence from work, reduced 
efficiency at work and difficulties with job performance (van Dam et al. 1998).   
Productivity losses as measured by the SF-HQL are valued according to the average 
value added per worker by age and gender per day and per hour. If respondents 
indicate that they have been absent for the entire recall period, data will be collected 
from the time when the period of long-term absence started. This additional 
information will be used to value the production losses according to the "friction cost 
method" (Koopmanschap et al. 1995). This method takes into account the economic 
circumstances that limit the losses of productivity to society, which are related to the 
fact that a formerly unemployed person may replace a person who becomes disabled.  
 
Statistical analyses 
Intention-to-treat analysis will be performed by multilevel analysis with time as the 
first hierarchical level, patients as the second hierarchical level and care managers with 
their  PCPs in the third level (Twisk 2006). Possible confounding characteristics (e.g. 
age, gender or level of experience) will be included in the analysis models. Propensity 
scores will be used to correct for bias that could be introduced by selection bias. In 
this calculation, variables that are not considered as dependent variables or 




either the CSC or the CAU group, using logistic regression analysis. This can be 
considered an appropriate procedure for cluster randomised trials (Van der Feltz-
Cornelis et al. 2006). 
Direct and indirect costs of the interventions will be reported. The results of the cost 
and QALY analyses will be presented as mean values with standard errors. Cost-
effectiveness and cost-utility analyses will be presented in incremental cost-
effectiveness ratios. The uncertainty will be assessed using bootstrapping (van Hout et 
al. 1994) and acceptability curves will be presented. As principled methods (e.g. 
multiple imputation) take into account the special characteristics of cost data that 
affect their analysis, a principled method for dealing with missing data will be applied 
to our economic evaluation (Oostenbrink et al. 2003). 
 
Ethical principles 
The study protocol has been approved by the Medical Ethical Committee of the VU 
University Medical Centre at April 29, 2008 and by the Medical Ethics Committee of 
the Leiden University Medical Centre at October 2nd 2008. 
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The presumed poor quality of care in the primary care setting for such prevalent, 
disabling and costly disorders as PD and GAD set the basis for this study. The aims 
of this study are to improve the quality of care for these patients with an acceptable 
increase in costs. 
This study is the first in which a stepped care approach is incorporated in a 
collaborative care intervention for the treatment of anxiety disorders in primary care. 
It is also the first study, to our knowledge, that evaluates the cost-effectiveness of such 
an intervention outside the United States. Effective elements of other studies have 
been brought together in the protocol of this study.  
A strength of this study is its pragmatic design. There is a minimum of exclusion 
criteria. Furthermore, care is provided by health care professionals from the field, 
unlike in other studies evaluating collaborative care (Roy-Byrne et al. 2001; Rollman et 
al. 2005; Roy-Byrne et al. 2005b). Consequently, the results of this study may be 
generalised to naturalistic health care settings with a comparable primary health care 
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Objective To evaluate the effectiveness of collaborative stepped care compared to 
care as usual for adults with panic disorder or generalised anxiety disorder in primary 
care.  
Design A cluster randomised controlled trial, with follow-up assessments at three, six, 
nine and twelve months.  
Setting Forty-three primary care practices employing 63 general practitioners (GPs) 
and 31 mental health professionals in the Netherlands. The mental health 
professionals were randomised to deliver collaborative stepped care (16 mental health 
professionals, 23 practices) or care as usual  (15 mental health professionals, 20 
practices).  
Participants An initial selection of 207 patients selected by their GP and 2499 
patients selected from the electronic medical records resulted in 180 included patients 
with a DSM-IV diagnosis of panic disorder or generalised anxiety disorder. Mean age 
was 46.5 years (SD 15.5), the majority was female (68.3 %) and 91% completed at least 
one follow-up questionnaire. 
Interventions One hundred fourteen patients received collaborative stepped care 
provided by a mental health professional (care manager), GP and a consultant 
psychiatrist who were trained in the collaborative stepped care intervention of three 
steps: guided self-help, cognitive behavioural therapy and antidepressants. Sixty-six 
patients received care as usual provided by their GP. 
Main outcome measure Change in Beck Anxiety Inventory (BAI) score.  
Results Collaborative stepped care was superior to care as usual at all follow-up 
measurements (difference in change scores 3 months -5.11, 95% confidence interval 
[CI] -8.28 to -1.94; 6 months -4.65, CI -7.93 to -1.38; 9 months -5.67, CI -8.97 to -
2.36; 12 months -6.84, CI -10.13 to -3.55). Effect sizes of between-group differences 
were small to moderate. 
Conclusions Collaborative stepped care, with guided self-help as a first step, was 
more effective than care as usual for primary care patients with panic disorder or 
generalised anxiety disorder. 
Trial registration: Netherlands Trial Register NTR1071 
 




Panic disorder (PD) and generalised anxiety disorder (GAD) are two of the most 
disabling and costly anxiety disorders (Greenberg et al. 1999; Andlin-Sobocki & 
Wittchen 2005; Olatunji et al. 2007) that are frequently presented in primary care (Roy-
Byrne & Wagner 2004; Roy-Byrne et al. 2005a). Both disorders often run a chronic 
course, since almost two thirds of the patients with one of these disorders still suffers 
from the disorder five years later (Yonkers et al. 2003). The majority of patients with 
PD or GAD receives general primary care (Bijl & Ravelli 2000; Stein et al. 2004). 
However, treatment offered in this setting often lacks adequate provision of 
psychotherapy or pharmacotherapy (Stein et al. 2011; Richards & Borglin 2011) as well 
as structural monitoring and relapse prevention.  
To improve primary care treatment for these patients, collaborative care models have 
been developed. Collaborative care aims at supporting the general practitioner (GP) in 
providing evidence based, continuous care by bringing mental health expertise in the 
primary care team. A  few studies provide evidence that collaborative care is more 
effective than usual primary care for patients with PD or GAD (Roy-Byrne et al. 2001; 
Rollman et al. 2005; Roy-Byrne et al. 2005b; Roy-Byrne et al. 2010). In these studies, 
the GP is supported by a consultant psychiatrist and/or a trained "care manager", 
often a (psychiatric) nurse or a psychologist, who monitors the patient’s symptoms 
and provides systematic follow-up. The interventions included in collaborative care 
studies vary in complexity. For example, in an early study of Roy-Byrne and 
colleagues, the intervention consisted of psycho-education in combination with 
medication provided by a consultant psychiatrist (Roy-Byrne et al. 2001). In a recent 
large trial of Roy-Byrne and colleagues (2010) treatment consisted of an extensive 
program of computer supported cognitive behavioural therapy (CBT) provided by a 
care manager who was supervised by a psychiatrist and/or antidepressants prescribed by 
the GP. The intervention addressed four anxiety disorders (PD, GAD, social phobia and 
post traumatic stress disorder). The results of the collaborative care studies for anxiety 
disorders are indeed promising for improving care, at least in the United States. 
Research on collaborative care for depression has already shown that collaborative 




2012; Huijbregts et al. 2012). However, none of the previous collaborative care studies 
focusing on anxiety followed a stepped care approach, which is nowadays 
recommended in several national guidelines (Spijker et al. 2010; Kendall et al. 2011). 
Stepped care starts with the least intrusive, most effective intervention. The rationale 
behind stepped care is that it should enhance self-management and lead to an efficient 
use of resources (Bower & Gilbody 2005). The updated guideline of the National 
Institute of Clinical Excellence (NICE) in the UK includes a stepped care algorithm 
for GAD and PD, starting with a (low intensity) psychological intervention (National 
Institute for Health and Clinical Excellence 2011). However, evidence of the 
effectiveness of stepped care for anxiety disorders is not yet  established firmly (Bower 
& Gilbody 2005; Seekles et al. 2011; Coull & Morris 2011). 
To evaluate the effectiveness of collaborative stepped care, we designed a 
collaborative stepped care model. We incorporated three interventions based on 
former research in the primary care setting: guided self-help (van Boeijen et al. 2005) as 
a first step, followed by CBT and antidepressants according to a guideline based 
algorithm (van der Feltz-Cornelis CM et al. 2006). A care manager working in the 
primary care practice provides guided self-help, CBT and follow-up, monitors 
symptoms and adjusts treatment accordingly in consultation with the GP, who 
prescribes medication. A consultant psychiatrist is available for advice. We evaluated 
the effects of this model compared to care as usual using a pragmatic cluster 
randomised controlled trial to ensure a naturalistic treatment setting. 
 





To evaluate the effectiveness of collaborative stepped care versus care as usual on the 
anxiety symptoms of adult primary care patients with a DSM IV diagnosis of panic 
disorder or generalised anxiety disorder. 
 
Design 
The study was a two armed, cluster randomised controlled trial. Unit of randomisation 
(clusters) were the mental health professionals who provided their services to the 
participating primary care practices.  
 
Randomisation of clusters 
All mental health professionals who provided their services to primary care practices 
located in the western part of the Netherlands (Leiden region) who were willing to 
participate in the study were eligible for participation. The participating mental health 
professionals were 28 psychiatric nurses and 3 primary care psychologists who 
provided their services to 43 primary care practices (with 63 participating physicians) 
in the Netherlands. The 31 mental health professionals were randomised using 
sequences obtained with an automated random sequence generation algorithm 
following a blocking scheme of variable length with allowance for restricted unbalance 
of at most three by an independent statistician. Sixteen mental health professionals 
serving 23 practices were allocated to the intervention group and 15 mental health 
professionals serving 20 practices were allocated to the control group (See Figure 1). 
Mental health professionals and general practitioners (GPs) were not blind to group 
assignment after randomisation. The design and methods of this study have been 







Figure 1. Flowchart of clusters and participants. GP: General practitioner, PHQ: Patient Health 
Questionnaire (anxiety modules), MINI-interview: MINI-International Neuropsychiatric Interview. 




Adult (>18 years of age) primary care patients with a primary diagnosis of panic 
disorder (PD) with or without agoraphobia and/or generalised anxiety disorder (GAD). 
 
Exclusion criteria 
Suicidal ideation, dementia or other severe cognitive disorders, psychotic disorder, 
bipolar disorder, dependence on drugs or alcohol, an unstable severe medical 
condition, insufficient knowledge of the Dutch language to complete the 
questionnaires, or receiving psychiatric or psychological treatment (>2 contacts per 
month). Receiving antidepressant medication was no reason for exclusion.  
 
Recruitment 
Between September 1st 2008 and March 31st 2010 patients were enrolled. GPs selected 
patients they encountered with anxiety problems for the study. In addition, a research 
assistant selected patients from the electronic medical records (EMR) who consulted 
the GP in the past four months for psychological or social problems, or physical 
symptoms possibly related to anxiety disorders (Kroenke et al. 1994; Roy-Byrne et al. 
2008; Muntingh et al. 2009). Patients who gave informed consent completed a 
screening questionnaire: the Patient Health Questionnaire anxiety modules (Spitzer et 
al. 1999). 
An independent trained research assistant, who was blind for group assignment, 
approached patients who screened positive (≥4 symptoms of panic or ≥ 1 symptoms 
of general anxiety (Spitzer et al. 1999)) plus all patients selected by their GP for a 
telephone interview (MINI-PLUS International Neuropsychiatric Interview). The 
MINI-PLUS is a semi-structured interview (van Vliet et al. 2000) used to classify 
psychiatric diagnoses according to the DSM-IV-TR (American Psychiatric Association 
2001). GPs in both groups were notified of the diagnosis of patients they themselves 
had selected for the study but GPs in the control group were not notified about the 
diagnosis and participation of patients selected from the EMR. Patients were kept 
blinded for the group assignment of their GP until baseline. See Figure 1 for a 





Training of professionals in the intervention group 
The mental health professionals were trained as care managers in a three day 
workshop about collaborative care (½ day), guided self-help (½ day), and CBT (2 
days). The GPs attended a three hour workshop about the recognition of anxiety 
disorders, collaborative care and the prescription of medication following an 
algorithm. The six consultant psychiatrists participated in a one-hour meeting in which 
collaborative stepped care, the medication algorithm and the consultation process 
were discussed.  
 
Collaborative stepped care intervention 
For detailed information about the CSC intervention, see Box 1. CSC was provided by 
the care manager (who was preferably located in the primary care practice), GP and a 
consultant psychiatrist. The intervention consisted of three steps: CBT-based guided 
self-help (step one), cognitive behavioural therapy (CBT) (step two) and 
antidepressants according to a medication algorithm (step three). The care manager 
monitored response to treatment with the Beck Anxiety Inventory (BAI) (Beck et al. 
1988) and when a patient achieved remission (BAI ≤11), the care manager offered 
relapse prevention. If remission was not reached, the patient entered the next step. 
The GP and care manager were instructed to frequently discuss treatment progress 
with each other and to contact a psychiatrist (by e-mail, telephone or in person at the 
office of the psychiatrist) when they encountered difficulties during treatment or had 
any questions about treatment steps or medication. Furthermore, care managers were 
encouraged to attend three-weekly supervision sessions with a cognitive behavioural 
therapist. Adherence to the treatment protocol by care managers and GPs was further 
encouraged by regular telephone calls by a study psychologist (AM). 
 
Care as usual (CAU) 
The GPs and mental health professionals in the care as usual group received no 
additional training and they provided care as usual to their patients. In the 
Netherlands, GPs use national primary care treatment guidelines for anxiety disorders 
(Terluin et al. 2004). Care as usual could encompass prescription of antidepressants,  
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Box 1. Description of the intervention 
Step 1: Guided self-help 
Guided self-help consisted of a self-help manual based on cognitive behavioural principles, 
with psycho-education, cognitive behavioural exercises and a guided relaxation CD, which 
the patient worked through independently. The care manager coached the patient in this 
process in 5 short consultations (20 minutes) at the primary care practice spread over 12 
weeks. In the first session, a treatment plan was discussed with the patient and signed by 
the patient, care manager and GP. The effectiveness of the guided self-help intervention 
was supported by a previous trial (van Boeijen et al. 2005). 
Step 2: Cognitive behavioural therapy (CBT) 
Two short duration CBT protocols (one for GAD and one for PD) and workbooks for 
patients were developed and adapted to the knowledge already gained in step one. 
Cognitive therapy as well as exposure were important elements in these protocols. CBT 
was delivered by the care manager in 6 sessions of 45 minutes. CBT has been proven 
effective in primary care in numerous studies (Cape et al. 2010). 
Step 3: Antidepressants 
The GP prescribed antidepressants and was encouraged to follow a medication algorithm 
which was based on (inter)national guidelines for anxiety disorders and an earlier study 
conducted in primary care (van der Feltz-Cornelis CM et al. 2006). The algorithm offered a 
choice of an SSRI, SNRI and a TCA, with instructions when to increase the dose or switch 
medication. We advised GPs to refrain from the use of anxiolytics (benzodiazepines) if 
possible.  
Monitoring and relapse prevention 
After each step, progress was evaluated with the Beck Anxiety Inventory (BAI) (Beck et al. 
1988). When the patient did not achieve remission (BAI score ≤ 11), the next step was 
offered. If necessary, the patient was referred to specialty mental health care. When 
remission was reached, the care manager provided relapse prevention through monthly 
follow-up calls with BAI administration until nine months after the end of treatment. 
 
but also referral to the attached mental health professional, a primary care 
psychologist or to specialty mental health care. All patients in the control group were 
advised to seek treatment from their GP. We assessed the actual care provided in care 






Patients completed questionnaires at baseline and after 3, 6, 9 and 12 months, which 
were processed by research assistants who were blind to group assignment. 
 
Primary outcome measure 
The primary outcome measure was the reduction in anxiety symptoms, measured with 
the Beck Anxiety Inventory (BAI) (Beck et al. 1988). This scale lists 21 symptoms of 
anxiety with a total score ranging from 0 to 63 points. The instrument has good 
psychometric properties (Ferguson 2000) and is suitable for assessing severity of the 
anxiety in primary care patients with anxiety disorders (Muntingh et al. 2011). The 
Overall Anxiety Severity and Impairment Scale (OASIS)(Norman et al. 2006) was used 
as a proxy for the severity of the anxiety at baseline. 
  
Secondary outcome measures  
Secondary outcome measure was time to first remission (BAI ≤ 11) or first response 
to treatment (≥50% reduction in score on the BAI) if remission was not achieved 
(Ader 2012). Depressive symptoms were measured with the Patient Health 
Questionnaire-9 (Spitzer et al. 1999) and quality of life was assessed with the Short-
Form Health Survey-36 (Ware, Jr. & Sherbourne 1992) and the EuroQol EQ5D 
(Euroqol group 1995).  
 
Adherence to treatment and content of care 
Adherence to treatment and content of care were assessed using a checklist, which 
was administered to the GP (and to the care manager in the CSC group) by a research 
assistant 12 months after inclusion of the patient. The CSC checklist assessed whether 
the indicated steps in treatment and other essential elements such as monitoring with 
the BAI were applied. Missing data about remission of a patient were collected from 
patient questionnaires at follow-up. The CAU checklist assessed what kind of care the 
GP offered to patients (ie counselling or referral to primary or specialty mental health 
care). Medication use in both groups was measured by the patient-completed 
Trimbos/iMTA questionnaire for Costs associated with Psychiatric Illness (TiC-P) 
(Hakkaart-van Roijen 2002). 
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Sample size calculation 
The study was powered to detect a clinically relevant difference of 0.5 standard 
deviation (6 points) of CSC versus CAU on the continuous measure of the BAI, 
(Cohen 1988) with a power of 0.90 (α=0.05), and an estimated intraclass correlation 
coefficient (ICC) of 0.01 with 5 patients per cluster. With an expected loss to follow-
up of 25% we aimed to include 89 patients per arm (Muntingh et al. 2009). 
 
Data analysis 
All analyses were done according to intention to treat principles. SPSS version 15.0 
(SPSS Inc. 2006) was used for the analysis of baseline characteristics using t-tests for 
continuous measures and χ2 tests for categorical variables. MLwiN V2 2.21 (Rasbash 
et al. 2011) was used for the linear multilevel regression analysis of the primary and 
secondary outcome measures. Multilevel analysis allows to model the variability of the 
outcome measure within clusters and allows to analyse a repeated measure design in 
the presence of missing data (Twisk 2006). In this cluster randomised trial, four levels 
were identified: (1) repeated measurements, (2) patients, (3) primary care practices and 
(4) care managers. An intraclass correlation coefficient (ICC) was calculated to give 
insight into the variability of the outcome measure at the level of the care manager 
(cluster). The effect size was calculated by dividing the between group difference by 
the pooled standard deviation (Cohens d). All p-values are two-tailed (α = 0.05).  
Propensity scores were used to correct for possible bias introduced by cluster 
randomisation (van der Feltz-Cornelis CM et al. 2006; Muntingh et al. 2009). The 
OASIS score was used as a proxy for the severity of the anxiety at baseline 
(correlation between OASIS and BAI score at baseline: r = 0.69). Variables that 
differed significantly at baseline between CSC and CAU were tested for a significant 
interaction with treatment condition. No patients were excluded from the analysis, 
except for patients who already had a score of 11 or below on the BAI at baseline, 










One hundred and eighty patients were included, 114 in the collaborative care group 
(83 selected by their GP and 31 selected in the EMR) and 66 in the care as usual 
group (16 patients selected by their GP and 50 selected in the EMR). Table 1 
summarises the demographic and clinical characteristics of the participants. The mean 
age was 46.5 (SD 15.5) and the majority of the patients was female (68.3 %). 
Significant differences between groups were found in baseline BAI and OASIS score 
and antidepressant use. Patients in the intervention group scored higher on both 
anxiety scales than patients in the control group. Furthermore, significantly more 
patients in the control group used antidepressants at baseline compared to the 
intervention group. 
 
Table 1. Baseline demographic and clinical patients characteristics for 
collaborative stepped care (CSC) and care as usual (CAU). 
 CSC 
(N = 114) 
CAU 
(N = 66) 
Total 






 N % N % N %  
Age, mean (SD) 44.98 (15.06) 49.08 (15.93) 46.48 (15.47) .087 
Anxiety score (BAI), mean (SD)
a 
24.59 (11.52) 20.04 (11.28) 22.09 (11.55) .01* 
Anxiety impairment score 
(OASIS), mean (SD)
a 
8.14 (4.14) 6.02  (4.26) 7.36 (1.30) .001* 
Depression score (PHQ9),  
mean (SD)
a 
9.40 (5.62) 8.98 (5.77) 9.25 (5.66) 0.64 
Mental health component  
score (SF-36 MCS), mean (SD)
a 
32.56 (11.26) 35.74 (13.00) 33.72 (11.99) 0.09 
Physical health component 
score (SF-36 PCS), mean (SD)
a 
48.43 (8.73) 47.75 (10.38) 48.18 (9.35) 0.64 
Euroqol EQ-5D score,  
mean (SD)
a 
0.67 (0.17) 0.70 (0.14) 0.68 (0.16) 0.26 
Gender       .09 
     Male 31 27.2 26 39.4 57 31.7  
     Female 83 72.8 40 60.6 123 68.3  
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Country of birth       .50 
    The Netherlands 101 89.4 58 89.2 159 89.3  
    Other European country 4 3.5 1 1.5 5 2.8  
    Non-European country 8 7.1 6 9.2 14 7.9  
Level of education       .709 
     Low 51 44.7 29 44.6 80 44.7  
     Intermediate 42 36.8 21 32.3 63 35.2  
     High 21 18.4 15 23.1 36 20.1  
Married / living together 65 57.5 41 63.1 106 59.6 .231 
Primary diagnosis       .943 
     PD 48 42.1 29 43.9 77 42.8  
     GAD 32 28.1 17 25.8 49 27.2  
     PD & GAD 34 29.8 20 30.3 54 30.0  
Age of onset, mean (SD)        














Co-morbid depression 34 29.8 22 33.3 56 31.1 0.624 
Psychological treatment in the 
past 
62 56.9 43 70.5 105 61.8 .080 
Use of antidepressants 23 21.9 23 38.3 46 27.9 .024* 
Nr of psychiatric diagnoses,  
mean (SD) 
2.59 (1.54) 2.26 (1.17) 2.47 (1.42) .107 
Nr of chronic conditions, mean 
(SD) 
1.35 (1.57) 1.58 (1.49) 1.4 (1.54) .348 
a














Three clusters (two in CAU and one in CSC) were excluded because they did not 
include any patients. The follow-up questionnaires were returned by 152 patients 
(85%) at three months, 137 patients (76%) at six months, 134 patients (74%) at nine 
months and 135 patients (75%) at twelve months. Seventeen patients did not return 
any of the follow-up questionnaires. There were no significant differences in dropout 
rates between the two conditions.  
 
Results primary outcome measure 
Clusters ranged from 1 to 15 included patients (median 5) and the ICC was 0.038. A 
significantly larger reduction was found in mean BAI score from baseline to three, six, 
nine and twelve months in CSC compared to CAU (see Table 2 and Figure 2). The 
effect sizes of the difference between mean BAI scores at the follow-up 
measurements were small to moderate. The results were not significantly influenced 
by antidepressant use at baseline.  
 
Results secondary outcome measures 
No significant differences between CSC and CAU were found for time to first 
remission (difference in change score (b) = 0.33, 95% CI -0.16 to 0.81), time to first 
response (b=-0.43, 95% CI -1.32  to 0.45) or the absence of response or remission 
(b=-0.003, 95% CI -0.33 to 0.33). Significant differences were found at three and 
twelve months on depressive symptoms (PHQ-9) and mental health (SF-36), and at 
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Table 2: Mean BAI scores, effect size and change scores of CSC (N=114) 
versus CAU (N=66) from baseline to 3, 6, 9 and 12 months 
a The multilevel model was corrected for propensity score and anxiety severity at baseline (OASIS 
score) 
b Between-group effect size was calculated by the difference in means, divided by the pooled 
standard deviation 
c Difference in reduction in BAI score from baseline to 3, 6, 9 and 12 months (CSC vs. CAU) 
d P-value of the difference in change scores, calculated with the Wald-test 
 



















     






-5.11 -8.28-   
-1.94 
0.001 






-4.65 -7.93-    
-1.38 
0.01 






-5.67 -8.97-     
-2.36 
0.001 













Figure 2. Mean score on the Beck Anxiety Inventory (BAI) over time for CSC and CAU, corrected 
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Adherence to treatment and content of care  
Checklists about adherence to treatment and content of care were retrieved of 103 
CSC patients (90.4%) and 56 CAU patients (84.8%). Table 3 shows that half of the 
CSC patients achieved remission after step 1. However, many patients (N=42, 41%) 
discontinued the CSC program before achieving remission of whom 11 (26%) were 
referred to another mental health professional. The psychiatrists were consulted for 
only 10 (22%) of the patients who discontinued the program. 
 
 Table 3 Proportion of patients in which essential elements of collaborative 
stepped care were indicated and applied (N=103) 
Elements of 
CSC 
























80 (78%) 15 8 (22%) 
Step 2 Patients who concluded 
step 1,  
but did not achieve 




9 (32%) 1 18 (68%) 
Step 3 Patients who concluded 
step 2,  
but did not achieve 
remission after step 2 





successfully concluded  
step 1, 2 or 3 




Patients who started 
step 1 




Patients who did not 
follow indicated steps 
45 (44%) 10 (22%) 0 35 (78%) 
1




 of patients with element (partly/not) applied/N
o 






We formed subgroups of patients in both CSC and CAU based on the form of 
treatment they received. Table 4 shows the outcome at twelve months for the 
different subgroups, with CAU patients who received no treatment  as the reference 
group. Only CSC patients who at least concluded step 1 had a significantly lower score 
than the CAU "no treatment" group. Non-adherent CSC patients differed from other 
CSC patients on various baseline variables:  they were more often widowed or 
divorced (34.7 vs. 7.6%), were selected from the EMR instead of selected by their GP 
(56.5% vs. 18.8%), had a low level of education (65.2% vs. 37.5%), were taking 
antidepressants at baseline (42.1% vs. 14.3%), were older (mean 53.6 vs. 42.8) and 
suffered from more chronic conditions (mean 2.1 vs. 1.3). 
 
Table 4 Content of care in the CSC group (N=103) and in the CAU group 
(N=63), related to the reduction in BAI score after 12 monthsa 
 
CSC (N=103) N , % Reduction in BAI 
score at 12 months  
Mean [95% CI] 









-7.32 [-14.19- -0.45] 
Non-adherent (guided self-help ≤2 sessions) 23 (22.3%) -1.17 [-9.11-6.78] 
CAU (N=63) N , %  




11  (17.5%) 
3.37 [-3.72-10.47] 
Specialty mental health care 11 (17.5%) 0.08 [-8.68-8.85] 
No treatment/non-adherent 15 (23.8%) Reference group 
a 
Analysis with a multilevel linear regression model, correcting for propensity score and baseline 
severity (OASIS) 
*≥3 sessions (no medication or medication unknown) 
**By GP, psychiatric nurse or primary care psychologist 




The results of this study indicate that collaborative stepped care is more effective in 
reducing anxiety symptoms than care as usual, both in the short and the long term. 
The largest difference between the two groups was found after twelve months, 
suggesting a relapse of the anxiety in care as usual patients and a persistence of a 
positive effect in the collaborative stepped care patients. This may be due to the 
activating elements in the collaborative stepped care treatment and the relapse 
prevention program provided to a significant proportion of collaborative stepped care 
patients. 
The anxiety disorders in our sample were fairly chronic, with a mean age of onset of 
31, while the mean age of participants was 46. This supports the idea that anxiety 
disorders in primary care need a continuous and multidisciplinary approach as offered 
in collaborative stepped care.  
The effectiveness of CSC in this study is generally comparable with the outcomes of 
collaborative care studies without stepped care, although the effect sizes in the early 
stages of the trial (3 to 9 months) tended to be smaller in our study, which may have 
to do with our stepped care approach. Moreover, in previous collaborative care 
studies, significant differences in response and remission rates were found (Roy-Byrne 
et al. 2001; Rollman et al. 2005; Roy-Byrne et al. 2005b; Roy-Byrne et al. 2010). We did 
not find such a difference, which may be explained by a large proportion of patients in 
the care as usual group who did either not improve or showed a worsening of 
symptoms. This effect is visible on a continuous outcome measure, but minimally on a 
dichotomous outcome measure. 
 
Strengths and limitations 
A strength of this study is the naturalistic setting in which care was provided. The 
participating care managers, GPs and psychiatrists were all professionals working in 
the field in contrast to care managers and psychiatrists in previous collaborative care 
studies (Curran et al. 2012). Therefore, the results are likely to approximate the results 
of collaborative stepped care in everyday practice. Indeed, the CAU patients in our 




in Dutch primary care (van Beljouw et al. 2010). Another strength of this study is that 
we used multilevel analysis, correcting for differences on the level of the health care 
professionals and accurately estimating the effects on the level of the participants. 
Furthermore, we did collect data about the actual content of care in both groups, 
while this information is often missing in collaborative care trials (Gilbody et al. 2006). 
The choice of a cluster randomised trial was based on the notion that there is a risk of 
substantial contamination in patient randomised trials using complex interventions 
such as collaborative care (Richards et al. 2008). However, cluster randomisation 
carries a risk of selection bias. To diminish this risk, all patients were interviewed with 
the MINI PLUS by a blinded interviewer and patients were kept blinded for the 
condition of their GP until baseline. Despite of these efforts, differences between the 
CSC group and the CAU group at baseline appeared. Patients in the collaborative 
stepped care group had a higher severity of anxiety and did less often take 
antidepressants at baseline. In the analysis we corrected for possible errors introduced 
by selection bias with propensity scores and we corrected for the anxiety severity at 
baseline. Antidepressant use at baseline did not have a significant influence on 
treatment effect. Another limitation of this trial is that, despite extensive supervision 
and instruction of the care managers and GPs, the stepped care model was not 
optimally implemented. A significant proportion of patients did either not complete 
step 1 (22%) or did not continue to step 2 while remission was not yet achieved 
(18%). Some of these patients (N=11, 26%) were referred to another professional, 
while other patients may have perceived no further need for treatment because of a 
decline in symptoms or the presence of medical or social problems that required 
attention. The relatively low rate of patients continuing to the second step compares to 
the results of a recent stepped care trial (Seekles et al. 2011) and an analysis of the 
implementation of stepped care in routine practice (Richards et al. 2012; Taylor et al. 2012). 
However, it does warrant attention because patients who have residual symptoms of 
anxiety are prone to a relapse of the anxiety disorder (Karsten et al. 2011).  
 
Further research and analysis 
To further improve the effectiveness of CSC, efforts may be needed to increase 
patient adherence, for example by offering patients a choice out of different 
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interventions at the start of treatment (Kwan et al. 2010) (matched care) and evaluating 
the treatment plan with the patient in an early stage of treatment. Provider adherence 
may be enhanced by increasing the case load and supervision of care managers, 
intensifying the role of psychiatrists, placing more emphasis on relapse prevention and 
using a web-based tracking system to guide professionals in providing care and 
communication (Roy-Byrne et al. 2010; Huijbregts et al. 2012). Another approach, 
exploring possibilities for matched care, might be to develop a prediction model 
resulting in a risk profile for early treatment drop-out or non-response. Following our 
exploratory analysis of variables related to non-adherence, living situation, level of 
education, antidepressant use, age, co-morbid chronic diseases and the clinical 
evaluation of the GP may be good candidates for such a prediction model. The cost-
utility of CSC will be described in a future paper. 
 
Conclusions 
This is the first study, to our knowledge, to demonstrate the effectiveness of 
collaborative stepped care for anxiety disorders, with guided self-help as a first step, 
compared to care as usual. Despite of a suboptimal implementation of the stepped 
care model, CSC patients experienced a greater decrease in anxiety symptoms, which 
was maintained over time. Effective elements in CSC may be the collaboration 
between professionals, the guided self-help method and relapse prevention. Policy 
efforts are needed to facilitate implementation of CSC in primary care.  
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Cost-utility analysis of a Collaborative Stepped Care intervention 
for panic - and generalised anxiety disorder in primary care 
 
Goorden, M., Muntingh, A.D.T., van Marwijk, H.W.J., Spinhoven, Ph., Adèr, H.J., 
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Background: Generalised anxiety and panic disorder are a burden on society because 
they have a significant adverse effect on the quality of life and are costly. Collaborative 
Stepped Care has proven to be an effective treatment. The aim of this study was to 
evaluate the cost-utility of a Collaborative Stepped Care intervention for panic 
disorder and generalised anxiety disorder in primary care compared to Care As Usual 
from a societal perspective.  
Methods: The design of the study was a two armed cluster randomised controlled 
trial. In total 43 primary care practices in the Netherlands participated in the study. 
Patients were selected by their general practitioner or by a research assistant using a 
screening instrument. To classify DSM-IV disorders, these patients were approached 
for a diagnostic interview (MINI-PLUS). Eventually, 180 patients, diagnosed with 
panic disorder or generalised anxiety disorder were included in the study (114 
Collaborative Stepped Care, 66 Care As Usual). Baseline measures and follow up 
measures (3, 6, 9 and 12 months) were assessed using questionnaires. We applied the 
TiC-P, the SF-HQL and the EQ-5D respectively measuring health care utilisation, 
production losses and general health related quality of life.  
Results: The average annual direct medical costs in the Collaborative Stepped Care 
group were 1,854 Euro (95% CI 1,726 to 1,986) compared to 1,503 Euro (95 % CI 
1,374 to 1,664) in the Care As Usual group. The average quality of life years (QALY's) 
gained was higher in the Collaborative Stepped Care group, with a difference of 0.05 
(95% CI 0.04 to 0.07). The direct medical costs were also higher in the Collaborative 
Stepped Care group, leading to an incremental cost-effectiveness ratio (ICER) of 
6,385 Euro per QALY. At a threshold of 20,000 Euro/QALY the probability that the 
ratio is acceptable was more than 90%. Inclusion of the productivity costs, 
consequently reflecting the full societal costs, decreased the ratio even more. 
Conclusion: The study showed that Collaborative Stepped Care was a cost effective 
intervention for panic disorder and generalised anxiety disorder and was even 
dominant when a societal perspective was taken.  
Trial registration: Netherlands Trial Register NTR1071 
 
 




Generalised anxiety disorder (GAD) and panic disorder (PD) occur in 4% to 8% of 
patients in primary care (Kroenke et al. 2007; Lieb et al. 2004; Roy-Byrne et al. 2004; 
Roy-Byrne et al. 2005a). They are associated with an adverse effect on quality of life 
(Barrera & Norton, 2009; Beard et al. 2010; Bereza et al. 2009; Olatunji et al. 2007), 
higher health care use, reduced productivity and higher health care costs compared to 
non-anxious individuals (Andlin-Sobocki & Wittchen, 2002; Bereza et al. 2009).  
Although they are a great burden to society, anxiety disorders are not sufficiently 
recognised and treated by general practitioners (GPs) (Fernandez et al. 2007; Roy-
Byrne et al. 2002; Stein et al. 2004; Stein et al. 2011). Whereas pharmacological 
treatment is frequently initiated for generalised anxiety and panic disorder (Smolders et 
al. 2008; Stein et al. 2004), research indicates that compared to care as usual, cognitive 
behavioural therapy is more cost-effective (Heuzenroeder et al. 2004), preferred by 
most patients (Prins et al. 2009; van Schaik et al. 2004; Walters et al. 2008) and leads to 
more sustainable effects (Heuzenroeder et al. 2004; Nadiga et al. 2003). Another 
problem in current primary care is that the continuity of care is not ensured, because 
response to treatment is rarely monitored. Consequently, there is no opportunity to 
adapt treatment accordingly (Bakker et al. 2010; Katon et al. 2001) or intervene post-
treatment when considered necessary (Roy-Byrne et al. 2004; Roy-Byrne et al. 2005a). 
Continuity of care is important because anxiety disorders often run a chronic or 
intermittent course (Roy-Byrne et al. 2004; Roy-Byrne et al. 2005a). 
To address these problems, collaborative care models have been developed. These 
days a promising treatment model is Collaborative Stepped Care (Bower & Gilbody, 
2005).  In Collaborative Stepped Care pharmacological treatment is only indicated if 
cognitive behavioural therapy is insufficient. In addition, Collaborative Stepped Care 
may work in a more efficient way in terms of resource use and costs, because of the 
focus on low intensity treatment in the first steps (Bower & Gilbody, 2005).  
There is evidence that the collaborative care model is an effective intervention for 
patients with anxiety disorders (Rollman et al. 2005; Roy-Byrne et al. 2010; Roy-Byrne 
et al. 2005b; Roy-Byrne et al. 2001). Recently, a study on the effectiveness of 




symptoms in panic and generalised anxiety disorder than care as usual (Muntingh et al. 
2012). Until now there have been no studies on the cost-effectiveness of the 
Collaborative Stepped Care model for anxiety disorders. Some research has been done 
regarding the cost-effectiveness of collaborative care for major depression which 
suggests that collaborative care is a cost-effective intervention (van Steenbergen-
Weijenburg et al. 2010)  and is associated with good economic value (Jacob et al. 2012). 
A study of Joesch and colleagues (2011) showed that a collaborative care intervention 
for patients with panic disorder, generalised anxiety disorders, social anxiety disorders 
and posttraumatic stress disorder, provided higher benefits and only slightly increased 
costs, compared to usual care (Joesch et al. 2011). Two previous studies concerning 
panic disorders indicate that collaborative care may be cost-effective (Katon et al. 
2006) or even dominant (Katon et al. 2002) compared to usual care. However, these 
studies were conducted in the United States, so results may not be easily generalised to 
the European health care setting. Furthermore, none of the studies used a stepped 
component in collaborative care.  Finally, most of these studies did not take a societal 
perspective.  
Hence, the aim of this study was to evaluate the cost-utility of a Collaborative Stepped 
Care intervention compared to a care as usual intervention in patients with panic 















Recruitment and randomisation 
This cost-utility analysis was part of a two armed cluster randomised trial to evaluate 
the effectiveness of the Collaborative Stepped Care program. Study methods are 
described in detail elsewhere and are summarised in this section (Muntingh et al. 2009). 
The study was conducted at 43 primary care practices (PCPs) with 63 GPs in the 
region of a large mental health centre (Rivierduinen) in the Netherlands. The PCPs 
assigned 31 mental health professionals, consisting of 3 psychologists and 28 
psychiatric nurses. Six experienced psychiatrists working in the mental health care 
centre operated as consultant psychiatrists for the intervention group. Cluster 
randomisation was executed at the level of the mental health professionals who were 
randomised to Collaborative Stepped Care or Care As Usual. A first selection of 
patients was performed by the GPs or by a research assistant using the electronic 
medical records (EMR) of patients. The selected patients were then assessed by a self-
report screening scale, the Patient Health Questionnaire anxiety subscales (PHQ) 
(Spitzer et al. 1999). The patients who were selected from the EMR and who were 
considered to be screen positive and all patients selected by the GP were approached 
for a telephone interview to detect mental disorders (MINI PLUS International 
Neuropsychiatric interview) (van Vliet et al. 2007).  
 
Intervention 
The intervention consisted of four integrated evidence-based treatment steps (Figure 
1): Guided self-help (van Boeijen et al. 2005), cognitive behavioural therapy, 
antidepressants according to a medication algorithm and optimisation of medication 
in primary care or referral to secondary care. After each step remission was 
determined with the Beck Anxiety Inventory (BAI)(Beck et al. 1988). If a patient did 
not achieve the criteria for remission (BAI≤11) after a certain step in the program the 
patient moved to the next step, otherwise the patient started a relapse prevention 
program. Mental health professionals (care managers) and general practitioners 
randomised to the Collaborative Stepped Care group were trained in the intervention. 






Figure 1: Collaborative Stepped Care treatment algorithm. 
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follow-up appointments in which both adherence and progress were evaluated. If a 
patient achieved remission after step one, two or three, relapse prevention was offered 
by the care manager by calling the patient every month and assessing anxiety 
symptoms with the BAI.  Details of the program are reported elsewhere (Muntingh et 
al. 2009). 
 
Care As Usual 
The patients treated by GPs assigned to the Care As Usual condition could obtain any 
services normally available in the Netherlands. Every PCP could use the assistance of 
a psychiatric nurse. As the Care As Usual was operating as a control group, the GPs 
and psychiatric nurses did not receive additional training. The Dutch guideline of the 
treatment of anxiety disorders in primary care was accessible for all the GP’s (Terluin 
et al. 2004). Although GPs were notified of the diagnosis of referred patients, they 
were not notified of the diagnosis and participation of screened patients. Patients in 
the Care As Usual group were all advised to seek treatment. After one year type of 
treatment delivered was assessed at the PCP by a research assistant using a checklist.  
 
Data collection and outcome measures 
The data was collected at 3-months intervals: Measurement took place at baseline 
(T0), three (T1), six (T2), nine (T9) and twelve (T4) months after inclusion. The self-
report questionnaires were processed by blinded research assistants. 
The aim of this economic evaluation was to assess the cost utility of Collaborative 
Stepped Care compared to Care As Usual. All relevant costs to society associated with 
the burden of anxiety disorders were taken into account: costs attributable to contacts 
with health providers, costs of medications (direct medical costs) and costs of 
productivity losses due to the anxiety disorder (productivity costs). Cost-utility was 
calculated by relating the difference in direct medical costs per patient receiving 
Collaborative Stepped Care or Care As Usual to the difference in terms of quality 
adjusted life years gained (cost-utility). This yielded a cost per QALY estimate. The 








For calculating the total direct medical costs, the Trimbos/IMTA questionnaire for 
Costs associated with Psychiatric Illness (TiC-P) (Hakkaart-van Roijen, 2002)  was 
used. The TiC-P measures utilisation of medical treatment such as the number of 
contacts with the GP and multiple other care providers (e.g. medical specialists and 
paramedics) during the last three months, as well as the medication used. The costs 
were estimated using the Dutch guidelines for cost calculations in health care 
(Oostenbrink et al. 2004). Reference unit prices from 2009 of the corresponding health 
care services were applied (Hakkaart-van Roijen et al. 2010).  Unit costs per contact of 
the care manager were comparable to that of a nurse practitioner. 
 
Productivity costs 
For calculating productivity losses the Health and Labor questionnaire (SF-HQL) (van 
Roijen et al. 1996) was used. The SF-HLQ consists of three modules: absence from 
work, reduced efficiency at work and difficulties with job performance (van Dam et al. 
1998).  Productivity losses as measured by the SF-HLQ were valued over 4 weeks by 
using the "friction cost method" (Koopmanschap et al. 1995). This method takes into 
account the economic circumstances that limit the productivity lost to society. 
 
Quality of life 
The EuroQol (EQ-5D) (Cheung et al. 2009) generic health index is a standardised, 
patient-completed instrument which consists of five dimensions (i.e. mobility, self-
care, usual activities, pain/discomfort, and anxiety/depression). Each dimension is 
rated by the patient on three levels (no problems, some problems, and extreme 
problems). Thus, 243 (3^5) distinct health states are defined, each with a unique utility 
score, ranging from 1 (perfect health) to 0 ('death'). The health states were linked to 
empirical valuations of the Dutch general public, allowing utilities to be computed. To 
obtain one utility score, the patients mean utility scores were first linearly interpolated 
between utility scores over the study period. To calculate utility gain or loss the area-
under-the curve method (AUC) was applied (Matthews et al. 1990).  
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Cost Utility analysis 
An incremental cost-effectiveness ratio was calculated to calculate the costs per 
Quality Adjusted Life Year (QALY). The incremental cost-effectiveness ratio was 
calculated by dividing the incremental costs by the incremental effects. 
 
Statistics  
Analyses were conducted using the Statistical Package for the Social Sciences 19.0 
(SPSS 19.0), Statistics and data (Stata 8.0 se) and Excel. First, the direct costs and 
quality of life scores were calculated by SPSS. No selective dropout was observed. The 
percentage of non-responders in the cost-data is shown in table 1.  
 
Table 1: Pattern of non-response of participants (N=180) on the EQ5D and 









Missing values in direct costs and quality of life scores per time unit were modelled 
and imputed with chained equations (PMM) in Stata. Ten imputed datasets were 
created. Different baseline variables, like age and gender were included to get a better 
estimate. Propensity scores were used to correct for baseline differences between both 
groups. As our outcome measures differed from those in the effectiveness study of 
Muntingh and colleagues (2012), different confounders were used to balance our 
scores and propensity scores were again calculated. The uncertainty in the analysis was 
assessed using bootstrapping. This was expressed in a cost-effectiveness acceptability 
curve. The acceptability curve illustrates the probability that the cost-effectiveness 
ratio will be accepted for different cost limits.  
 
    Non-response EQ5D Direct Costs 
      After 3 months 15.6 % 15.6 % 
      After 6 months 26.7 % 26.7 % 
      After 9 months 26.1 % 26.1 % 






Table 2 summarises the baseline demographic and clinical patient characteristics for 
Care As Usual and Collaborative Stepped Care. In total 180 participants were included 
in the study (66 participants in the CAU group and 114 in the CSC group). At 
baseline, there was a significant difference between the groups on the BAI scores 
which affected QALY’s gained, so propensity scores were calculated to compensate. 
 
Direct medical costs 
The total average direct medical costs were 1,854 Euro (95% confidence interval (CI) 
1,726 to 1,986) for the Collaborative Stepped Care group, compared to 1,503 Euro (95 
% CI 1,374 to 1,664) for the Care As Usual group. The average number of contacts 
and costs per health care provider are presented in Table 3. The percentage of costs 
are also presented in a pie chart, see Figure 2.  
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Table 2: Baseline demographic and clinical patient characteristics for Care As 
Usual and Collaborative Stepped Care 
 
 Collaborative Stepped 
Care (N = 114) 
Care As Usual 
(N = 66) 
Total 
(N = 180) 
Mean Age (SD) 44.98 (15.06) 49.08 (15.93) 46.48 (15.47) 
Gender (% male) 31 (27.2 %) 26 (39.4 %)  57 (31.7 %) 
Number of people with a 
paid job (%) 
77 (67.5%) 41 (62.1 %)  118 (65.6 %) 
Mean BAI Score * (SD) 24.59 (11.52) 20.04 (11.28) 22.09 (11.55) 
Depression score (PHQ9), 
mean (SD) 
9.40 (5.62) 8.98 (5.77) 9.25 (5.66) 
EQ-5D, mean (SD) 0.61 (0.25) 0.65 (0.23) 0.64 (0.25)  
Level of education   
Elementary school    10 (8.8%) 4 (6.2%) 14 (7.8%) 
High school 68 (59.6%) 35 (53.8%) 103 (57.5%) 
College 36 (31.6%) 26 (40.0%)  62 (34.6%) 
Primary diagnosis   
PD 48 (42.1%) 29 (43.9%) 77 (42.8%) 
GAD 32 (28.1%) 17 (25.8%) 49 (27.2%) 
PD & GAD 34 (29.8%) 20 (30.3%) 54 (30.0%) 
Co-morbid Depression   
Yes 34 (29.8%) 22 (33.3%) 56  (31.1%) 
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Productivity costs 
The indirect costs were €1,052 (SD=2,585) and €2,007 (SD=1,044) respectively for 
the Collaborative Stepped Care group and the Care As Usual group. Productivity cost 
due to absence from work were respectively €586 (SD=1,901) and €1,423 (SD=1,099) 
for the Collaborative Stepped Care group and the Care As Usual group. Costs caused 
by inefficiency at work were €611 (SD=1,552) and €677 (SD=1,330) for the 
Collaborative Stepped Care group and the Care As Usual group respectively. 
 
Quality of life 
Quality of life scores were imputed. The overall improvement in quality of life over 
time was calculated by the Area Under the Curve method. After imputation, outcome 
variables were corrected, using propensity scores and bootstrapping, which did bring 
more balance in our baseline scores on quality of life. A balance table was generated, 
see Table 4. Quality of life scores are shown in Table 5. The difference in 
improvement between both groups of 0.05 QALY’s was significant over time (95% 
CI 0.04 to 0.07, p<0.01). 
 
Table 4: Balance table for the EQ5D at baseline 
 Collaborative Stepped Care Care As Usual 
Baseline before propensity scores 0.61 (SD=0.25) 0.65 (SD=0.23) 
Baseline after propensity scores 0.62 (SD=0.24) 0.60 (SD=0.25) 
 
Table 5: Mean Utility scores (SD) by treatment arm at baseline, after 3 months, 
after 6 months and after 1 year. 
 Collaborative Stepped Care Care As Usual 
Baseline 0.62 (SD=0.24) 0.60 (SD=0.25) 
After 3 months 0.71 (SD=0.22) 0.65 (SD=0.23) 
After 6 months 0.73 (SD=0.24) 0.64 (SD=0.26) 
After 9 months 0.73 (SD=0.24) 0.72 (SD=0.25) 







Cost Utility Analysis 
The average quality of life years (QALY's) gained was higher in the Collaborative 
Stepped Care group. The direct medical costs were also higher in the Collaborative 
Stepped Care group, leading to an incremental cost-effectiveness ratio (ICER) of 
€6,385 per QALY, see Table 6.  
 
Table 6. The mean direct medical costs, QALY's gained (incremental utility), 
and the incremental costs per QALY (ICER) 
 Collaborative Stepped Care (n=114) Care As Usual (n=66) 
Average direct medical 
costs 
€ 1,854  
(95% CI 1,726 to 1,986) 
€ 1,503  
(95% CI 1,374 to 1,664) 
Incremental utility 0.05 (95% CI 0.04 to 0.07) 
ICER 6,385 
 
We first explored the incremental cost utility for the direct costs. The incremental 
cost-effect ratio (100%) falls in the northeast quadrant of the incremental cost-
effectiveness plane, demonstrating that Collaborative Stepped Care is more costly but 
also more effective than the Care As Usual. Another way to present the uncertainty in 
the data is the acceptability curve shown in Figure 3.  
For example, at a threshold of 20,000 Euro/QALY the probability that the ratio is 
acceptable is more than 90%. From this figure, we may also conclude that, taking 
uncertainty into account, Collaborative Stepped Care is cost effective.  
Including productivity costs did change our result as Collaborative Stepped Care 
became dominant, meaning that it was less costly and more effective compared to 
Care As Usual. The ratio decreased to -4,977 Euro/Qaly. The majority (91%) of the 
incremental cost-effect ratio now fell into the southeast quadrant demonstrating that 
collaborative care was dominant. At a threshold of 20,000 Euro/QALY the 
probability that the ratio is acceptable is 100 %, see Figure 4.  
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Figure 3. Acceptability curve for the direct costs of Collaborative Stepped Care. 
 
 







This study is the first cost-utility analysis comparing Collaborative Stepped Care to 
Care As Usual for anxiety disorders and shows that Collaborative Stepped Care is a 
highly cost-effective intervention. This study showed that the cost per QALY from a 
health care perspective was 6,385 Euro/QALY. Including productivity costs (societal 
perspective) decreased the ratio to -4,977 Euro/Qaly.  
According to the Council for Public and Health Care (RVZ) the threshold in relation 
to the acceptability of the treatment has to depend on the severity of disease with a 
maximum Incremental Cost-effectiveness Ratio (ICER) of 80,000 Euro/QALY. In 
our study, the uncertainty in the ICER was very low; at a threshold of 20,000 
Euro/QALY the probability that the ICER would be accepted was almost 90% and 
even 100% when including productivity costs. Hence, treating patients with 
generalised anxiety or panic disorder in primary care applying Collaborative Stepped 
Care is a highly cost-effective intervention. 
The differences in medical costs are mainly due to the higher costs of the care 
manager in the collaborative care group compared to the Care As Usual group. 
Paramedic costs were high for both groups showing that besides mental health care, 
somatic care is frequently used (Koopmans & Lamers, 2006). Medical costs of 
Collaborative Stepped Care were comparable to those of guideline concordant care 
for patients with anxiety or depressive disorders (Prins et al. 2011). Including the 
productivity costs did change our results as the costs for absence at work were higher 
in the Care As Usual group. This finding supports the research of Krol and colleagues 
(2011) and Smit and colleagues (2006), as productivity costs had a considerable effect 
on our outcomes.  
Over time, the quality of life improved more in the Collaborative Stepped Care group 
when compared to the Care As Usual group. In the Care As Usual group quality of 
life declined slightly after 9 months, indicating that Collaborative Stepped Care may 
have a more prolonged effect on the quality of life. In addition, the quality of life 
improved more rapidly in the intervention group. This may be due to the effectiveness 
of guided self-help that was administered in the first step of the treatment.  
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This study produced results which corroborate the findings of Katon and colleagues 
(2006) and Joesch and colleagues (2011) that the costs of collaborative care were 
higher and the effects were larger compared to care as usual for Panic Disorder. 
However, the findings of the current study do not fully support the previous research 
of Katon and colleagues (2002) which showed that collaborative care was dominant 
compared to care as usual from a health care perspective (only including medical 
costs). In our study, collaborative care was only dominant when including productivity 
costs. However, the intervention applied in the study of Katon and colleagues (2002) 
was different from our collaborative care intervention; a brief Psychiatric intervention 
was used in the intervention group that consisted of approximately 2 sessions per 
patient which was less than the approximately 6 sessions per patient in our 
intervention. In addition, there was no care manager involved in the study of Katon 
and colleagues (2002), who was responsible for the largest part of the additional costs 
in our study. None of the previous collaborative care studies used a stepped 
component in collaborative care. Furthermore, all previous studies were North 
American and since there are important differences between European and North 
American health care systems, these studies cannot be generalised without 
consideration.  
In the article of Bower and Gilbody (2005), it was suggested that Collaborative 
Stepped Care may cost less because of lower resource use.  However, in the present 
study resource use of both groups was comparable. At baseline, also patients who 
already received some (≤2 sessions per month) psychological or psychiatric treatment 
were included, so patients from the Care As Usual group and Collaborative Stepped 
Care were already equal in terms of resource use of these mental health care services. 
Despite the lack of difference concerning resource use, Collaborative Stepped Care 
was still cost-effective, due to the substantial influence that treatment had on quality 
of life.  
The study was conducted in a naturalised setting, which involved GPs selecting the 
patients. There was a selection bias for two reasons. Firstly, the GPs in the Care As 
Usual group had a preference for the collaborative care group and they had difficulties 
selecting patients for the Care As Usual group. Secondly, the GPs in the Collaborative 




improved ability to detect patients. To minimise selection bias after this initial 
selection, all patients followed the same procedure with a diagnostic interview 
conducted by a researcher who was blind for randomisation status. After selection 
patients were obliged to accept the assigned treatment. However, there were still more 
patients in the Collaborative Stepped Care group (N=114) than in the Care As Usual 
group (N=66). This study used cluster randomisation, which was necessary because 
otherwise the usual care would have been more restricted as the GP would not have 
the opportunity to send patients to a psychiatric nurse or psychologist because this 
professional was trained in the new intervention. In this way, the usual care would be 
restricted to prescription of medication or referral to secondary care.  
Based on age, gender, PHQ-score, EQ5D-score, level of education, primary diagnosis 
and comorbidity, the Care As Usual and the Collaborative Stepped Care group were 
comparable. They were not comparable with respect to their BAI score, so propensity 
scores were used to correct.  
Although Collaborative Stepped Care was cost-effective compared to Care As Usual, 
the results of this study leave room for improvement (Muntingh et al. 2012). Most 
importantly, not all the elements of stepped care approach were sufficiently 
implemented (Muntingh et al. 2012). There was a relatively large proportion of patients 
(36%) in the Collaborative Stepped Care group that did not want to continue 
treatment after step 1 (Muntingh et al. 2012). An explanation for this high rate of 
patients discontinuing after step 1 is that patients felt that they were sufficiently 
empowered to cope with their anxiety problems, although they did not achieve criteria 
for remission. As Scogin and colleagues (2003) already pointed out, research is needed 
to investigate if unsuccessfully treated patients with initial lower intensity treatments 
will be less willing to undergo further, more intensive treatment. The implementation 
of Collaborative Stepped Care may be further improved by increasing the case load of 
care managers, adjusting follow-up procedures to fit into the daily tasks of the care 
manager and improving medication prescription and adherence by a greater role of 
the care manager and the psychiatrist in medication management. 
Despite some of these limitations, the findings of this study suggest a high cost-
effectiveness for Collaborative Stepped Care for anxiety disorders. From a societal 
perspective, Collaborative Stepped Care even becomes dominant. In combination 
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with the effectiveness study (Muntingh et al. 2012), this finding highly supports the 
implementation of Collaborative Stepped Care in daily practice and widespread 
implementation is therefore justified.  
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Abstract 
Background: Questionnaires may help detection and diagnosis of anxiety disorders in 
primary care. However, utility of these questionnaires in target populations is rarely 
studied. Therefore the Patient Health Questionnaire anxiety modules (PHQ) were 
evaluated for use as: a) a screener in high risk patients, and/or b) a case-finder for 
general practitioners (GPs) to detect anxiety disorders. 
Methods: A cross-sectional analysis was performed, embedded in a cluster 
randomised controlled trial with 43 participating primary care practices in the 
Netherlands. The validity of the PHQ was assessed in two separate samples: 1) 170 
patients at risk for (developing) anxiety disorders according to their electronic medical 
records (high risk sample), 2) 141 patients identified as a possible ‘anxiety case’ by a 
GP (GP-identified sample). All patients completed the PHQ and were interviewed 
with the MINI International Neuropsychiatric Interview to classify DSM-IV anxiety 
disorders. Psychometric properties were calculated, and a logistic regression analysis 
was performed to assess the diagnostic value of the PHQ. 
Results: Using only the screening questions of the PHQ, the positive predictive value 
(PPV) was 76% and the negative predictive value (NPV) was 88% in the high risk 
sample. A positive PHQ score significantly increased the odds of an anxiety disorder 
diagnosis in high risk patients (odds ratio=23.4; 95% confidence interval 6.9 to 78.8). 
In GP-identified patients the official algorithm showed the best characteristics with a 
PPV of 96%, a NPV of 38% and an odds ratio of 13.9 (95% confidence interval 3.8 to 
50.6).  
Conclusions: The PHQ may be used to screen for anxiety disorders in high risk 
primary care patients and to confirm a preliminary anxiety disorder diagnosis made by 
a GP, but not for ruling out the presence of an anxiety disorder in GP-identified 
patients.  




In health care systems in which the general practitioner (GP) acts as the gatekeeper to 
mental health care, GPs ability to accurately detect and diagnose psychiatric disorders 
is crucial. Anxiety disorders are a major category of the psychiatric disorders 
encountered in primary care (Kessler et al. 2010). The ability of GPs to detect anxiety 
disorders has often been criticised (Kessler et al. 2002) as GPs only detect one third to 
one half of the patients with an anxiety disorder (Ormel et al. 1990; Wittchen et al. 
2002; Smolders et al. 2009). Although GPs do suspect psychological problems in many 
of these patients, they do not often classify these problems with a diagnosis of an 
anxiety disorder (Janssen et al. 2012). However, the classification of an anxiety disorder 
diagnosis facilitates the implementation of clinical guidelines, as these include 
diagnosis specific treatments (Smolders et al. 2009; National Institute for Health and 
Clinical Excellence 2011). Furthermore, the provision of multidisciplinary care may be 
enhanced by the use of common terms by GPs and mental health professionals 
(Gunn et al. 2010; Franx et al. 2012).  
To improve the identification of patients with anxiety disorders in primary care 
patients, screening is often considered (Buszewicz & Chew-Graham 2011). However, 
as screening large populations of patients is not considered feasible, purposeful 
screening of patients who are at high risk of developing a disorder has been proposed 
as an alternative (Christensen & Olesen 2005). As low-intensity treatments become 
increasingly available in primary care (Richards 2012) and through the internet 
(Andrews et al. 2010), this may open doors for the successful implementation of 
selective screening programs. Furthermore, a screening questionnaire might help GPs 
to distinguish psychological problems from an anxiety disorder (Tiemens et al. 1999). 
Patients appreciate the assessment of symptoms as part of the diagnostic process and 
GPs additionally use the questionnaire to explain the diagnosis to patients (Dowrick et 
al. 2009). However, the practical use of screening questionnaires, such as screening in 
high risk groups (selective screening) and assisting in diagnosing an anxiety disorder, 
are rarely studied. We chose to investigate the performance of the Patient Health 
Questionnaire (PHQ), because this scale was specifically designed for use in primary 
care (Spitzer et al. 1999) and has shown adequate psychometric properties (Spitzer et al. 
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1999; Diez-Quevedo et al. 2001; Persoons et al. 2003). The PHQ consists of different 
modules about common mental health disorders, including a module about panic 
disorder and one about general anxiety. Earlier studies about the PHQ anxiety module 
focused on the validity as a screener in a random primary care sample (Spitzer et al. 
1999), different groups of hospital patients (Spitzer et al. 2000; Diez-Quevedo et al. 
2001; Persoons et al. 2003), the community (Eack et al. 2006) and in psychosomatic 
outpatients (Lowe et al. 2003). A recent study showed that the ability of the PHQ 
panic module to detect panic disorder in high risk primary care patients was moderate 
(Wittkampf et al. 2010). However, most GPs will be interested in the presence of any 
anxiety disorder, where after they may decide to perform extra diagnostic procedures 
or to refer the patient to a mental health professional. Therefore, we evaluated the 
PHQ anxiety modules for use as: a) a screener in high risk patients, and/or b) a case-





The present study was embedded in a cluster randomised controlled trial (RCT), 
focusing on the treatment of panic disorder and generalised anxiety disorder in 
primary care (Muntingh et al. 2009). Patients were recruited between November 2008 
and March 2010 in the 43 primary care practices participating in the RCT. Two groups 
of patients were studied: 1) primary care patients at risk for (developing) anxiety 
disorders, identified from their electronic medical record (high risk sample);  2) 
patients identified as a possible 'anxiety case' by their GP (GP-identified sample).  
 
Exclusion criteria 
Excluded were patients who were suicidal, patients who suffered from dementia or 
other severe cognitive disorders, psychotic disorder, bipolar disorder, dependence on 
drugs or alcohol, and patients who were in an unstable severe medical condition as 
diagnosed by their GP. Other exclusion criteria were insufficient knowledge of the 
Dutch language to complete the questionnaire and receiving regular psychological 
treatment.  
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Selection of the high risk sample 
To select patients who were at risk for (developing) anxiety disorders, electronic 
medical records (EMR) were searched. Of the 43 practices participating in the RCT, 
24 practices agreed to the screening procedure and did have an electronic system 
suitable for selecting patients from the EMR. Patients were selected from the EMR if 
they were over 18 years of age and had visited their general practitioner in the past 
three months with symptoms that were considered to indicate a high risk for anxiety 
disorders. Such symptoms were fatigue, headache, dizziness, weakness, muscle- and 
joint pain, stomach ache, chest pain, hyperventilation, (symptoms of) anxiety or 
depression, or social problems (such as loneliness or marital problems). These 
symptoms have been identified as risk factors for having or developing anxiety 
disorders (Kroenke et al. 1994; Karsten et al. 2011; Flensborg-Madsen et al. 2012).  
 
Selection of the GP-identified sample 
GPs were asked to identify patients with an anxiety disorder (specifically panic 
disorder and generalised anxiety disorder) for participation in the RCT. GPs (N=37) 
who were allocated to the intervention group of the RCT attended a 3-hour workshop 
on the diagnosis and treatment of anxiety disorders. GPs in the control group (N=26) 
of the RCT received an educational folder with instructions on how to diagnose 




Patients who were selected from the EMR (high risk sample) and patients who were 
identified by their GP (GP-identified sample) received a letter informing them about 
the RCT, together with an informed consent form and the Patient Health 
Questionnaire (PHQ) anxiety module. The patients were asked to return the PHQ and 
the informed consent form directly to the researcher. They were not informed about 
the allocation of their GP in the RCT. Patients who gave informed consent were 








The PHQ anxiety modules (Spitzer et al. 1999) consist of 22 questions concerning 
anxiety symptoms experienced during the past four weeks. The first 15 questions 
screen for a panic disorder, starting with four questions about the presence of panic 
attacks and anxiety (e.g. "In the last 4 weeks, have you had an anxiety attack - suddenly 
feeling fear or panic?") and subsequently asking about symptoms of panic attacks, 
such as "Were you short of breath?". The second part of the PHQ consists of 7 
characteristics of generalised anxiety, starting with a screening question "Feeling 
nervous, anxious, on edge, or worrying a lot about different things", followed by 
symptoms of generalised anxiety. The respondents are asked to indicate how often 
they were bothered by these problems ("not at all", "several days" or "more than half 
the days"). Good overall accuracy has been reported for both sub-scales (Spitzer et al. 
1999; Diez-Quevedo et al. 2001; Lowe et al. 2003). To screen positive on the panic 
module, the first four questions should be answered affirmatively, and at least four 
symptoms of panic attacks should be present. To screen positive for any anxiety 
disorder/generalised anxiety disorder, the first question should be answered with 
"more than half the days" and at least three symptoms of generalised anxiety should 
be present more than half the days (Spitzer et al. 1999). A positive score on one of the 
sub-scales was counted as a positive PHQ score. We also tested the diagnostic validity 
of the two screening questions, because the use of this simplified algorithm may be 
better suitable for high risk groups (Wittkampf et al. 2010) and is attractive for use in 
busy general practices. A confirmative answer on one of the two screening questions 
was counted as a positive PHQ screening score ("In the last 4 weeks, have you had an 
anxiety attack - suddenly feeling fear or panic?" and "Feeling nervous, anxious, on 
edge, or worrying a lot about different things - more than half the days"). 
 
Reference standard 
The Mini International Neuropsychiatric interview (MINI-PLUS) was used as a 
reference standard. The MINI-PLUS is a short structured diagnostic interview that is 
used to determine the most common DSM-IV (American Psychiatric Association 
2001) and ICD-10 (World Health Organisation 1993) psychiatric disorders (Sheehan 
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et al. 1998)(Dutch version (van Vliet et al. 2000)). The following anxiety disorders 
were classified: panic disorder (PD) with or without agoraphobia, generalised anxiety 
disorder (GAD), social phobia, simple phobia, obsessive compulsive disorder, post 
traumatic stress disorder and agoraphobia (without panic disorder). The interviewers 
who conducted the MINI interviews by telephone had a medical or psychological 
background, with degrees varying from undergraduate to master. They received 
training in how to carry out the MINI interview and were supervised by a psychologist 
and a psychiatrist. At least two interviews carried out by each interviewer were audio-
taped and evaluated by the psychologist. All interviewers were blinded for the PHQ 
score to prevent confirmation bias.  
 
Recruitment 
High risk sample 
The PHQ was sent to 2,408 patients who were at risk for developing an anxiety 
disorder according to the information in their EMR. A total of 786 (32.6%) patients 
completed and returned the questionnaire (Figure 1). The proportion of females did 
not differ significantly between responders and non-responders (70% versus 69%, 
p>0.05) but the responders were slightly older than the non-responders  (51.9 versus 
48.3 years, p < .05). All screen-positive patients (N=150) and a random selection of 57 
screen-negative patients were invited for a MINI interview. After the exclusion of 
patients who met exclusion criteria (N=13, 8.7% screen-positives, N=1, 2% screen- 
negatives), and because of non-response (N=16, 10.7% screen-positives, N=7, 10.5% 
screen-negatives), 121 screen-positive participants and 49 screen-negative participants 
had a MINI interview (n=170). Figure 1 presents a flowchart of the high risk sample. 
 
GP-identified sample 
GPs of 37 practices selected 207 patients for the study. All patients who gave 
informed consent and who did not meet the exclusion criteria (N=164, 79.2%) were 
invited for a MINI interview, irrespective of their PHQ score, and eventually 141 
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Figure 1. Flowchart of participants at risk for (developing) an anxiety disorder according to their 
electronic medical record (high risk sample) 
 
Data analysis 
In the high risk sample, we had to correct for the fact that we included a random 
sample of screen negatives, while we did include all screen positives. Such a selection 
procedure creates an imbalance that influences the prevalence and thus the test 
characteristics. Weights were used to transform the sample back to the original 
distribution of screen positives and screen negatives (Pepe 2003). A screen-positive 
patient received a weight of 0.27 (150/121*170/786) and a screen-negative patient 
received a weight of 2.81 (636/49*170/786). A similar procedure was followed for the 
analysis in the high risk sample using the two screening questions. All psychometric 
analyses concerning the high risk group were performed on the weighted sample. The 
following indicators of criterion validity were calculated: positive predictive value, 
negative predictive value, sensitivity, specificity, overall accuracy and receiver 
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operating characteristics (area under the curve, AUC) (Fischer et al. 2003). The MINI 
classification functioned as reference standard for the diagnosis of an anxiety disorder. 
A multilevel logistic regression analysis was performed to determine whether a 
positive PHQ score increased the odds of a MINI anxiety disorder classification. SPSS 
version 15.0 (SPSS Inc. 2006) was used for most statistical analyses;  MLwiN V2 2.21 
(Rasbash et al. 2011) was used for the multilevel logistic regression analysis. 
 
 
Figure 2: Flowchart of patients identified as a case by GPs (GP-identified sample) 
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In the (weighted) high risk sample (N=170) the mean age was 54.6 (SD 13.2), the 
percentage of females was 74% and the prevalence of any anxiety disorder was 39%. 
In the GP-identified sample (N=141) the mean age was 47.5 (SD 16.4), the percentage 
of females was 71%  and the prevalence of any anxiety disorder was 80% (Table 1).  
 
Table 1. Characteristics of the high risk sample (weighted) and the GP-
identified sample 
 1) High risk sample  
(N=170) 
2) GP-identified sample  
(N=141) 
N (%)   
Mean age (range) 54.6 (19-82) 47.52 (18-83) 
Female 
Male 




Anxiety disorder diagnosis* 
Panic disorder 
Generalised anxiety disorder 
Social phobia 
Simple phobia 
Obsessive compulsive disorder 
Post traumatic stress disorder 
Agoraphobia 
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Test results 
The results are summarised in Table 2. For the high risk sample the two screening 
questions of the PHQ showed the best test characteristics, because of an increase in 
sensitivity. The positive predictive value (PPV) was 76%, the negative predictive value 
(NPV) was 88% and the overall performance of the PHQ as expressed by the area 
under the curve was 84% which may be interpreted as moderate to high (Fischer et al. 
2003). In GP-identified patients the official algorithm performed best, with a PPV of 
96%, a NPV of 38% and the area under the curve was moderate (77%).  
 
Diagnostic value of the PHQ  
In the high risk sample, a positive answer on one of the two screening questions of 
the PHQ significantly increased the odds for a MINI anxiety disorder classification 
(odds ratio 23.4; 95% confidence interval 6.94 to 78.82). In the GP-identified patients, 
a positive PHQ (based on the original algorithm) resulted in an odds ratio of 13.89 
(95% confidence interval 3.81 to 50.63).  
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Table 2. Performance of the Patient Health Questionnaire to detect an anxiety 
disorder in a high risk sample (weighted) and a GP-identified sample 









Cross tabulation a b c d a b c d a b c d 
 25 8 42 95 49 15 12 93 73 3 40 25 


















Positive likelihood ratio 5.1 [4.41-5.79] 5.71 [4.93-6.49] 6.03 [5.12-6.94] 
Negative likelihood 
ratio  
0.68 [0.61-0.75] 0.23 [0.17-0.30] 0.40 [0.32-0.48] 



























a: true positives, b: false positives, c: false negatives, d: true negatives 
a
 Official algorithm panic disorder: All the first four questions are answered with "yes" and four 
symptoms related to panic attacks are present. Official algorithm general anxiety: The first question 
is answered with "more than half  the days" and three symptoms related to general anxiety are 
present more than half the days. 
b
 Screening question for panic disorder ("In the last 4 weeks, have you had an anxiety attack - 
suddenly feeling fear or panic?") is answered with yes AND/OR screening question for general 
anxiety ("Feeling nervous, anxious, on edge, or worrying a lot about different things") is answered 
with "more than half the days". 
*Because weighting in the receiver operating characteristics (ROC) analysis is only possible with 
integer values, the weights were multiplied by 100 




Summary of main findings  
The results imply that the PHQ may be used as a screener in high risk groups, and to 
confirm a preliminary anxiety disorder diagnosis made by the GP, but not for ruling 
out the possibility of a present anxiety disorder in GP-identified patients. In the high 
risk sample, the performance of the PHQ using the official algorithm was moderate, 
but the two screening questions of the PHQ showed particularly good test 
characteristics. A positive score on one of the screening questions significantly 
increased the odds of receiving an anxiety disorder diagnosis. The PPV was 76%, the 
NPV was 88% and the area under the curve was moderate to high (83%) in the high 
risk sample. In the GP-identified sample, a positive score on the official algorithm of 
the PHQ did adequately predict the presence of an anxiety disorder (PPV of 96%) and 
significantly increased the odds for receiving an anxiety disorder diagnosis, but the 
ability of the PHQ to filter out non-cases was inadequate in these patients (NPV of 
38%). The are under the curve was moderate (77%) in GP-identified patients.  
 
Strengths and limitations of the study 
A strength of this study is its focus on the practical purpose of screening and case-
finding. A limitation is that the study was performed within a RCT and not all 
practices did participate in the screening procedure. The participating practices in this 
study may thus not be fully representative for the total population of primary care 
practices. We also may have missed patients who did not want to participate in a 
randomised controlled trial or who did not want treatment for their anxiety. 
Nevertheless, in reality probably only patients with a need for treatment will respond 
to an invitation for a screening procedure, so our findings may be applicable for 
patients who are in principle motivated for treatment. 
 
Comparison with existing studies 
The performance of the PHQ in the high risk sample is consistent with the 
performance of the panic module in a previous study with a high risk sample 
consisting of frequent attenders, patients with medically unexplained symptoms and 
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patients with mental health problems in primary care (Wittkampf et al. 2010). The 
authors also found that using only the screening questions improved the performance 
of the PHQ substantially and concluded that the PHQ was of moderate value for 
screening in high risk groups. Other studies have found a better performance of the 
PHQ (Spitzer et al. 1999; Diez-Quevedo et al. 2001; Persoons et al. 2003). This may be 
due to the characteristics of our study population (patients at risk for anxiety 
disorders), with our study design (cross-sectional analysis within a RCT) or with the 
characteristics of the instrument itself. The Generalised Anxiety Disorder-7 item scale 
(GAD-7), which is largely similar to the general anxiety module of the PHQ, and was 
developed by the same research group (Spitzer et al. 2006), might be more accurate in 
detecting an anxiety disorder (Kroenke et al. 2007). However, a recent study 
questioned the ability of the GAD-7 to detect an anxiety disorder other than 
generalised anxiety disorder (Donker et al. 2011). Few studies have examined the 
characteristics of screening questionnaires in patients identified by their GP. A study 
using the Hospital Anxiety and Depression Scale (HADS) and the Four Dimensional 
Symptom Questionnaire (4DSQ) has shown an area under the curve of 76% and 79% 
respectively (Terluin et al. 2009). Although the predictive values found for both the 
HADS and the 4DSQ in the study of Terluin and colleagues (2009) were more 
balanced, this may also have been caused by the lower prevalence of mental disorders 
found in their study (34% versus 80%).  
 
Implications for future research and practice 
The high prevalence of anxiety disorders (39%) in the high risk sample suggests that 
selecting patients from the EMR on the basis of psychological symptoms, social 
problems or physical symptoms related to anxiety disorders, might be a successful 
method for selective screening in primary care. This may be especially relevant for 
patients presenting with physical symptoms because it is more difficult for GPs to 
recognise anxiety disorders in these patients (Kirmayer et al. 1993). The finding that 
the use of the two screening questions of the PHQ resulted in the best performance is 
positive, because this makes the screening procedure minimally time consuming. 
However, when implementing a selective screening procedure, it needs to be followed 
by a structured approach of further clinical diagnostic procedures and evidence-based 
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treatment, as recommended in clinical guidelines (National Institute for Health and 
Clinical Excellence 2011). Therefore, low-intensity interventions need to be available 
in primary care to be able to treat a large number of patients (Richards & Borglin 
2011). Only then selective screening will be an effective way of improving 
management of anxiety disorders. Considering GPs who referred patients to this 
study, it is noteworthy that they did correctly suspect the presence of an anxiety 
disorder in 80% of the cases. This suggests a high specificity of GPs considering 
anxiety disorders. However, the number of patients that GPs identified varied widely 
(from 0 to 17). Efforts to improve detection of anxiety disorders may thus be aimed at 
GPs with a low recognition rate of anxiety disorders. Furthermore, it may be 
worthwhile to prompt GPs to investigate the presence of an anxiety disorder also in 
patients with less obvious anxiety symptoms. Subsequently, GPs have the option of 
using the PHQ to confirm their diagnosis, because a positive PHQ increased the 
predictive value of the GPs to 96%. We recommend that future diagnostic studies will 
also pay attention to the practical purposes of screening instruments, to help 
informing primary care on the best way to use these instruments. Further research will 
also have to determine whether selective screening will increase the number of 
patients with anxiety disorders starting with evidence based treatment. 
 
Conclusions 
The results of this study show that the two screening questions of the PHQ form a 
suitable instrument for screening for anxiety disorders in high risk primary care 
patients. GPs may use the official algorithm of the PHQ as a confirmation of their 
preliminary diagnosis, however, they are not advised to use the PHQ for ruling out the 
presence of an anxiety disorder. Following this study, research should focus on the 
effectiveness of selective screening for anxiety disorders  in primary care and on 
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Abstract 
Background: Appropriate management of anxiety disorders in primary care requires 
clinical assessment and monitoring of the severity of the anxiety. This study focuses 
on the Beck Anxiety Inventory (BAI) as a severity indicator for anxiety in primary care 
patients with different anxiety disorders (social phobia, panic disorder with or without 
agoraphobia, agoraphobia or generalised anxiety disorder), depressive disorders or no 
disorder (controls). 
Methods: Participants were 1601 primary care patients participating in the 
Netherlands Study of Depression and Anxiety (NESDA). Regression analyses were 
used to compare the mean BAI scores of the different diagnostic groups and to 
correct for age and gender.  
Results: Patients with any anxiety disorder had a significantly higher mean score than 
the controls. A significantly higher score was found for patients with panic disorder 
and agoraphobia compared to patients with agoraphobia only or social phobia only. 
BAI scores in patients with an anxiety disorder with a co-morbid anxiety disorder and 
in patients with an anxiety disorder with a co-morbid depressive disorder were 
significantly higher than BAI scores in patients with an anxiety disorder alone or 
patients with a depressive disorder alone.  Depressed and anxious patients did not 
differ significantly in their mean scores.  
Conclusions: The results suggest that the BAI may be used as a severity indicator of 
anxiety in primary care patients with different anxiety disorders. However,  because 
the instrument seems to reflect the severity of depression as well, it is not a suitable 
instrument to discriminate between anxiety and depression in a primary care 
population. 
 




In primary care, many patients present with anxiety symptoms but these are seldom 
systematically assessed (Bakker et al. 2010). To improve anxiety management, 
assessment of the severity of the anxiety (and subsequent monitoring) is 
recommended by researchers and also in clinical guidelines (McIntosh et al. 2010; 
Muntingh et al. 2009; Roy-Byrne, Wagner, & Schraufnagel, 2005). With regard to 
depression, the use of severity indicators in primary care is supported by the results of 
studies showing that patients value the use of questionnaires as a supplement to the 
diagnosis made by  their general practitioner and as evidence that their problems are 
taken seriously (Dowrick et al. 2009). Furthermore, when questionnaires to assess 
severity are used, higher severity scores are related to better care (i.e. higher 
prescription rates of antidepressant medication and increased referral to secondary 
care) (Kendrick et al. 2009). Moreover, in some countries incentives are offered when 
a validated instrument is used at the start of and during the treatment of patients 
diagnosed with depression (British Medical Association & NHS Employers, 2009). 
For similar reasons the use of severity scales to assess anxiety symptoms in primary 
care might be advocated. However, we first have to determine which questionnaires 
can be used as severity indicators in primary care and what their characteristics are. 
As anxiety disorders differ in type and symptoms, assessing the severity of anxiety in 
general may be more difficult than assessing the severity of depression. General rating 
scales may not be specific enough to assess the severity of a specific anxiety disorder 
(i.e. panic disorder or generalised anxiety disorder). However, extensive testing for 
different forms of anxiety is also not feasible during the short consultations in primary 
care. Considering its brevity, simplicity, and presumed ability to measure general 
anxiety, the Beck Anxiety Inventory (BAI) (Beck, Epstein, Brown, & Steer, 1988) 
might be a good candidate for use as a severity indicator. Since its development, the 
BAI has been widely used in clinical research in mental health care, mainly as a 
measure of general anxiety (Piotrowski, 1999). 
However, the BAI has been disputed for its focus on psychophysiological symptoms 
linked to panic. The results of several studies have found that patients with panic 
disorder score higher on the BAI than patients with for example generalised anxiety 
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disorder (Beck & Steer, 1991; Cox, Cohen, Direnfeld, & Swinson, 1996; Fydrich, 
Dowdall, & Chambless, 1992; Leyfer, Ruberg, & Woodruff-Borden, 2006). Either 
way, patients with panic disorder and patients with other anxiety disorders have been 
found to score significantly higher than patients with no anxiety disorder (Kabacoff, 
Segal, Hersen, & Van Hasselt, 1997; Steer, Ranieri, Beck, & Clark, 1993; Wetherell & 
Gatz, 2005). Remarkably, no study has specifically investigated the co-morbidity of 
anxiety disorders and how this influences BAI scores, even though co-morbidity 
occurs frequently (De Graaf, Bijl, Smit, Vollebergh, & Spijker, 2002). Furthermore, 
none of the previous BAI studies have focused on primary care populations.  
Another presumed quality of the BAI is its ability to discriminate anxiety from 
depression (Beck et al. 1988). Even though in primary care this might be of less 
importance than in research settings, it is important to know whether the BAI only 
measures anxiety or whether it is also sensitive to depressive symptomatology. The 
results of earlier studies suggest a substantial overlap of the BAI with depressive 
symptoms, illustrated by a moderate correlation between the BAI and depression 
scales (Ferguson, 2000). In terms of differences in the BAI scores of anxious and 
depressed patients, a large difference was found in the original validation study (Beck 
et al. 1988), but in two later studies no difference was found. However, in these studies 
the authors questioned the results because of limitations in the methodology (Hewitt 
& Norton, 1993; Steer et al. 1993). 
In the present study, we investigated whether the BAI reflects the severity of anxiety 
in primary care patients with different anxiety disorders. The mean scores of several 
patient groups were compared: healthy controls, patients with one anxiety disorder, 
patients with multiple anxiety disorders, patients with one depressive disorder, and 
patients with co-morbid anxiety-depression. The diagnostic groups were separated 
into patients with no co-morbidity and patients with co-morbidity, to ensure 
homogeneity of the groups. It was hypothesised that the BAI scores of patients with 
an anxiety disorder would be higher than the BAI scores of healthy controls or 
depressed patients. Patients with a panic disorder were expected to score higher than 
patients in the other anxiety disorder groups. We also expected patients with co-
morbid disorders to score higher than patients with no co-morbidity.  





The participants in this study were recruited for a large cohort study: the Netherlands 
Study of Depression and Anxiety (NESDA) (Penninx et al. 2008). From the baseline 
sub-sample of 1601 primary care patients in the NESDA cohort we selected all 
patients with a current anxiety or depressive disorder according to the WHO 
Composite Interview Diagnostic Instrument (CIDI lifetime version 2.1) and patients 
with no history of anxiety or depression. DSM-IV classifications of diagnoses within 
the past month were used to assure present symptomatology. Patients with a history 
of anxiety or depression, but no current diagnosis, were excluded from the analysis. 
The mean BAI scores of patients with an anxiety disorder (N=276) and patients with 
a depressive disorder (N=155), were compared to the mean BAI scores of a control 
group of patients with no history of anxiety or depressive disorders (N= 513). The 
NESDA study protocol was approved by the Medical Ethics Committee of the VU 
University Medical Centre. 
 
Procedures 
The primary care sample in the NESDA study was recruited between September 2004 
and February 2007 through 65 general practitioners situated in different parts of the 
Netherlands (Amsterdam, Groningen, and Leiden). A screening questionnaire was 
sent to 23750 patients between 18 and 65 years of age who had consulted their general 
practitioner in the past four months. This questionnaire consisted of the Kessler-10 
(K-10) (Kessler et al. 2002), which screens for affective disorders, supplemented with 
five questions about anxiety (Extended K-10, or EK-10). The EK-10 showed 
adequate psychometric properties, with a sensitivity of .90 and a specificity of .75 to 
detect anxiety or depressive disorders (Donker et al. 2010). Participants who returned 
the EK-10 (N =10706, 45.9%), scored positively (N = 4592, 43%), gave informed 
consent (N=3420, 74%) and could be contacted (N=2995, 88%) had a telephone 
screening interview based on short-form sections of the CIDI (major depression, 
dysthymia, social phobia, panic disorder, agoraphobia, and generalised anxiety 
disorder). 
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Patients who were unwilling to be interviewed (N=267, 9%), were not fluent in Dutch 
(N=86, 3%) or were being treated in a mental health organisation (N = 155, 5%), 
were excluded. All other patients who screened positive on the telephone screening 
(N = 1162, 47%) and a random sample of patients who screened negative (N = 924) 
were contacted for a face-to-face interview. As 437 (24%) participants were unwilling 
to participate and 39 (2%) could not be contacted or were not fluent in Dutch, 1610 
primary care patients were finally included in the NESDA study and completed the 
baseline assessment. More details about the recruitment process are described 
elsewhere (Penninx et al. 2008). Of the 1610 NESDA participants, 9 patients who did 
not complete the BAI were excluded from the analysis. The present sample therefore 
consisted of 1601patients, 617 of whom had at least one current diagnosis of anxiety 
or depression, 471 had a history of anxiety or depression, and 513 were controls with 
no history of anxiety or depression. 
 
Assessment 
Composite Interview Diagnostic Instrument (CIDI) 
The CIDI (version 2.1) is an interview that classifies psychiatric diagnoses according 
to the DSM-IV (American Psychiatric Association, 2001). It is a widely used interview, 
which has good interrater reliability (Wittchen et al. 1991), high test-retest reliability 
(Wacker, Battegay, Mullejans, & Schlosser, 2006), and high validity for the 
classification of depressive and anxiety disorders (Wittchen et al. 1989; Wittchen, 
1994). CIDI interviews were conducted by specifically trained research assistants. The 
CIDI classifies diagnoses that were present at some point in the patient’s life (lifetime 
diagnoses), in the past half year and in the past month. 
 
Beck Anxiety Inventory (BAI) 
The BAI is a short list describing 21 anxiety symptoms such as “wobbliness in legs”, 
“scared” and “fear of losing control” (Beck et al. 1988). Respondents are asked to rate 
how much each of these symptoms bothered them in the past week, on a scale 
ranging from 0 (not at all) tot 3 (severely, I could barely stand it). The total score has a 
minimum of 0 and a maximum of 63. The scale was validated in a sample of 160 
psychiatric outpatients with various anxiety and depressive disorders, diagnosed  with 
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the Structured Clinical Interview for DSM-III (Spitzer & Williams, 1983). The BAI 
has a high internal consistency (Cronbachs α= .92) and a test-retest reliability over one 
week of .75 (Beck et al. 1988). 
 
Statistical analysis 
All analyses were conducted in SPSS version 15.0 (SPSS Inc., 2006). Regression 
analysis was performed to examine differences between group scores. The analyses 
were corrected for age and gender, because age was differentially distributed over the 
diagnostic groups and because female patients scored significantly higher than male 
patients in the total sample. All variables were entered simultaneously into the analysis. 
The analyses were repeated with different groups as the reference group to be able to 
compare all groups. 
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The average age of the participants was 45.9 years and the majority of the patients 
were female (68.8%). Almost one third of the participants had been diagnosed with an 
anxiety disorder in the past month (N = 493, 30.8%). Table 1 shows the age, gender 
and DSM-IV diagnosis of the participants. 
 
Table 1.  Age, gender and current DSM-IV diagnoses of participants (N = 1601) 
 N % 
 
All participants 1601  
Age [range] 45.8 [18-65]  
Female gender 1102 68.8% 
Any anxiety disorder 493  
Age [range] 45.7 [18-65]  
Female gender 346 70.2% 
Social phobia* 68 13.8% 
Panic disorder with agoraphobia* 42 8.5% 
Panic without agoraphobia* 28 5.7% 
Agoraphobia* 42 8.5% 
Generalised anxiety disorder* 34 6.9% 
>1 anxiety disorder 76 15.4% 
Co-morbid anxiety & depression 203 41.2% 
Any depressive disorder 327  
Age [Range] 46.2 [18-64]  
Female gender 223 68.2% 
Dysthymia* 8 2.4% 
Major depression* 101 30.9% 
>1 depressive disorder 





Patients with a history of anxiety or depression 471 29.4% 
Controls (no history of anxiety or depression) 513 32.0% 
*Disorder with no co-morbid anxiety disorder or co-morbid depressive disorder  
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Many patients with a diagnosis of an anxiety disorder had at least one co-morbid 
anxiety disorder. The percentage of patients with a co-morbid anxiety disorder varied 
over the diagnostic groups: anxiety co-morbidity was highest in patients with panic 
disorder or generalised anxiety disorder (54%) followed by patients with social phobia 
(51%) and patients with agoraphobia alone (35%). Almost half (41%) of the patients 
with an anxiety disorder also suffered from a depressive disorder, while 62% of the 
patients with a depressive disorder were also diagnosed with an anxiety disorder.  
 
Anxiety disorders 
Table 2 shows the mean BAI scores of the control group (no history of anxiety or 
depression), patients with one anxiety disorder and patients with multiple anxiety 
disorders. Patients with a co-morbid depression were excluded from this analysis 
(n=203). 
 
Table 2. Mean BAI scores of patients with different anxiety disorders (with no 
co-morbid depression) and controls 
*Single anxiety disorder diagnosis 
 
Patients with an anxiety disorder scored significantly higher than the controls (p 
<0.001) and patients with multiple anxiety disorders scored considerably higher than 
all other groups (p < .05). The mean BAI score of patients with a panic disorder and 
agoraphobia was significantly higher than the mean score of patients with social 
phobia (p=0.03) or agoraphobia alone (p<0.001).  
 
Diagnosis (past month)    
 N M  SD 
Controls 513 4.09  5.06 
Social phobia* 68 12.97  9.03 
Panic disorder with agoraphobia* 42 16.00  11.02 
Panic disorder without agoraphobia* 28 13.04 6.61 
Agoraphobia* 42 11.62  8.51 
Generalised anxiety disorder* 34 13.15 5.67 
Multiple anxiety disorders 76 18.54  8.54 
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Anxiety and depressive disorders 
Table 3 shows that the score of depressed patients approximates the score of anxious 
patients (p = .41). Patients with co-morbid anxiety-depression scored significantly 
higher than patients with either an anxiety disorder or a depressive disorder alone (p 
<0.001).  
 
Table 3. Mean BAI scores of patients with a depressive disorder, an anxiety 




The results of our study show that primary care patients with different anxiety 
disorders score significantly higher than patients with no anxiety or depressive 
disorder. These results suggest that the BAI does reflect general anxiety in primary 
care patients. With regard to the different diagnostic groups of anxiety disorders, we 
did partly confirm the strong focus of the BAI on panic symptoms (Cox et al. 1996; 
Leyfer et al. 2006). Patients with a panic disorder and agoraphobia scored significantly 
higher than patients with agoraphobia alone or social phobia. However, patients with 
a panic disorder without agoraphobia did not score significantly higher than the other 
groups. The high scores of patients with a panic disorder and agoraphobia might thus 
be explained by the severity of this specific disorder. In other studies in which the BAI 
was used, greater differences were found between the group of patients with a panic 
disorder and other diagnostic groups (Beck & Steer, 1991; Fydrich et al. 1992; Leyfer et 
al. 2006; Steer & Beck, 1996). One reason for this discrepancy in findings might be the 
setting in which studies took place. Most of the previous studies were conducted in 
treatment centres for anxiety disorders, while the participants in the present study 
were actively recruited in primary care, also including patients with previously 
Diagnosis (past month)    
 N M SD 
Depressive disorder 109 13.34 8.72 
Anxiety disorder 214 13.94 8.69 
Co-morbid anxiety-depression 203 21.89 10.95 
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undiagnosed anxiety or depression. It is likely that more primary care patients present 
with less severe forms of panic disorder. Indeed, the mean score of patients with panic 
disorder in the present study seems to be substantially lower than the scores reported 
in studies with secondary care patients (Beck & Steer, 1991; Fydrich et al. 1992; Leyfer 
et al. 2006; Steer & Beck, 1996) coming closer to the scores of patients with a panic 
disorder in an epidemiological sample (Hoyer, Becker, Neumer, Soeder, & Margraf, 
2002). Furthermore, in the analysis of the present study, patient groups were 
specifically selected on the basis of (the absence of) co-morbidity, thus resulting in 
pure diagnostic groups. This may have provided a more accurate estimate of the mean 
scores of specific patient groups. 
Beck and colleagues (Beck et al. 1988) claimed that the BAI measures anxiety while 
minimizing its overlap with depression but this was not sustained by the results of the 
present study. For practical purposes, this is a two-sided finding. The BAI appears to 
be robust for depression, but not entirely specific for anxiety in a primary care 
population. These findings are consistent with the results of earlier studies that 
compared the total BAI scores of depressed and anxious patients (Hewitt & Norton, 
1993; Steer et al. 1993). Steer and colleagues relate their findings to the low co-
morbidity rate in their sample, but this argument does not hold up in the present 
study. There could be several explanations why depressed patients score almost as 
high as anxiety patients. First of all, sub-threshold anxiety experienced by patients with 
a depressive disorder may have increased their anxiety scores. Sub-threshold anxiety 
was not assessed in the present study, but previous research has shown that a 
substantial number of depressed patients also experience some form of (sub-
threshold) anxiety (Lowe et al. 2008; Roy-Byrne et al. 2000). Secondly, somatoform 
disorders were not classified with the CIDI interview, while these disorders are 
prevalent in primary care patients with a depressive disorder, and can also cause the 
physiological symptoms described in the BAI (Mergl et al. 2007). A third explanation 
might be that anxiety and depression share a common underlying factor, often 
referred to as 'negative affect' (Brown & Barlow, 2009; Lowe et al. 2008). There is 
longstanding debate about this question, growing stronger due to the pressure of the 
upcoming publication of the DSM-V and fuelled by the considerable prevalence of 
co-morbidity between anxiety and depression and the symptom overlap on anxiety 
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and depression scales. With regard to this third hypothesis, the sensitivity of the BAI 
for shared symptomatology would be more of a quality than a deficiency. Fourthly, 
total scores for self-report questionnaires, in general, might not be precise enough to 
measure difficult constructs such as anxiety and depression. There is some evidence 
that the BAI is able to discriminate between anxiety and depression when items are 
weighted, as happens in factor analysis (Hewitt & Norton, 1993). However, weighting 
the items would complicate the use of the BAI to such an extent that its use would 
not be feasible in primary care. 
A strength of this study is the large size of this primary care sample, diagnosed with a 
valid interview identifying five different anxiety disorders and two depressive 
disorders. Because of the high prevalence of co-morbidity in patients with anxiety and 
depressive disorders, such a large sample is needed to compare (sub-)groups of 
patients with a specific anxiety or depressive disorder. However, even in this large 
sample, patients with one specific anxiety disorder are scarce, limiting the power of 
the analyses. Another limitation of the analysis was the skewed distribution of the 
scores. Although we considered performing a log transformation, we decided to use 
raw scores to facilitate the interpretability of the scores in clinical practice.  
 
Conclusions 
The results indicate that the BAI reflects the severity of anxiety in primary care 
patients with different anxiety disorders. The use of questionnaires such as the BAI 
may improve the care that is provided and is desirable from the viewpoint of primary 
care patients (Dowrick et al. 2009). However, as the use of questionnaires in primary 
care is not common practice, this should be stimulated by means of guidelines, 
training and education. Further research will be needed to evaluate the usefulness of 
the BAI in monitoring the severity of anxiety during treatment and over time. In 
addition, researchers should establish criteria for improvement and remission 
according to the BAI score, in primary care patients. When questionnaires such as the 
BAI are used within a framework of care, such as case management or collaborative 
care, they will optimally help to improve the treatment of primary care patients with 
anxiety disorders (Gilbody, Sheldon, & Wessely, 2006; Muntingh et al. 2009; Roy-
Byrne et al. 2010).  
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Background and objectives of this thesis 
Anxiety disorders are chronically intermittent conditions that are highly prevalent, 
disabling and costly. Patients with anxiety disorders may be adequately treated in 
primary care using a chronic and integrated care perspective. However, there are many 
barriers in primary care for providing continuous, evidence based care for anxiety 
disorders. These barriers consider patient, provider and health care system 
characteristics. A collaborative stepped care model may be an effective and efficient 
method to improve the quality of primary care for patients with anxiety disorders, by 
introducing mental health expertise into primary care, ensuring evidence-based 
treatment, systematic monitoring and follow-up and supporting self-management of 
the patient within a framework of collaboration between professionals. Panic disorder 
and generalised anxiety disorder are target conditions for collaborative stepped care, 
because they are often inadequately treated in primary care while evidence based 
treatments suitable for primary care do exist. In this thesis, the effectiveness of 
collaborative stepped care for panic disorder and generalised anxiety disorder in 
primary care was evaluated. Furthermore, the costs of collaborative stepped care 
relative to its effectiveness and manners to improve recognition and assessment of 
anxiety disorders were examined. 
 
Summary of the main findings 
In chapter 2 it was investigated whether collaborative care for adult patients with 
anxiety disorders was more effective than usual primary care. A systematic search of 
the literature identified five randomised controlled trials that met the inclusion criteria. 
Four studies originated from the United States and one from Germany. The studies 
included a total of 1931 participants and were of varying methodological quality. The 
included studies provide evidence that collaborative care may be effective for anxiety 
disorders in general and is significantly more effective than care as usual for patients 
with panic disorder. More studies are needed that evaluate the effectiveness of 
collaborative care for anxiety disorders other than panic disorder and that are 
conducted in other countries than the United States.  
In chapter 3 we described a cluster randomised controlled trial to compare 
collaborative stepped care to usual primary care for patients with panic disorder or 
General discussion 
183 
generalised anxiety disorder. The trial was carried out in 43 primary care practices and 
a total of 180 patients with panic disorder or generalised anxiety disorder were 
enrolled. Patients in the collaborative care stepped group (N=114) received guided 
self-help as a first step, followed by CBT and antidepressants when necessary. Care 
was provided by a care manager and the general practitioner (GP), who both had 
access to the advice of a psychiatrist. Patients in the care as usual group (N=66) 
received care as usual through their GP. Data were collected by means of patient-
completed questionnaires at baseline, at 3, 6, 9 and 12 months. The primary outcome 
measure was the Beck Anxiety Inventory (BAI). Collaborative stepped care was more 
effective than usual primary care in reducing anxiety symptoms at all time points, with 
the largest difference at 12 months (diff. -6.84, 95% confidence interval -10.13 to -
3.55). The clinical effect of collaborative stepped care compared to care as usual was 
small to moderate. 
Alongside the cluster randomised controlled trial we conducted a cost-effectiveness 
analysis (chapter 4). The difference in quality of life gained and health care and 
productivity costs generated in the collaborative stepped care group and care as usual 
group was compared. Collaborative stepped care led to a marginal increase in health 
care costs of €351, but the incremental gains in quality of life (diff. 0.05 QALY) 
outweighed these extra costs. The extra health care costs in the collaborative stepped 
care group were mostly due to contacts with the care manager. Including productivity 
costs in the analysis strengthened the results, as productivity costs were higher in the 
care as usual group. Consequently, collaborative stepped care was more effective and 
less costly compared to care as usual, which makes it a highly cost-effective 
intervention. 
In chapter 5 we assessed the added value of the Patient Health Questionnaire (PHQ) 
in the detection and diagnosis of anxiety disorders in two patient groups: 1) patients at 
high risk for (developing) anxiety disorders, 2) patients identified by their GP as 
possibly having an anxiety disorder. In patients at high risk for developing anxiety 
disorders, the use of only two screening questions of the PHQ showed the best 
characteristics. The positive predictive value was 76% and the negative predictive 
value was 88% in the high risk patients. In patients identified by the GP as possibly 
having an anxiety disorder, the full PHQ did adequately predict the presence of an 
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anxiety disorder (positive predictive value of 96%), but the ability of the PHQ to filter 
out non-cases (negative predictive value of 38%) was inadequate in these patients. 
These results imply that the PHQ may be used as a screener in high-risk groups, and 
to confirm a preliminary diagnosis of the GP, but not for ruling out the possibility of a 
present anxiety disorder in GP-identified patients. Furthermore, we examined the 
ability of the Beck Anxiety Inventory (BAI) to reflect the severity of the anxiety in 
patients with different anxiety disorders. Primary care patients with an anxiety disorder 
(N=493) had a significantly higher score (Mean (M)=13.9, standard deviation 
(SD)=8.7) than patients without a disorder (N=513; M=4.1; SD=5.1). Patients with 
co-morbid anxiety and depression (N=203; M=21.9, SD=11) scored significantly 
higher than patients with a single disorder, albeit an anxiety disorder (N=214; M= 
13.9; SD=8.7) or a depressive disorder (N=109; M=13.3; SD=8.7). Of the anxiety 
disorders, patients with panic disorder and agoraphobia had the highest mean score 
(M=16, SD=11).We concluded that the BAI may be used as a severity indicator for 
anxiety disorders in primary care. 
 
Interpretation of the results and comparison with existing literature 
Effectiveness of collaborative stepped care compared to care as usual 
Our hypothesis that collaborative stepped care would lead to improved patients 
outcomes compared to care as usual was confirmed. At all time points, patients in the 
collaborative stepped care group showed a significantly larger reduction in anxiety 
symptoms. Because of the complexity of the collaborative stepped care intervention it 
is difficult to say what elements of the intervention contributed most to the larger 
decrease in anxiety symptoms as observed in the collaborative stepped care group. 
The guided self-help method may have induced cognitive and behavioural change in 
intervention patients (van Boeijen et al. 2005). Most patients and professionals 
appreciated the guided self-help method as a practical and effective method (Bouman 
et al. 2010). The structured method of working with scheduled appointments, a 
treatment protocol and standardised evaluation of symptoms was certainly different 
from the usual working methods of the mental health professionals. The provision of 
evidence based psychological treatment was probably lower in the care as usual group. 
Unfortunately, we were unable to extract the type of intervention patients received in 
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the care as usual group. However, if we look at the 50% of the care as usual patients 
who received counselling with or without antidepressant medication from their GP, it 
appears that only 40% of those received regular consultations (defined as ≥ 4 contacts 
in 15 weeks). Furthermore, based on previous surveys with primary care professionals 
in the Netherlands, we may assume that the provision of structured evidence based 
interventions was minimal (Zwaanswijk & Verhaak 2009; Sinnema et al. 2010). The 
fact that the care managers had a mental health background and received supervision 
from experienced psychotherapists may have further improved the quality of 
treatment of the collaborative stepped care intervention, because these aspects of the 
collaborative care model have been identified as crucial for its effectiveness in the 
literature (Bower et al. 2006). Another element of collaborative stepped care that may 
be responsible for a larger effectiveness was that patients who needed a more 
intensive or different form of treatment were identified and provided medication 
(11%) or a smooth transition to a different health care professional (14%). In the 
introduction it was suggested that collaborative stepped care might lead to the 
avoidance of unnecessary prescription of medication or referral to secondary care. 
Our data show that fewer patients in the collaborative care group used antidepressants 
during the follow-up period (31% versus 45%), while collaborative stepped care was 
more effective.  No difference appeared between collaborative stepped care and care 
as usual in the number of contacts patients had in specialty mental health care. 
However, it is difficult to define which of these contacts were "unnecessary". The 
finding that the decrease in symptoms in the collaborative stepped care group was 
sustained until twelve months is particularly important. A relapse of symptoms is 
often seen in patients with anxiety disorders and was also visible in the scores of 
patients in the care as usual group. This sustained decrease of symptoms in the 
collaborative stepped care group may have been the result of the relapse prevention 
that was offered to 60% of the patients that successfully concluded treatment. In 
conclusion, the results of our study confirm that usual primary care can be improved 
by implementing evidence based mental health in primary care, with support from 
mental health professionals and structural monitoring and follow-up (i.e. collaborative 
stepped care).  
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Discrepancy between the continuous and dichotomous outcomes in the RCT 
In contrast to the significant differences found on the continuous outcome measure 
of the Beck Anxiety Inventory (BAI), we did not find a difference in the time to 
response (≥ 50% reduction in BAI score) or remission (BAI ≤ 11) between patients in 
the collaborative stepped care and care as usual group. This discrepancy between the 
two outcome measures may partly be attributed to the lower power of the 
dichotomous analysis to detect a difference (Streiner 2002). Another (more important) 
explanation for the discrepancy between the continuous and dichotomous outcome 
measure lies in the distribution of BAI scores. It appeared that in 40% of the patients 
in the care as usual group the BAI score remained stable or even increased from 
baseline to 12 month follow-up, while in the collaborative stepped care group this 
happened in only 20% of the patients (Figure 1). Furthermore, a larger proportion of 
the collaborative stepped care patients showed a large decrease (>1 standard 
deviation) in symptoms. While these differences are visible on the continuous 
measure, they are less apparent in the dichotomous outcomes.  
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Comparison of the RCT with other collaborative care studies 
The results of our study are comparable to the results found in collaborative care 
studies conducted in the United States (see chapter 2). However, with the exception of 
the study of Rollman and colleagues (Rollman et al. 2005), we found smaller effect 
sizes during the first nine months of follow-up than found in the North American 
studies. This may be related to the difference in the intensity of the interventions  
used. The collaborative care intervention of the two latest trials of Roy-Byrne and 
colleagues (Roy-Byrne et al. 2005; Roy-Byrne et al. 2010) started with an intensive 
intervention, in most cases consisting of a combination of CBT and antidepressant 
medication. Conversely, we used a stepped care intervention, with an advice to GPs to 
prescribe medication only if the patient did not sufficiently respond to the first two 
CBT-based steps. Hence, the smaller effect size in the early stages of our study may be 
an effect of the stepped care method we used, with patients responding at different 
stages in treatment. Compared to a German trial on collaborative care for anxiety 
disorders (Konig et al. 2009), our intervention was more effective. As suggested in 
chapter 2, this is probably due to an inadequate implementation of the intervention in 
the study of König and colleagues. The similarity in effect of our collaborative stepped 
care intervention compared to collaborative care interventions in the United States 
may be an indication for the external validity of the model for different health care 
settings. In depression research, it was already shown that collaborative care leads to 
quality improvement in different health care settings (Thota et al. 2012). However, 
more research is needed to draw conclusions on the relative effectiveness of 
collaborative (stepped) care for anxiety disorders in different health care settings. 
 
Comparison of the RCT with similar studies from the Netherlands 
Van Boeijen and colleagues (2005) developed the guided self-help method that was 
used in our study. They compared the guided-self-help method to guideline based 
usual care and cognitive behavioural therapy by an experienced therapists in a primary 
care population in a RCT. Surprisingly, they found no differential effects between the 
three groups (van Boeijen et al. 2005). The guided self-help method alone was as 
effective as usual primary care, while in our study the guided self-help method, as part 
of a collaborative stepped care approach, was more effective than usual primary care. 
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Although the studies may not be directly comparable, we may speculate about 
explanations for these differences. The care as usual provided in the study of van 
Boeijen and colleagues (2005) was highly effective, while the guided self-help method 
seemed to be less effective in reducing anxiety symptoms than the collaborative 
stepped care intervention evaluated in our study. The authors explain the high 
effectiveness of care as usual in their study by the high number of patients that 
received antidepressants or were referred to specialty mental health care. Furthermore, 
the number of patients included by the GPs in the care as usual condition in the study 
of Van Boeijen and colleagues was small (26 patients) and may not be representative 
for care as usual. The higher effectiveness of the collaborative stepped care 
intervention compared to the guided self-help method could be related to the 
additional elements in the collaborative stepped care intervention, such as monitoring 
of symptoms, a second or third step if patients did not respond to treatment, active 
follow-up of patients, and the involvement of a care manager and psychiatrist.  
Seekles and colleagues (2011) did compare a stepped care program for patients with 
anxiety or depressive disorders to usual primary care. The stepped care program 
comprised three subsequent steps, consisting of guided self-help, problem solving 
treatment and pharmacological treatment or referral to specialty mental health care. A 
care manager (psychiatric nurse) coordinated care and provided problem solving 
treatment. Almost all (92%) of the 120 included patients had a diagnosis of an anxiety 
disorder. Their intervention did not lead to a greater effectiveness than care as usual. 
The authors explain this insignificant finding by difficulties in implementing the 
stepped care program and the relatively mild, but chronic symptoms of depression 
and anxiety in their screened population (Seekles et al. 2011). A complicating factor in 
the design of the intervention of Seekles and colleagues (2011) may be that the care 
manager did not guide the self-help method. Guidance through email or telephone 
was available from a junior psychologist, but only if the patient requested this which 
may have resulted in a low adherence to the program. 
Huijbregts and colleagues (2012) evaluated the effectiveness of a collaborative care 
intervention compared to usual primary care for patients with a major depression in a 
cluster randomised trial. Their collaborative care program consisted of a choice of 
problem solving treatment and/or antidepressant medication, with care coordination 
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and monitoring by a care manager and access to specialist input of a consultant 
psychiatrist with IT support. They recruited patients through a screening procedure 
and through referral by the GP (referrals were only made by GPs in the collaborative 
care group). They found that collaborative care led to a significantly higher response 
rate than care as usual in the short term and also in the long term for patients referred 
by their GP. However, it is difficult to compare these results because both the 
interventions and the population (depression or anxiety) differed between the two 
studies.  
 
Cost-effectiveness of collaborative stepped care for anxiety disorders 
To our knowledge, this was the first study that assessed the cost-effectiveness of 
collaborative stepped care for anxiety disorders (chapter 4). As we expected, 
collaborative stepped care was cost-effective compared to care as usual. Health care 
costs were, however, higher in the collaborative stepped care group compared to care 
as usual. The higher costs of €351,- per patient were largely caused by the extra 
contacts with the care manager (€177). The premise of stepped care to induce a more 
efficient use of resources was thus not supported by the results of our study. 
However, because the costs of care as measured in our RCT were not particularly high 
the question is whether further decreasing contacts with health care professionals can 
be realised while sustaining the positive effects of the intervention. Furthermore, the 
productivity costs caused by sickness absence were higher in the care as usual group. 
Including the productivity costs in the cost-effectiveness analysis resulted in a higher 
effectiveness and lower costs of the collaborative care intervention, which means that 
taking a societal perspective, collaborative stepped care was dominant compared to 
care as usual.  
 
The added value of questionnaires in detecting anxiety disorders 
As already laid out in this thesis, the recognition, diagnosis and assessment of anxiety 
disorders is a condition for the provision of collaborative stepped care treatment. 
Therefore, we assessed the added value of two questionnaires in the diagnostic 
process (chapter 5). The PHQ seems to be a valuable instrument for screening high-
risk populations. However, screening for anxiety disorders in high risk populations 
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will not necessarily improve patient outcomes. For example, Baas and colleagues 
found that the use of the PHQ as a depression screener in primary care did not 
substantially increase the number of patients starting with treatment for depression 
(Baas et al. 2009): only 1% of the patients who were sent a screening questionnaire 
eventually started treatment. It appeared that many patients who were screened did 
not accept the diagnosis of depression or did not have a need for treatment 
(Wittkampf et al. 2008). In our study, 3% of the patients who were sent a screening 
questionnaire participated in the RCT, which may mean that screening for anxiety 
disorders is not much more effective than for depression. In conclusion, the 
effectiveness of screening high risk populations for anxiety disorders is not yet clear 
and further research is necessary to examine whether selective screening will lead to 
improved management of anxiety disorders.  
 
How to improve the recognition and diagnosis of anxiety disorders? 
The PHQ had a limited added value for improving detection of anxiety disorders in 
patients identified by their GP as having a probable anxiety disorder. However, that 
does not mean that questionnaires are useless in the diagnostic process. Patients do 
appreciate the use of questionnaires which they perceive as a thorough examination of 
their symptoms. Moreover, GPs who use a screening instrument feel that it helps 
them explain the diagnosis to patients (Dowrick et al. 2009). If GPs are trained and 
adequately supported in working with screening instruments, this may eventually lead 
to better recognition and diagnosis of anxiety disorders. Sinnema and colleagues may 
shed light on this issue, as they are currently conducting a study using tailored advice 
to GPs to improve recognition, diagnosis and treatment of depressive and anxiety 
disorders (Sinnema et al. 2011).  
 
Assessing the severity of anxiety with a questionnaire 
Measuring the severity of anxiety is an important part of the treatment of anxiety 
disorders. The severity of anxiety may be used as an indication for stepped care 
treatment: a low severity of anxiety may be treated by a low intensity treatment, while 
a high severity of anxiety may be an indication for a more intensive form of treatment 
(Landelijke Stuurgroep Multidisciplinaire Richtlijnontwikkeling in de GGZ 2010). The 
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BAI seems to give an adequate indication of the severity of anxiety in different anxiety 
disorders (chapter 5). Besides the ability to measure the severity of anxiety across 
anxiety disorders, the BAI has the advantage that it is a short and easy to use 
instrument, which makes it easily applicable in clinical practice.  
 
Methodological considerations 
Collaborative care was provided in a naturalistic setting 
A strength of the cluster RCT (chapter 3) was that we were able to conduct a 
pragmatic trial in a naturalistic setting. Few RCTs considering collaborative care have 
used existing staff in providing collaborative care (Craven & Bland 2006). All 
professionals that participated in our study (GPs, care managers and psychiatrist) were 
recruited in practice settings and underwent additional training to provide 
collaborative stepped care. This enabled us to estimate the effects of collaborative 
stepped care as implemented in daily practice. Because we used cluster randomisation, 
we could also correctly estimate care as usual. The GPs in the care as usual group had 
access to all the options normally available to them to deliver mental health care, such 
as prescribing medication, providing counselling themselves or referring the patient to 
a mental health professional. The GPs in the care as usual group also had access to a 
one of the 15 mental health professionals who were allocated to the care as usual 
group. However, only 12.5% of the care as usual patients were referred to these 
professionals. To indicate that care as usual in our study reflects care as usual in daily 
practice, we may compare our data to data from a large naturalistic cohort study 
conducted in primary care (NESDA). The cohort of primary care patients with an 
anxiety disorder in this study showed the same reduction in anxiety symptoms 
(measured with the BAI) over the course of one year as seen in our care as usual 
group (van Beljouw et al. 2010).  
 
Additional strengths 
Another strength is that we designed a comprehensive collaborative stepped care 
program, with evidence based interventions suitable for primary care, a valid 
monitoring instrument and a treatment plan to increase adherence and foster 
collaboration between the care manager and the GP. We provided training for all 
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professionals and supervision for care managers. We included sufficient patients to 
detect a significant difference between collaborative stepped care and care as usual. 
The additional cost-effectiveness analysis conducted alongside the RCT is also a 
strength, because information about cost-effectiveness is essential for decision 
making. Furthermore, as few stepped care trials have included a cost-analysis, this 
study provides insight into the cost-effectiveness of stepped care.   
 
External validity 
Patients were recruited for this study in various primary care practices in the western 
part of the Netherlands, located in urban areas as well as rural areas. The anxiety 
disorders in our sample were fairly chronic, with a mean age of onset of 31, while the 
mean age of participants was 46. Our study included a relatively large proportion of 
patients with a basic (45%) to intermediate level (35%) of education, which is 
important because these patients often do not receive adequate treatment (Prins et al. 
2010). Furthermore, many patients had a comorbid chronic medical condition (73%) 
or a comorbid depression (30%) which are prevalent comorbid conditions in anxiety 
disorders (Roy-Byrne et al. 2008; Penninx et al. 2011). This suggests that collaborative 
stepped care is effective for a heterogeneous group of patients with panic disorder 
and/or generalised anxiety disorder. The primary care practices that participated in 
our study may differ from the average primary care practice in the Netherlands. 
Participating GPs may have had a special interest in anxiety disorders. However, this 
applies to both GPs in the collaborative stepped care group as well as the care as usual 
group. Furthermore, as the collaborative stepped care treatment was standardised to a 
substantial degree we may assume that other mental health care professionals and GPs 
are able to achieve similar effects in treatment. 
 
The pitfalls of cluster randomisation 
We have experienced that collaborative stepped care is a complex intervention, which 
makes it difficult to test in a randomised controlled trial (Richards 2012). The choice 
to use cluster randomisation was based on the notion that there is a risk of 
contamination in patient randomised trials using complex interventions such as 
collaborative care (Richards et al. 2008). However, cluster randomisation suffers from 
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a number of limitations that became apparent during our study. The first problem we 
encountered was the imbalance between the number of patients referred to the study 
by GPs in the collaborative stepped care group and the care as usual group. GPs in 
the collaborative stepped care group referred 137 patients to the study, while GPs in 
the care as usual group referred 70 patients. We tried to stimulate GPs to refer 
patients, by regular reminders through newsletters, telephone calls or e-mails, but it 
was very difficult to increase the number of referrals from GPs in the care as usual 
group. Perhaps GPs in the care as usual group were less motivated to refer patients to 
the study, because they did not see an advantage for themselves or their patients in 
participating. Another possibility is that GPs in the collaborative stepped care group 
had an increased attention for the study because they were confronted with the new 
method in the treatment of their patients. A second problem of cluster randomisation 
is that it carries a risk of selection bias: GPs in the collaborative stepped care group 
may refer a different type of patients than GPs in the control group. To diminish the 
risk of selection bias, all patients were interviewed with the MINI PLUS by a blinded 
interviewer and patients were kept blinded for the condition of their GP until baseline. 
This meant that patients had to be willing to accept both treatment as usual and 
collaborative stepped care. Despite of these efforts, differences between the 
collaborative stepped care group and the care as usual group at baseline appeared. 
Patients in the collaborative stepped care group had a higher severity of anxiety and 
did less often take antidepressants at baseline. The difference in antidepressant use 
may be explained by an early effect of the intervention, as we instructed GPs in the 
collaborative stepped care group not to prescribe antidepressants to patients they 
referred to the study. We do not have a valid explanation for the higher severity of  
anxiety in patients in the collaborative stepped care group. In the analyses we 
corrected for possible errors introduced by selection bias with propensity scores and 
we corrected for anxiety severity at baseline. Antidepressant use at baseline did not 
have a significant influence on treatment effect. Furthermore, we conducted a 
sensitivity analysis on the effect of the intervention in patients that were selected from 
the electronic medical record (and were thus not subject to selection bias of the GP) 
and this analysis yielded similar results. Nonetheless, it is better to prevent than to 
cure. A strategy to prevent selection bias in a cluster RCT is to exclusively use a 
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screening procedure carried out by blinded research assistants. A drawback of this 
approach is that it stands further away from common practice as patients usually are 
not identified using a screening procedure. Another option would be to use patient 
randomisation instead of cluster randomisation. Notwithstanding the risk of 
contamination, it may be preferable to eliminate the risk of selection bias and give a 
conservative estimate of the effects of collaborative stepped care compared to care as 
usual. As research has shown that behavioural change in GPs is hard to establish (Lin 
et al. 1997) and a system change is needed to induce improved patient outcomes 
(Gilbody et al. 2003), the risk of contamination of the effect may be acceptable.  
 
Suboptimal implementation of the collaborative stepped care intervention 
Another limitation of our trial is that, despite extensive supervision and instruction of 
the care managers and GPs, the stepped care model was not followed through as 
intended in a substantive amount of cases (see Figure 2). A significant proportion of 
patients did either not complete step 1 or did not continue to step 2 while remission 
was not yet achieved. Some of these patients were referred to another mental health 
professional, but others discontinued mental health treatment in general. The patients 
who did not complete step 1 had different reasons for discontinuing the program: 
they had other problems they needed to focus on (legal issues or problems in their 
family), they were dissatisfied with treatment or they experienced no anxiety 
symptoms anymore. An exploratory analysis revealed that the patients who did not 
complete step 1 were more often widowed or divorced, were selected from the 
electronic medical record instead of selected by their GP, had a lower level of 
education, were more often taking antidepressants at baseline, were older and suffered 
from more chronic conditions. Further research should evaluate the predictive value 
of these characteristics on treatment outcome and the effects of extra efforts to 
increase adherence of these patients to collaborative stepped care.  
Most patients who did not want to continue with step 2 were already satisfied with 
their achievements and did not desire further treatment. The relatively low rate (10%) 
of patients continuing to the second step compares to the results of a recent stepped 
care trial (Seekles et al. 2011) and an analysis of the implementation of stepped care in 
routine practice (Richards et al. 2012). Apparently, 90% of the patients recovers after a 
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minimal intervention, is referred to another health care professional, or desires no 
further treatment. The question is whether this is a limitation of the stepped care 
approach. One could argue that stepped care is not necessary if only 10% makes use 
of a subsequent step. Patients could simply be referred after step one to another 
mental health care professional or continue treatment with medication. However, the 
second step in our protocol was reasonably effective. Furthermore, the possibility of 
continuity of care may seem more attractive to patients than being referred to yet 
another professional.  
 
 
Figure 2. Flowchart of patients in the stepped care program 
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Choosing criteria for remission 
Another issue is whether we chose the right criteria for remission. We determined the 
criteria for remission based on the BAI scores of the NESDA cohort. Using the 
criteria for reliable change (Jacobson & Truax 1991b) we calculated the mean between 
the population with the disorder (patients with a panic disorder or generalised anxiety 
disorder) and the healthy population (patients without an anxiety disorder). This 
resulted in a score of 11 on the BAI. We added to this criterion the requirement of a 
50% reduction in score for patients who scored below 22 at baseline. In our analyses 
however, we only kept the criterion of a score of 11 or below to avoid overlap 
between response and remission and it is likely that the care managers placed more 
emphasis on this criterion as well. On the one hand, it is possible that our criteria were 
too strict, as many patients decided to terminate treatment while they did not meet our 
criteria for remission yet. On the other hand, as (subclinical) anxiety symptoms are an 
important predictor of a relapse of the anxiety disorder (Batelaan et al. 2010), it is of 
arguable importance to treat the anxiety disorder until a low level of symptoms has 
been reached. These arguments, together with the agreement between our cut-off 
score and the norm scores based on a population sample (Ferguson 2000), support 
the validity of our criterion. Furthermore, because the use of the BAI to determine 
remission is a fairly simple method and because both care managers and patients 
appreciated the monitoring of symptoms with the BAI (Bouman et al. 2010; van 
Weelden et al. 2010), we conclude that our remission criterion is practical and 
sufficiently valid. 
 
Improving the collaborative stepped care intervention 
Three aspects of the collaborative stepped care intervention deserve special attention 
as they leave room for  improvement: patient adherence, psychiatrist involvement and 
training and supervision of the care managers. Patient adherence may be increased by 
offering patients a choice between different forms of low-intensity treatments (Kwan 
et al. 2010). Furthermore, early evaluation of the treatment plan may prevent 
dissatisfied patients from discontinuing the program. However, as noted earlier, 
personal circumstances probably also prevented patients from engaging in the 
collaborative stepped care program and this kind of problems may not be averted.  
General discussion 
197 
The involvement of the psychiatrists in our study was lower than seen in other 
collaborative care trials. The care managers and GPs stated that they solved most of 
the problems amongst themselves and rarely felt the need for the specialist advice of a 
psychiatrist (Bouwmeester et al. 2010; Bouman et al. 2010). Furthermore, the 
supervision of the care managers by a cognitive behavioural therapist instead of the 
psychiatrist may have hindered the involvement of the psychiatrist with treatment. 
Moreover, in contrast to other collaborative care studies, we used psychiatrists 
working in practice as consulting psychiatrist. The psychiatrists may have been less 
active in approaching the care managers or GPs themselves, because the collaborative 
stepped care study was just a small part of their activities (Ouwerkerk 2010). 
Psychiatrists also thought that their role was to give their expert opinion only when 
there were difficulties in treatment and did not think it was their job (or that it was 
necessary) to monitor the total caseload of the care managers. A web-based tracking 
system, such as used in some collaborative care studies (Roy-Byrne et al. 2010; 
Huijbregts et al. 2012) might enhance contact between the primary care professionals 
and the psychiatrist. Such a system could also be used as an evaluation tool, with a 
shared patient record including charts of symptom scores.  
For care managers without any experience with CBT, the training of two days in CBT 
was short and they had limited confidence in their CBT skills. Conversely, care 
managers who had previously received training in CBT were confident in providing 
CBT because they had easy access to the advice of the supervising cognitive 
behavioural therapists. Extra training for care managers in CBT may thus improve 
quality of treatment. Furthermore, although our intention was that care managers 
attended supervision sessions once every three weeks, this was not feasible in practice. 
It appeared to be difficult to organise supervision sessions for the care managers, as 
they had a small caseload (one to fifteen patients each over the course of the study 
period) and had to attend the supervision sessions outside their working hours. 
Nonetheless, the care managers valued the supervision sessions as informative and 
important for the quality of their work (Bouman et al. 2010). Supervision attendance 
could be increased by offering supervision during working hours and at the office of 
the care manager. Individual supervision sessions by telephone and larger caseloads 
for care managers may also improve the frequency of supervision sessions.  
6 
Chapter  6   
198 
Focus on two anxiety disorders 
We chose to include only patients with panic disorder or generalised anxiety disorder, 
as both disorders are prevalent, disabling and costly, and because there are short-
duration treatments available for both disorders (van Boeijen et al. 2005; Seekles et al. 
2012). Therefore, our results are limited to patients with panic disorder and 
generalised anxiety disorder. To maximise the utility of collaborative stepped care, it 
would be better to include social phobia as well, because this disorder is also prevalent 
and disabling (Barrera & Norton 2009) and may also be adequately treated with 
cognitive behavioural therapy in a collaborative care framework (Roy-Byrne et al. 
2010). However, as only one RCT of a short-duration psychological treatment of  
social phobia in primary care has been identified (Seekles et al. 2012), this kind of 
intervention needs to be studied more thoroughly before incorporating this anxiety 
disorder into a collaborative stepped care program.  
 
Limited information about effectiveness for subgroups and mediating variables 
In this thesis, limited attention was paid to the effectiveness for subgroups of patients. 
It may be interesting to look at differential effects for patients with different types of 
comorbidities, level of education or other demographic or clinical variables. 
Furthermore, information about mediating variables such as coping style may provide 
interesting insights into the working mechanisms of the interventions. Ideally, we 
could create a prognostic model of patient flow through the stepped care program 
resulting in prognostic factors for adherence, response and remission.  
 
Implications for practice 
Implementing collaborative stepped care 
Much effort is needed to implement a complex intervention such as collaborative 
stepped care in primary care which requires different levels of involvement. Especially 
the organisational changes that are necessary for collaborative stepped care, including 
the involvement of a psychiatrist and the supervision of care managers are a challenge 
for current Dutch primary care. Training of professionals and guidance in 
implementing the new approach will be necessary, as research has shown that it is 
extremely difficult to change the habits of busy primary care personnel (Grol et al. 
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2005). This is also confirmed by the findings from our study that simply placing a 
mental health professional in primary care does not automatically lead to a frequent 
use of this professional for anxiety treatment.  
Fortunately, examples of implementation efforts for collaborative (stepped) care are 
available from other countries. One example is the DIAMOND project (Depression 
Improvement Across Minnesota, Offering a New Direction) in Minnesota in the 
United States (Lauren Crain et al. 2012). In this statewide project an independent 
quality improvement organisation supports a collaborative effort of health care payers 
and health care professionals to implement collaborative care for depression 
management in primary care. They provide training and certification, tailored 
implementation support and an online tracking system. Almost 100 medical groups 
and clinics joined the DIAMOND project and researchers aim to evaluate data of 
more than 2000 patients. Another promising initiative is the Increasing Access to 
Psychological Therapies (IAPT) program in the United Kingdom (Richards & Borglin 
2011). The goal of the program is to increase access to psychological therapies using a 
collaborative stepped care approach as a framework to provide care. The IAPT 
program is an initiative from the government that provides services similar to those in 
the DIAMOND project, with a focus on depression and other common mental health 
problems. Two demonstration sites tested the implementation of guidelines and it 
appeared that the site that used a stepped care approach with short-duration therapies 
was able to treat 3 to 4 times more patients than the site that followed a more 
traditional approach of delivering psychological therapies. Outcome data of the 
program were very promising (Richards & Borglin 2011). These two projects show 
that implementing collaborative stepped care is feasible, however, not without a 
considerable effort from the government or health care payers. 
 
Required policies 
An important step towards effective implementation of collaborative stepped care for 
anxiety disorders is the revision of the Dutch guideline for general practitioners, that 
now advises a stepped care approach for anxiety disorders (Hassink-Franke et al. 
2012). However, to facilitate implementation of collaborative stepped care in the 
Netherlands further, several adjustments in the Dutch health care system are required. 
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First of all, the financial resources that are available for the placement of a psychiatric 
nurse, social worker or a psychologist in the primary care practice to support the GP 
in mental health tasks ("praktijkondersteuner huisarts GGZ" (POH-GGZ), from now 
on referred to as psychiatric nurse) are very important for the implementation of 
collaborative care, because this professional may function as a care manager. In 2011 
psychiatric nurses were employed in an estimated 35% of all primary care practices in 
the Netherlands (Landelijke Vereniging Georganiseerde eerste lijn 2011). It is 
important that there are no restrictions placed by health care insurers on the number 
of sessions the psychiatric nurse is allowed to provide. Furthermore, the psychiatric 
nurse needs to be able to attend supervision sessions. In addition, the financial fees 
that patients are obliged to pay for consulting a primary care psychologist or a 
psychiatrist as was commissioned in 2012 need to be abolished, since patients who do 
not sufficiently respond to the collaborative stepped care treatment need to have 
access to the services of those professionals.  
In 2011 the Dutch Health Care Authority (Nederlandse Zorgautoriteit) has written an 
advisory report about reforming primary mental health care (Nederlandse 
Zorgautoriteit 2011). Their advice to expand the function of the psychiatric nurse in 
primary care is a positive development for the implementation of collaborative 
stepped care. Furthermore, the reimbursement of primary care consultations by 
psychiatrists as proposed by the Dutch Health Care Authority would facilitate the 
implementation of psychiatric consultation in collaborative care.  
 
Implementing the use of questionnaires in clinical practice 
The use of questionnaires in primary mental health care is not common practice. This 
may be  caused by the equivocal findings about the additive value of questionnaires 
for the recognition of mental disorders, or by the idea that the existing questionnaires 
are not suitable for primary care (Van Rijswijk et al. 2009). The Four Dimensional 
Symptom Questionnaire was developed specifically for use in primary care practice 
(Terluin et al. 2006) and has been successfully implemented in an estimated third of 
the Dutch primary care practices (Sinnema et al. 2010). An advantage of the 4DSQ is 
that it measures anxiety, depression, distress and somatisation, which are four 
prevalent and frequently comorbid conditions in primary care. However, the 4DSQ 
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might not be very accurate in detecting generalised anxiety disorder (Terluin et al. 
2009) and the ability of the 4DSQ to measure the severity and fluctuations of anxiety 
has yet to be studied. To increase the use of questionnaires in primary care, there are 
several requirements that must be met. First, it must be clear for primary care 
personnel which instrument they should use considering a specific disorder and if it 
may be used for screening or measuring severity (or both). Preferably, there should be 
a limited amount of short and simple questionnaires for the most prevalent disorders. 
Clinical guidelines could be used to advice professionals on which instruments to use, 
where to find them and how to use them. Second, primary care professionals must 
know what the advantages are of using the instrument. Therefore more research is 
needed to assess the practical use of questionnaires i.e. for screening in high risk 
groups, assisting in diagnosis or for monitoring symptoms in primary care patients. A 
different stimulating factor for GPs may be to incorporate the use of questionnaires in 
a quality certificate of the Dutch college of GPs (Nederlands Huisartsen 
Genootschap). The internet may play a role in increasing the accessibility of 
questionnaires (Donker et al. 2011). Lastly, it should be clear that a questionnaire 
cannot replace but only complement the clinical judgement of the GP or another 
health care professional. This is important both for addressing the concerns of GPs 
that questionnaires may replace their clinical judgement (Dowrick et al. 2009) and for 
ensuring the quality of the diagnostic process. The option to financially reward GPs 
for the use of questionnaires, does not seem to be desirable (Dowrick et al. 2009). 
 
Transforming primary mental health care 
Collaborative stepped care as described in this thesis is just one treatment method for 
one class of disorders. In reality, the GP has to cope with many different kinds of 
symptoms, disorders and patients. The diagnosis of mental disorders may be 
particularly difficult because symptoms vary in intensity and are often accompanied by 
other symptoms or problems. Furthermore, patients' demands for help are frequently 
not related to their anxiety problems. Therefore, the GP needs adequate skills and 
resources to recognise, diagnose and treat the patient. It was already suggested that a 
form of standardisation of the diagnosis such as the routine use of the 4DSQ or PHQ 
may help. Furthermore, the GP can be assisted by a psychiatric nurse or psychologist 
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to investigate the nature of the symptoms (with the aid of a questionnaire), the 
demand for help of the patient and the different possibilities for assistance or 
treatment. Ideally, the primary care team  formulates a treatment plan according to the 
severity and duration of the symptoms, the preferences of the patient and the available 
resources. To realise this, the primary care team would need a mental health care 
'toolkit' with preventive interventions for patients with only symptoms, collaborative 
stepped care for those with a disorder and local resources for referral for patients with 
a severe disorder or predominantly social or relational problems. For patients with 
recurrent episodes, diagnosis of a psychologist or psychiatrist may be required 
together with an adequate follow-up on the treatments received, as many patients 
might fall through the cracks of the primary care system. However, such a systematic 
approach to mental health problems in primary care does not yet exist. Pilot projects 
will be necessary to examine the need for and feasibility of such an approach and to 
design pathways for integrated primary mental health care. 
 
Implications for further research 
Research on care models for comorbidity or multimorbidity 
It was already stated that the collaborative stepped care intervention needs to be 
expanded to anxiety disorders other than panic disorder and generalised anxiety 
disorder. Furthermore, more research is needed about integrated care for patients with 
multiple chronic conditions. As stressed in the introduction, the presence of multiple 
chronic conditions, or multimorbidity, is increasingly prevalent in our aging 
populations (van Oostrom et al. 2011). However, for many chronic conditions clinical 
guidelines exist and in our current health care system it is impossible for GPs to 
adhere to all of these guidelines (Ostbye et al. 2005). Consequently, there is an urgent 
need to integrate care for different conditions (Vrijhoef 2010). The chronic care 
model may be used as a framework to reorganise care and to create individualised 
health care plans in which different aspects of health care are described and which are 
regularly updated (Boyd et al. 2010). A care manager may coordinate care for the 
patients, keep contact with the different health care providers involved and make 
decisions together with the patient about goals in treatment. A patient may choose to 
focus on one chronic condition or goal, for instance the anxiety disorder, and actively 
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work on the chosen health problem. For example, Katon and colleagues (2012) 
designed a collaborative care intervention for patients with depression and coronary 
heart disease and/or diabetes mellitus (Katon et al. 2012). In their intervention, the 
patient was assisted by a nurse care manager, who was supervised by different 
specialists and also provided problem solving treatment. Although the intervention 
was not effective in improving the medical parameters important for coronary heart 
disease or diabetes, depression symptoms significantly improved. Similar studies are 
warranted to provide guidelines on how to organise health care for patients with 
comorbidity or multimorbidity. 
 
Other relevant topics 
Other relevant topics for further research have emerged from the discussion of our 
findings. Risk factors for non-response as well as factors that increase the benefits of 
collaborative stepped care need to be identified to improve its effectiveness. Further 
research is also warranted to identify effective strategies to improve recognition and 
increase the number of patients receiving evidence based treatment for anxiety 
disorders. Research aimed at decreasing health care costs is also needed, for example 
by identifying target groups for costs savings. Lasts, research aimed at finding 
opportunities to integrate care for multiple chronic conditions and to define standards 
for integrated primary mental health care is desirable. 
 
Conclusion 
In the introduction it was suggested that collaborative stepped care may be the 
solution to several important problems in primary care: infrequent initiation of 
treatment with evidence based psychological therapies, a low intensity of collaboration 
between health care professionals and the absence of structural monitoring and 
follow-up. Collaborative stepped care did lead to an increased quality of care in all of 
these issues and to improved patient outcomes. However, collaborative stepped care is 
not the solution to all problems encountered in primary care for anxiety disorders. As 
stated above, the effectiveness of collaborative stepped care leaves room for 
improvement and more research is needed about the cost-effectiveness of 
collaborative stepped care for patients with different anxiety disorders and to integrate 
6 
Chapter  6   
204 
care for patients with comorbid conditions. Furthermore, although questionnaires 
may help, diagnosing an anxiety disorder in primary care remains complex. However, 
we may conclude that collaborative stepped care is a valuable intervention that 
improves the quality of primary care for anxiety disorders. Although further research 
is warranted, implementation of collaborative stepped care in daily practice is justified 
as the intervention is highly cost-effective. Substantial efforts are needed to transform 
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Background and objectives of this thesis 
Anxiety disorders are chronically intermittent conditions that are highly prevalent, 
disabling and costly. Patients with anxiety disorders may be adequately treated in 
primary care using a chronic and integrated care perspective. However, there are many 
barriers in primary care for providing continuous, evidence based care for anxiety 
disorders. These barriers consider patient, provider and health care system 
characteristics. A collaborative stepped care model may be an effective and efficient 
method to improve the quality of primary care for patients with anxiety disorders, by 
introducing mental health expertise into primary care, ensuring evidence-based 
treatment, systematic monitoring and follow-up and supporting self-management of 
the patient within a framework of collaboration between professionals. Panic disorder 
and generalised anxiety disorder are target conditions for collaborative stepped care, 
because they are often inadequately treated in primary care while evidence based 
treatments suitable for primary care do exist. In this thesis, the effectiveness of 
collaborative stepped care for panic disorder and generalised anxiety disorder in 
primary care was evaluated. Furthermore, the costs of collaborative stepped care 
relative to its effectiveness and manners to improve recognition and assessment of 
anxiety disorders were examined. 
 
The effectiveness of collaborative care for anxiety disorders in primary care 
In chapter 2 it was investigated whether collaborative care for adult patients with 
anxiety disorders was more effective than usual primary care. A systematic search of 
the literature identified five randomised controlled trials that met the inclusion criteria. 
Four studies originated from the United States and one from Germany. The studies 
included a total of 1931 participants and were of varying methodological quality. The 
included studies provide evidence that collaborative care may be effective for anxiety 
disorders in general and is significantly more effective than care as usual for patients 
with panic disorder. More studies are needed that evaluate the effectiveness of 
collaborative care for anxiety disorders other than panic disorder and that are 
conducted in other countries than the United States. 
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The effectiveness of collaborative stepped care for panic disorder and 
generalised anxiety disorder 
In chapter 3 we described a cluster randomised controlled trial to compare 
collaborative stepped care to usual primary care for patients with panic disorder or 
generalised anxiety disorder. The trial was carried out in 43 primary care practices and 
a total of 180 patients with panic disorder or generalised anxiety disorder were 
enrolled. Patients in the collaborative stepped care group (N=114) received guided 
self-help as a first step, followed by cognitive behavioural therapy (CBT) and 
antidepressants when necessary. Care was provided by a care manager and the general 
practitioner (GP), who both had access to the advice of a psychiatrist. Patients in the 
care as usual group (N=66) received care as usual through their GP. Data were 
collected by means of patient-completed questionnaires at baseline, at 3, 6, 9 and 12 
months. The primary outcome measure was the Beck Anxiety Inventory (BAI). 
Collaborative stepped care was more effective than usual primary care in reducing 
anxiety symptoms at all time points, with the largest difference at 12 months (diff. -
6.84, 95% confidence interval -10.13 to -3.55). The clinical effect of collaborative 
stepped care compared to care as usual was small to moderate. 
 
The cost-utility of collaborative stepped care for panic disorder and generalised 
anxiety disorder 
Alongside the cluster randomised controlled trial we conducted a cost-utility analysis. 
The difference in quality of life gained and health care and productivity costs 
generated in the collaborative stepped care group and care as usual group was 
compared. Collaborative stepped care led to a marginal increase in health care costs of 
€351, but the incremental gains in quality of life (diff. 0.05 QALY) outweighed these 
extra costs. The extra health care costs in the collaborative stepped care group were 
mostly due to contacts with the care manager. Including productivity costs in the 
analysis strengthened the results, as productivity costs were higher in the care as usual 
group. Consequently, collaborative stepped care was more effective and less costly 
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The additive value of questionnaires for screening and assisting in the 
diagnostic process 
In chapter 5 we assessed the added value of the Patient Health Questionnaire (PHQ) 
in the detection and diagnosis of anxiety disorders in two patient groups: 1) patients at 
high risk for (developing) anxiety disorders, 2) patients identified by their GP as 
possibly having an anxiety disorder. In patients at high risk for developing anxiety 
disorders, the use of only two screening questions of the PHQ showed the best 
characteristics. The positive predictive value was 76% and the negative predictive 
value was 88% in these high risk patients. In patients identified by the GP as possibly 
having an anxiety disorder, the full PHQ did adequately predict the presence of an 
anxiety disorder (positive predictive value of 96%), but the ability of the PHQ to filter 
out non-cases (negative predictive value of 38%) was inadequate in these patients. 
These results imply that the PHQ may be used as a screener in high-risk groups, and 
to confirm a preliminary diagnosis of the GP, but not for ruling out the possibility of a 
present anxiety disorder in GP-identified patients. In the second part of chapter 5, we 
examined the ability of the Beck Anxiety Inventory (BAI) to reflect the severity of the 
anxiety in a large cohort of primary patients (NEDSA cohort) with various anxiety 
disorders, depressive disorders and  healthy controls. Primary care patients with an 
anxiety disorder (N=493) had a significantly higher score (Mean (M)=13.9, standard 
deviation (SD)=8.7) than patients without a disorder (N=513; M=4.1; SD=5.1). 
Patients with co-morbid anxiety and depression (N=203; M=21.9, SD=11) scored 
significantly higher than patients with a single disorder, albeit an anxiety disorder (N= 
214; M= 13.9; SD=8.7) or a depressive disorder (N= 109; M=13.3; SD=8.7). Of the 
anxiety disorders, patients with panic disorder and agoraphobia had the highest mean 
score (M=16, SD=11).We concluded that the BAI may be used as a severity indicator 
for anxiety disorders in primary care. 
 
Interpretation of the main findings and comparison with the literature 
In chapter 6 the results of the above described studies are discussed. We found 
collaborative stepped care to be significantly more effective than care as usual. 
Probably the additional elements of collaborative stepped care – structured treatment 
steps based on cognitive behavioural therapy, active monitoring of symptoms and 
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follow-up, supervised care managers working in collaboration with the GP- induced 
this increased effectiveness. The results of our study about the effectiveness of 
collaborative stepped care are generally comparable to studies about collaborative care 
that were conducted in the United States. The effect sizes found in our study were 
somewhat smaller (at least in the early stages of the study), which may be explained by 
the gradual increase in treatment intensity that was part of our stepped care program.  
 
Suboptimal implementation of the collaborative stepped care intervention 
Contrary to our expectations, a significant proportion of patients did either not 
complete step 1 (22%) or did not continue to step 2 while remission was not yet 
achieved (18%). The fact that many patients discontinued treatment after step one 
may be interpreted in different ways. On the one hand, it seems favourable that these 
patients felt adequately equipped to cope with their anxiety after a minimal 
intervention. On the other hand, subclinical anxiety symptoms are an important risk 
factor for relapse of the anxiety disorder. Therefore, active monitoring of patients 
who do not reach complete remission, as was done in our intervention, is essential. 
Furthermore, future research may identify which patients are likely to (not) respond to 
guided self-help. Adherence of patients to the first step in treatment may be improved 
by offering a choice between initial interventions. The performance of professionals 
may be further increased by the implementation of a digital communication and 




A strength of our study was that all professionals who participated in our study were 
recruited in practice settings, which enabled us to estimate the effects of collaborative 
stepped care as implemented in daily practice. A limitation of our study was that we 
had to correct for baseline differences between treatment groups in our analyses. 
These differences may have been caused by the design of our study (cluster 
randomisation). Although individual randomisation carries a risk of contamination of 
the effect (GPs would have to provide treatment to both intervention and control 
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patients) this risk may be more acceptable than the risk of baseline differences in 
cluster randomised trials.  
 
Transforming primary mental health care 
The studies concerning questionnaires show that questionnaires may assist in the 
process of diagnosing anxiety and assessing severity, in conjunct with the clinical 
assessment of a primary care provider. Because mental health problems are divers and 
prevalent in primary care, primary care personnel should ideally be provided with a 
mental health toolkit. This toolkit should support them to provide (preventive) 
intervention to patients with  only symptoms, collaborative stepped care for those 
with a disorder and local resources for referral for patients with a severe disorder or 
predominantly social or relational problems.  
 
Implications for research and practice 
Future research should focus on the effectiveness of collaborative stepped care for 
patients with various anxiety disorders, patients with multiple (medical and mental) 
conditions and targeting interventions for specific patient groups. Furthermore, 
primary care models that integrate physical and mental health care, from prevention to 
chronic care need to be developed and evaluated. Financial and educational resources 
are necessary to facilitate implementation of collaborative stepped care in primary care 
in the Netherlands. 
 
Conclusion 
Collaborative stepped care is a valuable intervention that may improve the quality of 
primary care for anxiety disorders. Although further research is warranted, 
implementation of collaborative stepped care in daily practice is justified as the 
intervention is cost-effective compared to care as usual. Substantial efforts are needed 








Angststoornissen komen veel voor 
Stress, spanning en angstklachten komen veel voor. Er is sprake van een angststoornis 
als iemand zoveel last heeft van de angstklachten dat die hem of haar beperken in het 
dagelijks leven. Ongeveer één op de vijf Nederlanders krijgt eens in zijn leven een 
angststoornis (de Graaf et al. 2010). Vaak houden angstklachten lang aan, of komen in 
periodes terug. Dit is niet alleen nadelig voor de persoon zelf, maar ook voor de 
maatschappij, omdat iemand met een angststoornis zich vaker ziek meldt en meer 
gebruik maakt van zorgvoorzieningen.  
 
De zorg voor mensen met een angststoornis is niet optimaal 
Angststoornissen kunnen in principe goed behandeld worden met gesprekstherapie of 
met medicatie. Volwassenen met angstklachten komen over het algemeen eerst terecht 
bij hun huisarts. Hoewel de huisartspraktijk een goede plek lijkt voor de behandeling 
van angstklachten –laagdrempelige zorg dichtbij huis- blijkt het lastig om in de 
huisartspraktijk mensen met angststoornissen goed te behandelen. Hier zijn 
verschillende redenen voor: huisartsen zijn niet altijd voldoende ervaren in 
gesprekstherapie of hebben hiervoor te weinig tijd, patiënten kunnen bezwaren 
hebben tegen medicatie of tegen een doorverwijzing naar de psycholoog en contacten 
tussen hulpverleners of instellingen zijn niet altijd goed geregeld (van Marwijk 2004; 
Prins et al. 2009; Van Rijswijk et al. 2009; Muntingh et al. 2012).  
 
Leren van de zorg voor chronische ziekten 
Hoewel angststoornissen niet per definitie chronisch verlopen, bestaan de klachten 
vaak langdurig, of komen ze in periodes terug. Daarom is het nodig om de zorg voor 
patiënten met angststoornissen anders in te richten dan voor kortdurende kwalen. 
Voor patiënten met een angststoornis is het belangrijk dat de zorg erop gericht is hen 
zo goed mogelijk zelf om te leren gaan met de klachten (zelfmanagement), dat 
verschillende hulpverleners (zoals huisartsen en psychologen) goed met elkaar 
samenwerken en dat de klachten van de patiënt regelmatig worden geëvalueerd 
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(monitoren). De huidige zorg voor patiënten met een angststoornis ziet er nog niet zo 
uit. We kunnen hierin leren van de zorg voor mensen met  chronische aandoeningen 
als diabetes en hart- en vaatziekten. De zorg voor chronische ziekten wordt 
tegenwoordig zo georganiseerd dat de patiënt een vaste hulpverlener heeft (de 
praktijkondersteuner) die hem of haar ondersteunt in het omgaan met de ziekte in 
samenwerking met de huisarts, waarbij er vaste controlemomenten zijn en goede 
afspraken met andere zorgverleners. Het collaborative care model  is een behandelmodel 
voor psychische stoornissen dat sterk lijkt op het hierboven beschreven model voor 
chronische zorg. In het collaborative care model werken verschillende hulpverleners 
samen (huisarts, verpleegkundige, psychiater), wordt er gewerkt met wetenschappelijk 
onderbouwde behandelingen, en worden de klachten van de patiënt regelmatig 
geëvalueerd (Katon et al. 2010).    
 
Het collaborative care model 
Bij collaborative care wordt de huisarts doorgaans ondersteund door een care manager 
(meestal een sociaal psychiatrisch verpleegkundige (SPV) of psycholoog), die nauw 
samenwerkt met de huisarts. De care manager geeft de patiënt uitleg over de klachten 
en de behandeling, verleent psychologische zorg met behulp van wetenschappelijk 
onderbouwde protocollen en evalueert de voortgang van de behandeling met de 
patiënt. De huisarts en care manager kunnen advies vragen aan een psychiater over de 
patiënt of de behandeling (Figuur 1). Collaborative care heeft goede resultaten geboekt 
bij de behandeling van depressie (Gilbody et al. 2006; Thota et al. 2012), met name in 
de Verenigde Staten, maar ook in Nederland (Huijbregts et al. 2012). Ook voor 
angststoornissen lijkt het collaborative care model veelbelovend (Smolders et al. 2008; 
Roy-Byrne et al. 2010), maar hier is tot nu toe nog weinig onderzoek naar gedaan. 
 
Stepped care en collaborative care 
Om de zorg betaalbaar te houden, is het belangrijk dat mensen de zorg krijgen die zij 
nodig hebben, maar niet meer dan dat. Hier sluit het principe stepped care op aan: 
mensen krijgen eerst een lichte vorm van zorg. Alleen als het nodig is krijgen zij een 
meer intensieve behandeling (Davison 2000). Hoewel dit een logisch en aantrekkelijk 




Figuur 1: Schematische weergave van collaborative care bij angststoornissen  
© Meere & Muntingh, 2009 
 
of goedkoper is dan de huidige huisartsenzorg (Bower & Gilbody 2005). Het 
collaborative stepped care model kan een goede methode zijn om stepped care toe te 
passen: met een care manager die de voortgang goed in de gaten houdt en een psychiater 
op de achtergrond die kan ingrijpen wanneer nodig. 
 
Paniekstoornis en gegeneraliseerde angststoornis  
De paniekstoornis en gegeneraliseerde angststoornis zijn twee typen angststoornissen 
waarvoor collaborative stepped care goed zou kunnen werken. Beide stoornissen 
komen regelmatig voor, mensen hebben vaak gedurende langere tijd of in periodes last 
van de klachten en er zijn kortdurende, wetenschappelijk onderbouwde behandelingen 
beschikbaar voor toepassing in de eerste lijn, die echter onvoldoende worden 
toegepast.  
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Collaborative stepped care voor huisartspatiënten met paniekstoornis en 
gegeneraliseerde angststoornis 
Samengevat kan worden gesteld dat het collaborative stepped care model een 
veelbelovende methode lijkt om de zorg voor patiënten met een paniekstoornis of 
gegeneraliseerde angststoornis te verbeteren. Door het plaatsen van een care manager in 
de huisartspraktijk, die kortdurende behandelingen uitvoert, de klachten van de patiënt 
gedurende langere tijd in de gaten houdt en regelmatig overlegt met de huisarts en 
eventueel de psychiater wordt het zorgsysteem verbeterd wat tot betere 
behandelresultaten moet leiden. Echter, de effectiviteit van een dergelijk collaborative 
stepped care model bij paniekstoornis en gegeneraliseerde angststoornis is nog niet 
onderzocht. Daarom komen in dit proefschrift de volgende vraagstellingen aan de 
orde: 
• Wat is de effectiviteit van collaborative care voor angststoornissen wereldwijd? 
(Hoofdstuk 2) 
• Wat is de effectiviteit van collaborative stepped care bij patiënten met een 
paniekstoornis of gegeneraliseerde angststoornis in de huisartspraktijk ten 
opzichte van de gebruikelijke zorg? (Hoofdstuk 3)  
• Hoe verhouden de kosten en baten van collaborative stepped care zich met die van 
de gebruikelijke zorg? (Hoofdstuk 4) 
• Hoe kunnen vragenlijsten bijdragen aan het herkennen van een angststoornis 
door de huisarts en het vaststellen van de ernst van angstklachten in de eerste 
lijn? (Hoofdstuk 5) 
 
Systematische literatuurstudie naar gerandomiseerd onderzoek over 
collaborative care voor angststoornissen 
In hoofdstuk 2 werd het wetenschappelijke bewijs voor de effectiviteit van 
collaborative care bij angststoornissen onderzocht. In wetenschappelijke databases 
werd gezocht naar artikelen die de resultaten beschreven van gerandomiseerde, 
gecontroleerde studies die een collaborative care behandeling vergeleken met een 
andere behandeling voor angststoornissen in de huisartspraktijk. Er werden vijf 
studies gevonden die aan deze criteria voldeden, met in totaal 1931 deelnemende 
patiënten. Vier studies waren uitgevoerd in de Verenigde Staten en één in Duitsland. 
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Alle studies vergeleken collaborative care met gebruikelijke huisartsenzorg. De 
resultaten van de vijf studies werden statistisch samengevat in een meta-analyse. 
Hieruit bleek dat de collaborative care interventies effectiever waren dan de 
gebruikelijke zorg, zeker voor patiënten met een paniekstoornis. Er werd 
geconcludeerd dat collaborative care waarschijnlijk een effectieve interventie is voor  
angststoornissen in de eerste lijn, maar dat er nog meer studies nodig zijn van buiten 
de Verenigde Staten en die betrekking hebben op andere angststoornissen dan de 
paniekstoornis. 
 
Een Nederlands onderzoek naar de effectiviteit van collaborative stepped care 
bij angststoornissen 
Opzet onderzoek 
Hoofdstuk 3 beschrijft de opzet en resultaten van een Nederlands onderzoek naar de 
effectiviteit van collaborative stepped care bij angststoornissen. Aan dit cluster-
gerandomiseerde, gecontroleerde onderzoek namen 43 huisartspraktijken en 31 
praktijkondersteuners geestelijke gezondheidszorg (POHs-GGZ) deel. De POHs-
GGZ waren allen verbonden aan één of twee huisartspraktijken. De POHs-GGZ 
werden via loting ingedeeld in één van twee groepen: de collaborative stepped care 
groep (16 POHs-GGZ) of de gebruikelijke zorg groep (15 POHs-GGZ). De POHs-
GGZ  en de huisartsen die in de collaborative stepped care groep werden ingedeeld, 
werden getraind in de collaborative stepped care interventie. Deze getrainde POHs-
GGZ vervulden de functie van care manager. Er waren zes psychiaters beschikbaar 
die advies konden verlenen aan de care managers en de huisartsen in de collaborative 
stepped care groep.  
 
Inhoud collaborative stepped care interventie 
De collaborative stepped care interventie bestond uit drie stappen: 1) Begeleide 
zelfhulp, 2) Cognitieve gedragstherapie, 3) Medicatie (Figuur 2). De begeleide zelfhulp 
bestond uit een zelfhulpboek met begeleiding in vijf korte consulten door de care 
manager. Er stond informatie in het boek over angstklachten en er stonden 
oefeningen in uit de cognitieve gedragstherapie, zoals het leren herkennen van 
angstige gedachten en het opzoeken van moeilijke situaties (van Boeijen 2007). Stap 2 
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bestond uit zes sessies cognitieve gedragstherapie, gegeven door de care manager op 
basis van een protocol. In stap 3, medicatie, werden antidepressiva voorgeschreven 
door de huisarts op basis van wetenschappelijke richtlijnen. Het effect van de 
behandeling werd na elke stap geëvalueerd met behulp van een angstvragenlijst (de 
Beck Anxiety Inventory (BAI) (Beck et al. 1988)) door de care manager. Het doel was 
hierbij om een "normale" angstscore (herstel) te bereiken. Als een patiënt niet 
herstelde, werd de volgende stap ingezet. Was een patiënt wel hersteld, dan werd hij 
na de behandeling nog een aantal keer opgebeld door de care manager, om terugval in 
de klachten te voorkomen.  
 
Inhoud gebruikelijke zorg 
De gebruikelijke zorg verliep via de huisartsen in de gebruikelijke zorg groep. Deze 
huisartsen hadden alle opties tot hun beschikking die zij normaal gesproken ook 
hebben, zoals het zelf voeren van een aantal gesprekken, medicatie voorschrijven of 
verwijzen naar een eerstelijnspsycholoog of een GGZ instelling. Daarnaast konden zij 
patiënten verwijzen naar de POH-GGZ (die niet aanvullend getraind was). 
 
Werven van deelnemers en analyses 
Huisartsen uit beide groepen konden patiënten met een vermoedelijke angststoornis 
aanmelden voor het onderzoek. Daarnaast werden er patiënten geselecteerd uit het 
elektronisch dossier van de deelnemende huisartsen op basis van risicofactoren voor 
angststoornissen. Alle patiënten die aan de onderzoekscriteria voldeden en wilden 
meewerken aan het onderzoek kregen een diagnostisch interview om vast te stellen of 
er sprake was van een paniekstoornis of een gegeneraliseerde angststoornis. 
Uiteindelijk werden er 180 patiënten geworven voor het onderzoek: 114 in de 
collaborative stepped care groep en 66 in de gebruikelijke zorg groep. Deze mensen 
werden 12 maanden lang gevolgd en zij vulden in totaal vijf keer een vragenlijst in (om 
de drie maanden). Met behulp van deze vragenlijst werden onder andere de 
angstklachten en het zorggebruik gemeten. Statistische analyses (multilevel regressie 






*Herstel: score op BAI vragenlijst is ≤ 11. BAI=Beck Anxiety Inventory. CM=care manager. 
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Resultaten 
Zowel bij de patiënten in de collaborative stepped care groep als bij de patiënten in de 
gebruikelijke zorg groep namen de angstklachten af bij de vervolgmetingen (zie Figuur 
3). Bij de collaborative stepped care groep was deze daling significant sterker dan in de 
gebruikelijke zorg groep. Daarom werd er geconcludeerd dat collaborative stepped 
care een effectieve methode is om patiënten met een paniekstoornis of 
gegeneraliseerde angststoornis te behandelen in de huisartspraktijk. 
 
  
Figuur 3. Het verloop van de angstklachten (BAI score) gedurende een jaar in de collaborative 
stepped care groep en de gebruikelijke zorg groep. 
 
Kosten-effectiviteit van collaborative stepped care 
In een aparte analyse (hoofdstuk 4) werden de kosten en baten van de collaborative 
stepped care behandeling afgezet tegen de kosten en baten van de gebruikelijke zorg. 
De gemiddelde zorgkosten werden berekend per patiënt en ook de kosten die werden 
gemaakt door ziekteverzuim of door verminderde productiviteit werden meegenomen. 
De baten werden uitgedrukt als de toegenomen kwaliteit van leven bij de patiënten 
over een jaar gemeten. Uit deze analyse bleek dat de zorgkosten voor patiënten die de 
collaborative stepped care behandeling kregen gemiddeld €351,- hoger waren dan 
voor patiënten die de gebruikelijke zorg kregen. Echter, de kwaliteit van leven van 
Samenvatting 
225 
patiënten die de collaborative stepped care behandeling kregen nam ook sterker toe 
(verschil van 0,05 QALY). De kosten voor ziekteverzuim en verminderde 
productiviteit waren gemiddeld €955,- lager in de collaborative stepped care groep dan 
in de gebruikelijke zorg groep. Dit betekent dat de collaborative stepped care 
behandeling kosten-effectief is ten opzichte van de gebruikelijke zorg voor patiënten 
met een paniekstoornis of gegeneraliseerde angststoornis. 
 
Bijdrage van vragenlijsten aan het herkennen en vaststellen van de ernst van 
angstklachten in de eerste lijn 
In hoofdstuk 5 worden twee studies beschreven over vragenlijsten. In de eerste studie 
werd onderzocht of een screeningsvragenlijst (de angstschaal van de Patient Health 
Questionnaire, PHQ) waarde toevoegt bij het herkennen angststoornissen bij twee 
patiëntgroepen: 1) huisartspatiënten die een hoog risico hebben op een angststoornis 
(hoog-risico patiënten) en 2) patiënten bij wie de huisarts het vermoeden heeft op een 
angststoornis (patiënten met een vermoedelijke angststoornis). Er namen 170 hoog-
risico patiënten en 141 patiënten met een vermoedelijke angststoornis deel aan het 
onderzoek. Zij vulden de PHQ in en kregen een telefonisch diagnostisch interview om 
een angststoornis vast te stellen. Het bleek dat bij de hoog-risico patiënten het gebruik 
van twee screeningsvragen van de PHQ een betere voorspelling gaf dan het gebruik 
van de volledige PHQ. De conclusie was dat de PHQ goed gebruikt kan worden om 
angststoornissen op te sporen bij hoog-risico groepen en om een vermoedelijke 
angststoornis te bevestigen, maar dat de PHQ niet gebruikt mag worden om het 
bestaan van een angststoornis uit te sluiten bij patiënten bij wie de huisarts een 
angststoornis vermoedt. In de tweede studie uit hoofdstuk 5 werd onderzocht of de 
Beck Anxiety Inventory (een korte angstvragenlijst) de ernst van de angst kon meten 
bij patiënten met verschillende typen angststoornissen. Er werd gebruik gemaakt van 
data van 1601 huisartspatiënten die deelnamen aan het NESDA onderzoek (the 
Netherlands Study of Depression and Anxiety). Dit cohort van huisartspatiënten 
bestaat uit patiënten zonder angststoornis of depressie (N=984) en patiënten met een 
angststoornis en/of een depressie (N=617). Bij alle patiënten werd een diagnostisch 
interview en de Beck Anxiety Inventory (BAI) afgenomen. De gemiddelde score op de 
BAI van verschillende groepen patiënten werd vergeleken: patiënten zonder 
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angststoornis of depressie, patiënten met één angststoornis (paniekstoornis, sociale 
fobie, gegeneraliseerde angststoornis of agorafobie), patiënten met meerdere 
angststoornissen, patiënten met een depressie en patiënten met een angststoornis en 
een depressie. De patiënten met een angststoornis scoorden gemiddeld hoger dan 
patiënten zonder een angststoornis of depressie, waarbij de patiënten met een 
paniekstoornis met agorafobie het hoogst scoorden. Patiënten met meerdere 
angststoornissen scoorden weer hoger dan patiënten met één angststoornis. 
Opvallend was dat er geen verschil werd gevonden in gemiddelde score tussen 
patiënten met een depressie en patiënten met een angststoornis. Er werd 
geconcludeerd dat de BAI goed gebruikt kan worden om de ernst van de angst te 
meten bij huisartspatiënten met verschillende typen angststoornissen, maar dat de 
score op de BAI geen onderscheid maakt tussen een angststoornis of een depressie. 
 
Discussie 
In de discussie (Hoofdstuk 6) worden de resultaten van de verschillende studies en de 
aanbevelingen voor praktijk, beleid en onderzoek besproken.  
 
De kosten- effectiviteit van collaborative stepped care 
Uit Hoofdstuk 3 bleek dat collaborative stepped care een effectieve behandeling is 
ten opzichte van de gebruikelijke zorg. De toegevoegde elementen van collaborative 
stepped care – gestructureerde behandelstappen gebaseerd op cognitieve gedrags-
therapie, het actief monitoren van klachten en terugvalpreventie, care managers die 
supervisie kregen en samenwerkten met de huisarts –hebben waarschijnlijk 
bijgedragen aan deze hogere effectiviteit. Dit resultaat komt redelijk overeen met de 
resultaten van Amerikaans onderzoek naar de effectiviteit van collaborative care (Roy-
Byrne et al. 2001; Roy-Byrne et al. 2005; Rollman et al. 2005; Roy-Byrne et al. 2010). De 
Amerikaanse studies vonden echter een groter effect van de collaborative care 
behandeling dan wij in onze studie gedurende de eerste 9 maanden. Een belangrijke 
verklaring hiervoor lijkt te zijn dat onze stepped care behandeling in het begin minder 
intensief was dan de combinatie van medicijnen en cognitieve gedragstherapie die 
meestal werd ingezet in de Amerikaanse studies. In vergelijking met een Nederlandse 
stepped care studie (Seekles et al. 2011) vonden wij juist een groter effect, wat 
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verklaard zou kunnen worden door de grotere rol van de care manager en de 
samenwerking met de huisarts en psychiater in ons onderzoek. De hogere zorgkosten 
van de collaborative stepped care behandeling vergeleken met de gebruikelijke zorg 
werden voor het grootste deel verklaard door de inzet van de care manager. De extra 
zorgkosten van de collaboratie stepped care interventie werden echter op andere 
gebieden (gezondheid en arbeidsproductiviteit) "terugverdiend". 
 
Sterke en zwakke punten van het onderzoek 
Een sterk punt van het effectonderzoek (hoofdstuk 3) is dat de behandeling werd 
uitgevoerd door professionals die in de praktijk werken, waardoor de resultaten de 
dagelijkse praktijk goed benaderen. Daarnaast werden er statistische analyses gebruikt 
die geschikt zijn voor het analyseren van groepen (multilevel analyse). Er zijn ook een 
aantal beperkingen van het onderzoek te noemen. Wij hebben in dit onderzoek 
gekozen voor cluster randomisatie: POHs-GGZ en hun huisartspraktijken werden 
ingedeeld in een interventie- en een controlegroep. Dit is gedaan om de interventies 
strikt gescheiden te houden: de zorgverleners in de interventiegroep gaven de 
collaborative stepped care interventie en de hulpverleners in de controlegroep 
verleenden de gebruikelijke zorg. Echter, het probleem ontstond dat huisartsen in de 
interventiegroep meer patiënten aanmeldden voor de studie dan de huisartsen in de 
controlegroep. Huisartsen in de controlegroep waren wellicht minder gemotiveerd om 
patiënten aan te melden voor de studie omdat zij hun patiënten niets "nieuws" konden 
bieden. Daarentegen hadden huisartsen in de interventiegroep wellicht een verhoogde 
aandacht voor patiënten met angststoornissen door het werken met de nieuwe 
methode. Behalve dat er meer patiënten deelnamen aan de interventiegroep bleken er 
ook inhoudelijk verschillen te bestaan tussen patiënten in de interventie- en 
controlegroep bij de start van het onderzoek (baselinemeting). Voor deze verschillen 
is gecorrigeerd in de analyses. Echter, voor vervolgonderzoek is het wellicht beter om 
de patiënten in plaats van de hulpverleners random toe te wijzen aan een interventie.  
 
Verbeteren van de collaborative stepped care interventie 
Hoewel de collaborative stepped care interventie goed resultaat had, werkte het niet 
voor alle patiënten even goed. Een deel van de patiënten maakte ofwel de eerste stap 
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van de behandeling (begeleide zelfhulp) niet af (22%) of ging niet door met de tweede 
stap terwijl ze nog niet volledig hersteld waren van de angststoornis (18%). Dat veel 
mensen van verdere behandeling afzagen na stap 1 kan worden gezien als een goed 
resultaat: veel mensen gaven aan voldoende handvatten te hebben om verder te 
kunnen. Echter, uit onderzoek weten we dat onvolledig  herstel een hoger risico geeft 
op terugval in de angstklachten. Het is daarom belangrijk om de deze patiënten goed 
in de gaten te blijven houden en een andere interventie aan te bieden wanneer nodig. 
De betrokkenheid van patiënten bij de behandeling zou verder verhoogd kunnen 
worden door hen een keuze tussen behandelingen aan te bieden in plaats van een vast 
behandelprogramma. Vervolgonderzoek zou inzicht kunnen geven in welke patiënten 
voldoende baat hebben bij begeleide zelfhulp en welke niet. Een andere mogelijke 
verbetering is het gebruik van een digitaal communicatie systeem inclusief gedeeld 
patiëntendossier om de samenwerking tussen professionals (en daarmee de kwaliteit 
van zorg) nog verder te verhogen. 
 
Gebruik van vragenlijsten voor het opsporen van angststoornissen en het 
vaststellen van de ernst van de angst 
Voor het aanbieden van collaborative stepped care is het eerst nodig dat er een 
diagnose van een paniekstoornis of gegeneraliseerde angststoornis wordt gesteld. 
Daarom is in hoofdstuk 5 onderzocht of vragenlijsten een goede toevoeging kunnen 
zijn aan het diagnostisch proces in de huisartspraktijk. Het gebruik van vragenlijsten 
wordt aanbevolen, maar altijd als onderdeel van een gesprek met de patiënt. Er 
moeten nog strategieën worden gevonden die ervoor zorgen dat huisartsen die het 
lastig vinden om angststoornissen op te sporen hierbij te ondersteunen. Selectieve 
screening van hoog-risicopatiënten kan hierbij een optie zijn, maar alleen als de 
huisartspraktijk beschikking heeft over laagdrempelige behandelingen, zoals begeleide 
zelfhulp of internetinterventies. 
 
Aanbevelingen voor onderzoek 
Het is belangrijk om te onderzoeken of collaborative stepped care ook kosten-effectief 
is voor patiënten met andere angststoornissen, zoals sociale fobie. Daarnaast moet er 
onderzocht worden hoe de zorg voor patiënten die meerdere aandoeningen 
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tegelijkertijd hebben (co- of multimorbiditeit) het beste ingericht kan worden. 
Uiteindelijk is er een geïntegreerd pakket nodig aan interventies, tools (zoals 
vragenlijsten) en samenwerkingsverbanden die huisartsen kunnen gebruiken om de 
vraag naar hulp bij psychische klachten goed op te kunnen vangen.  
 
Aanbevelingen voor praktijk en beleid 
Collaborative stepped care zal niet vanzelf zijn weg vinden naar de huisartspraktijk. 
Hier is niet alleen scholing van huisartsen en care managers voor nodig, maar ook 
financiële en praktische ondersteuning. Een belangrijke stap in de goede richting is dat 
de praktijkondersteuner huisarts GGZ (POH-GGZ) een grotere rol krijgt in de 
eerstelijnszorg omdat deze professional de rol van care manager op zich kan nemen. 
Daarnaast zou het goed zijn als psychiaters en andere professionals op basis van een 
consulttarief advies konden bieden aan eerstelijns hulpverleners en als er geld 
beschikbaar komt voor de implementatie van collaborative stepped care. 
 
Conclusie 
Collaborative stepped care is een veelbelovende, kosten-effectieve interventie voor de 
behandeling van angststoornissen in de huisartspraktijk. Vervolgonderzoek is 
wenselijk, maar op basis van dit proefschrift kan gesteld worden dat collaborative 















Beck, A. T., Epstein, N., Brown, G. & Steer, R. A. (1988). An inventory for measuring clinical 
anxiety: psychometric properties. J Consult Clin Psychol 56, 893-897. 
Bower, P. & Gilbody, S. (2005). Stepped care in psychological therapies: access, effectiveness and 
efficiency. Narrative literature review. Br J Psychiatry 186, 11-17. 
Davison, G. C. (2000). Stepped care: doing more with less? Journal of Clinical Psychology 68, 580-585. 
de Graaf, R., ten Have, M., & van Dorsselaer, S. (2010). De psychische gezondheid van de 
Nederlandse bevolking. NEMESIS-2: Opzet en eerste resultaten [Mental health in the Dutch 
general population. Design and results of the Netherlands Mental Health Survey and Incidence 
Study-2 (NEMESIS-2) In Dutch.]. 
Gilbody, S., Bower, P., Fletcher, J., Richards, D. & Sutton, A. J. (2006). Collaborative care for 
depression: a cumulative meta-analysis and review of longer-term outcomes. Arch Intern.Med 166, 
2314-2321. 
Huijbregts, K. M., de Jong, F. J., van Marwijk, H. W., Beekman, A. T., Ader, H. J., 
Hakkaart-van, R. L., Unutzer, J. & van der Feltz-Cornelis CM (2012). A target-driven 
collaborative care model for Major Depressive Disorder is effective in primary care in the 
Netherlands. A randomized clinical trial from the depression initiative. J Affect Disord. 
Katon, W., Unutzer, J., Wells, K. & Jones, L. (2010). Collaborative depression care: history, 
evolution and ways to enhance dissemination and sustainability. Gen.Hosp.Psychiatry 32, 456-464. 
 Muntingh, A. D. T., Hermens, M., Franx, G., Van Splunteren, P., & Nuyen, J. (2012). Hoe 
verhouden de werkelijke en wenselijke eerstelijns depressiezorg zich tot elkaar? Resultaten van 
een verkennend onderzoek in de huisartspraktijk.Trendrapportage GGZ. Deel 3: Kwaliteit en effectiviteit. 
(ed. J. Nuyen). Trimbos-instituut: Utrecht. 
Prins, M. A., Verhaak, P. F., Van der Meer, K., Penninx, B. W. & Bensing, J. M. (2009). 
Primary care patients with anxiety and depression: need for care from the patient's perspective. J 
Affect Disord 119, 163-171. 
Rollman, B. L., Belnap, B. H., Mazumdar, S., Houck, P. R., Zhu, F., Gardner, W., 
Reynolds, C. F., III, Schulberg, H. C. & Shear, M. K. (2005). A randomized trial to improve 
the quality of treatment for panic and generalized anxiety disorders in primary care. Arch Gen 
Psychiatry 62, 1332-1341. 
Roy-Byrne, P., Craske, M. G., Sullivan, G., Rose, R. D., Edlund, M. J., Lang, A. J., 
Bystritsky, A., Welch, S. S., Chavira, D. A., Golinelli, D., Campbell-Sills, L., Sherbourne, 
C. D. & Stein, M. B. (2010). Delivery of evidence-based treatment for multiple anxiety disorders 
in primary care: a randomized controlled trial. Journal of the American Medical Association 303, 1921-
1928. 
Roy-Byrne, P. P., Craske, M. G., Stein, M. B., Sullivan, G., Bystritsky, A., Katon, W., 
Golinelli, D. & Sherbourne, C. D. (2005). A randomized effectiveness trial of cognitive-
behavioral therapy and medication for primary care panic disorder. Arch Gen Psychiatry 62, 290-
298. 
Roy-Byrne, P. P., Katon, W., Cowley, D. S. & Russo, J. (2001). A randomized effectiveness trial 




Seekles, W., van Straten, A., Beekman, A., van Marwijk, H. & Cuijpers, P. (2011). Stepped 
care treatment for depression and anxiety in primary care. a randomized controlled trial. Trials 12, 
171. 
Smolders, M., Laurant, M., Roberge, P., Van Balkom, A., Van Rijswijk, E., Bower, P. & 
Grol, R. (2008). Knowledge transfer and improvement of primary and ambulatory care for 
patients with anxiety. Can J Psychiatry 53, 277-293. 
Thota, A. B., Sipe, T. A., Byard, G. J., Zometa, C. S., Hahn, R. A., McKnight-Eily, L. R., 
Chapman, D. P., Abraido-Lanza, A. F., Pearson, J. L., Anderson, C. W., Gelenberg, A. J., 
Hennessy, K. D., Duffy, F. F., Vernon-Smiley, M. E., Nease, D. E., Jr. & Williams, S. P. 
(2012). Collaborative care to improve the management of depressive disorders: a community 
guide systematic review and meta-analysis. Am J Prev Med 42, 525-538. 
van Boeijen, C. A. Handboek Begeleide Zelfhulp: Overwinnen van angstklachten (Handbook guided 
self help: Overcoming anxiety).  2007. Apeldoorn.  
van Marwijk, H. (2004). How to improve mental health competency in general practice training?--
a SWOT analysis. Eur J Gen Pract 10, 61-65. 
Van Rijswijk, E., van Hout, H., van de Lisdonk, E., Zitman, F. & Van Weel C. (2009). 
Barriers in recognising, diagnosing and managing depressive and anxiety disorders as experienced 
by Family Physicians; a focus group study. BMC Fam Pract 10, 52. 
& 




Ja, eindelijk, het dankwoord! Wat heerlijk dat het resultaat van ruim vier jaar werk hier 
nu ligt en dat ik daar mensen voor mag bedanken. 
Na afronding van mijn studie in 2008 maakte ik de afweging: eerst praktijk of eerst 
wetenschap. Het is het laatste geworden. Ik kan me mijn sollicitatiegesprek voor deze 
AIO-positie met Christina, Harm en Ton nog aardig goed herinneren. Zij merkten 
terecht bij mij de aarzeling op of ik wel geschikt was voor onderzoekswerk: het kan 
behoorlijk solistisch werk zijn. Gelukkig ben ik aangenomen en ben ik de uitdaging 
aan gegaan. De combinatie van logistieke werkzaamheden, analyseren, schrijven en het 
Trimbos-instituut als werkplek hebben ervoor gezorgd dat ik het promotie-traject als 
leerzaam en leuk heb ervaren. 
Eén van de leukste dingen vond ik het uitwisselen van gedachten over onderzoek en 
zorg met hoogleraren, zorgverleners, patiënten en experts. Daarom keek ik ook altijd 
uit naar de overleggen met de onderzoeksgroep, vaak op de kamer van Ton van 
Balkom op de AJ Ernststraat. Deze overleggen waren mijn eerste kennismaking met 
de onderzoeksgroep van Christina, Ton en Harm, met wat meer op afstand Philip 
Spinhoven en Herman Adèr als statisticus. Als ik binnenkwam zat Ton daar al met een 
stuk of drie stapeltjes papier voor zich, zeer goed voorbereid op de vergadering. 
Vervolgens kwam Harm binnen, wat gehaast en met beslagen bril, waarna hij wat 
opgevouwen velletjes papier uit zijn jas toverde. Christina ten slotte, opende de 
vergadering met een "Zo, wat leuk om jullie weer te zien!", of "Ik heb vreselijke 
honger…!". Christina, Ton, Harm, Philip en Herman, graag wil ik jullie allemaal 
bedanken voor jullie bijdrage aan het tot stand komen van dit proefschrift. 
Beste Christina, ik heb jou leren kennen als iemand die altijd positief is en zich 
volledig inzet. Je laat je niet gauw kisten, je staat voor wat je doet en laat dat ook zien. 
Dat heb ik zeer bewonderd in de afgelopen jaren. Soms kwam ik uit een overleg met 
jou alsof ik in een wervelwind had gezeten: punten aftikken en artikelen doorspreken 
gingen als een trein door jouw snelle denkniveau. Geweldig dat je hoogleraar bent 
geworden en hoe jij alle ballen op het werk (Tilburg, Breburg, Trimbos) in de lucht 
houdt naast een gezinsleven. In onze samenwerking moest je me soms wat afremmen, 
omdat ik veel dingen wilde en leuk vond, maar je hebt me ook de ruimte gegeven die 
ik nodig had om me te ontwikkelen, met deelname aan het TOP-programma en reizen 
naar het buitenland.  
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Beste Ton, het was (en is) heel prettig met jou samenwerken, omdat je altijd de tijd 
nam om mijn werk te bekijken, waarbij je met opbouwende feedback kwam en ook de 
relevantie voor de praktijk goed in het oog hield. Je bent goed gehumeurd, staat open 
voor andermans ideeën en bent pragmatisch in je oplossingen. Ik ben heel blij dat je 
mij de mogelijkheid hebt gegeven om wetenschap en praktijk te combineren bij GGZ 
inGeest en dat we nu nauwer met elkaar samenwerken. 
Beste Harm, het lukte mij bijna nooit om als eerste te vragen hoe het met jou ging, 
omdat je me altijd voor was. Jouw vrolijke en praktische houding heeft mij gesteund in 
het werk. Je was altijd bereid om te helpen en pende dan behoorlijk wat zinnen in een 
stuk, met een begeleidende e-mail met "mooi werk!" aan het einde. Maar ook voor het 
geven van trainingen of adviezen over de eerstelijnszorg vanuit het oogpunt van de 
huisarts, stond je klaar. 
Beste Philip, jij volgde de onderzoeksgroep wat meer op afstand, maar je commentaar 
op de artikelen was altijd snel, relevant en to the point.  
Beste Herman, vaak hebben wij zitten puzzelen op de ingewikkelde statistische 
modellen die nodig waren voor het onderzoek. Je nam de tijd om mijn vragen te 
beantwoorden en in discussie te gaan als we het ergens niet over eens waren. Heel leuk 
om te merken dat we hier altijd goed uitkwamen en uiteindelijk helemaal niet zo van 
mening bleken te verschillen. 
Leden van de leescommissie, heel hartelijk dank voor het kritisch lezen en beoordelen 
van mijn proefschrift. 
Natuurlijk wil ik iedereen bedanken die heeft deelgenomen aan het onderzoek: alle 
huisartsen, verpleegkundigen, psychologen, psychiaters en huisartspatiënten. Heel erg 
bedankt voor het aanmelden van deelnemers voor het onderzoek, het bijwonen van 
trainingen en supervisiebijeenkomsten en het invullen van vragenlijsten. Ik heb het 
contact en de supervisiebijeenkomsten met alle care managers die de interventie 
uitvoerden erg gewaardeerd. Henriëtte, Yvonne, Guido, Rob, Jaap, Marijke, Ans 
Zikkenheimer, Monique, Aart en in het bijzonder Ans van Vliet, Onno, Nardy en 
Ellen, heel hartelijk dank voor jullie inzet en enthousiasme. Door jullie (en door de 
contacten met patiënten) ging het onderzoek voor mij 'leven'. Huisartsen Berend 
Terluin en Martijn Daniels, hartelijk dank dat ik bij jullie in de praktijk mee mocht 
draaien als "POH-GGZ" en zo zelf de interventies uit het onderzoek leerde 
toepassen. Bert en Hans-Jaap bedankt voor de inzet van jullie kennis over cognitieve 
gedragstherapie in training en supervisie. Ik kan niet alle huisartsen, psychiaters en 
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patiënten bij naam noemen, maar jullie ook allemaal bedankt voor jullie inzet. Zonder 
jullie had dit proefschrift hier niet gelegen. 
GGZ-instelling Rivierduinen, en in het bijzonder Sandra Schuiten, heeft zich sterk 
ingezet voor het goede verloop van dit onderzoek. Het was erg prettig met je 
samenwerken Sandra! Daarnaast wil ik Margot de Waal en Pim Assendelft zeer 
bedanken voor hun betrokkenheid en ondersteuning vanuit het LUMC. Jullie inzet bij 
het werven van huisartsen via het huisartsennetwerk LEids Onderzoeks Netwerk 
(LEON) heeft gezorgd voor een soepele start van het onderzoek en jullie blijvende 
betrokkenheid is zeer gewaardeerd. Christine, jij ontwikkelde de zelfhulpmethode die 
werd gebruikt in dit onderzoek. Bedankt voor je aanstekelijke enthousiasme bij het 
geven van trainingen en bieden van supervisie! Maartje en Leona, veel dank voor jullie 
inzet bij het analyseren van de kosten-data en het schrijven van het kosten-
effectiviteits artikel. Het was leuk en leerzaam om met jullie samen te werken en het 
was heel fijn dat jullie bereid waren een tandje erbij te zetten als er ineens weer een 
deadline was! ZonMW wil ik graag bedanken voor het toekennen van subsidie voor 
dit onderzoek. 
Het Trimbos-instituut was een geweldige werkplek voor mij tijdens mijn onderzoek. 
Het is een organisatie met gedreven, slimme, enthousiaste en vrolijke mensen. Met 
veel van jullie heb ik samengewerkt, zeker toen ik naast mijn promotie-traject ook 
andere projecten ben gaan oppakken. Helaas kan ik ook jullie niet allemaal bij naam 
noemen. Jan Walburg, jou wil ik als eerste bedanken, omdat je veel deuren voor mij 
hebt geopend. Ik stapte in het Talent-Ontwikkelings-Programma, waardoor ik behalve 
de kwaliteiten die je als AIO nodig hebt ook mijn andere talenten kon ontdekken en 
ontwikkelen. Je hebt meteen veel vertrouwen in mij gesteld en zette mijn eigen 
ontwikkeling voorop. Daar ben ik je erg dankbaar voor en ik leer nog steeds veel van 
onze gesprekken. Door de organisatie van de Kennisdag De Eerste Lijn in 2012 en 
deelname aan de stakeholdergroep over de eerste lijn, leerde ik steeds meer over de 
organisatie van zorg in deze sector en breidde mijn netwerk flink uit. Met TOP deden 
we hippe plekken in Amsterdam aan zoals de Hub voor onze "Doe-tank", gingen we 
in groepen aan de slag met kort-cyclische trajecten en waren wij even de pioniers van 
het Trimbos-instituut. Alle mede-TOPpers Peggy, Lotte, Debbie, Dieneke, Caroline, 
Iris, Kirsten en Brigitte heel erg bedankt voor de inspirerende tijd die we samen 
hebben gehad en nog steeds hebben.  
Alle members van The Institute (de Trimbos-band) wil ik graag bedanken voor de 
oefensessies en optredens tijdens personeelsfeesten, let's Come Together some time! 
En ook de borrels bij de Yuppenclub hebben bijgedragen aan mijn werkplezier.  
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Kamergenootjes Lianne, Ina en Annelies het was fijn om promotie-perikelen met jullie 
te delen en gezellig te kletsen.  
Collega's van Diagnostiek & Behandeling Moniek, Daniëlle, Daphne, Eric, Klaas, 
Siska, Kirsten, Henny, David, Jasper, Corinne, Lianne, Dorine, heel erg bedankt voor 
mijn leuke tijd bij D&B. Wandelingen, etentjes, kruis-bestuivings-overleggen, het was 
inspirerend om onderdeel van zo'n jong en enthousiast team te zijn. Klaas, Siska, 
Kirsten en Moniek, wat was het fijn dat jullie al een eind verder waren in het 
promotie-traject over collaborative care en dat ik voor advies bij jullie kon 
aankloppen. Dat heeft een hoop "gerommel" gescheeld en een hoop 
kennisuitwisseling over collaborative care opgeleverd! Henny, dank voor jouw niet 
aflatende enthousiasme, je luisterende oor bij lastige kwesties en het gezamenlijk 
optrekken bij eerstelijnsprojecten. 
Joske, heel erg bedankt voor jouw toewijding aan het afnemen van interviews bij 
patiënten. Eric, Tessa & Tessa, Maaike & Ottelien, Paul, Berdien en nu ook nog 
Rhodé, jullie hebben je stuk voor stuk ingezet voor je Masters thesis wat weer een 
bijdrage heeft geleverd aan dit proefschrift. Het was ontzettend leuk met jullie te 
werken. 
Jan Spijker, Matthijs, Gerdien, Peter, Jasper, Marleen, Filip, Yvonne, jullie zijn fijne 
collega's om mee te werken en om van te leren!   
Graag wil ik ook alle deelnemers aan de Baltimore studie-reis bedanken. Het was voor 
mij heel leerzaam om met een club van professionals, onderzoekers, verzekeraars en 
organisatie-adviseurs op reis te zijn en de Nederlandse eerstelijnszorg in het 
perspectief van "managed care" te plaatsen. Met dank aan de Travel Grant van het 
EMGO+ en het Trimbos-instituut.  
Many thanks to Tracy Novak and Chad Boult who arranged a warm welcome and 
many interesting activities about Guided Care in Baltimore. Dr. Jürgen Unützer, Dr. 
Wayne Katon, Julie Cooper and Diane Powers, thank you for the opportunity to 
participate in the collaborative care course in New York and to experience how 
collaborative care is organised at the Washington University in Seattle, which was a 
great pleasure to me.  
Collega's bij GGZ inGeest, dank voor jullie interesse in de afronding van mijn 
proefschrift en bedankt voor alle promotie-tips! Neeltje en Ton, geweldig dat ik in de 
eerste weken van mijn nieuwe baan bij jullie de ruimte kreeg om mijn proefschrift af te 
ronden. Annemieke en Carla, dank voor jullie hulp bij de logistieke zaken.  
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Marjolein en Jeroen, dank voor het mooie omslagontwerp en de lay-out! 
Paranimfen Daniëlle en Moniek, super bedankt voor jullie steun en voor de 
gezelligheid. Met zijn drieën op één kamer bij de IJmuiden dagen, lunchrondjes en nu 
gaat het shoppen er ook weer eens van komen! Jullie snoeppot en betrokkenheid 
zorgde ervoor dat ik vaak even stoom kon afblazen of met een nieuw idee verder kon 
gaan. Bedankt ook voor het meelezen in de laatste fase. Nooit gedacht dat mijn 
paranimfen twee (bijna) mama's zouden zijn! 
Lieve Marijn, Manon, Valérie, dank voor jullie interesse in mijn werk en bezigheden, 
voor de gezellige doordeweekse etentjes, weekendjes naar Spanje, Portugal of België, 
ik hoop dat we nog heel lang zo doorgaan. Lieve vrienden, vriendinnen en familie, fijn 
dat jullie er allemaal zijn! 
Lieve Maarten, Nettie, Sanne & Laurens, jullie waren altijd geïnteresseerd in mijn 
vorderingen. Laurens, jij ploegde je met jouw financiële achtergrond door mijn 
designartikel en ik ga graag nog eens met je in discussie over de rest van dit 
proefschrift.   
Lieve broer, het ziet er naar uit dat ik onze wedstrijd gewonnen heb, maar jouw 
tweede Masters titel zit er ook snel aan te komen! Geweldig hoe jij je baan combineert 
met een tweede studie en het verbouwen van een huis.  
Lieve papa en mama, mijn leergierigheid en interesse in mensen heb ik niet van 
vreemden. Van jongs af aan hebben jullie mij gestimuleerd me te ontwikkelen en 
vooral de dingen te doen die ik leuk vond.  Jullie staan altijd voor me klaar, zijn 
geïnteresseerd en trots op wat ik doe. Dank jullie wel! 
Lieve Robert, jij bent mijn rots in de branding. Jij kreeg het meeste mee van het hele 
proces, wat vaak heel goed ging, maar soms ook doorbijten was. Zeker aan het einde 
heb jij mij gemotiveerd nog even door te pakken en maakte je zelfs een planning voor 
me waar ik me aan kon houden. Met jouw ambitie heb je mij ook een beetje 
aangestoken. Maar het meest geniet ik van onze tijd samen, onze wandelingen, reizen, 
lekker koken of uit eten. Wat fijn dat we na de verdediging samen een prachtige reis 
door Argentinië gaan maken, daar kijk ik erg naar uit. 
Tot slot wil ik iedereen die op enige wijze heeft bijgedragen aan dit proefschrift heel 
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